细胞株Cell Lines 27-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心
- 价 格：¥19200
- 货 号：Cell Line CV27
- 产 地：北京
- BioVector NTCC典型培养物保藏中心
- 联系人：Dr.Xu, Biovector NTCC Inc.
电话：400-800-2947 工作QQ:1843439339 (微信同号)
邮件：Biovector@163.com
手机：18901268599
地址：北京
- 已注册
细胞株Cell Lines
BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心
Email:biovector@163.com
ID HBEC6-KT
AC CVCL_ER01
SY HBEC6KT
DR GEO; GSM794412
CC Transfected with: HGNC; 11730; TERT.
CC Transfected with: MGI; MGI:88357; Cdk4.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Telomerase immortalized cell line
//
ID HBEC7-KT
AC CVCL_ER02
SY HBEC7KT; HBEC7kt
DR GEO; GSM794413
CC Transfected with: HGNC; 11730; TERT.
CC Transfected with: MGI; MGI:88357; Cdk4.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Telomerase immortalized cell line
//
ID HBF
AC CVCL_1G89
SY Horabagrus Brachysoma Fin
RX PubMed=25359669;
WW http://mail.nbfgr.res.in/nrfc/celldetail.php?id=8
CC Group: Fish cell line.
CC Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC008.
OX NCBI_TaxID=337739; ! Horabagrus brachysoma
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID HBF/TERT88
AC CVCL_9Q52
WW http://www.evercyte.com/hbf-tert88-81.html
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Telomerase immortalized cell line
//
ID HBL
AC CVCL_J075
DR Cosmic; 2051678
RX PubMed=2174414;
WW http://www.gentaur.com/melanoma_hbl_lnd1.htm
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HBL-1 [Human AIDS-related non-Hodgkin lymphoma]
AC CVCL_M572
DR Cosmic; 1086334
DR Cosmic; 1515192
DR PRIDE; PXD000589
RX PubMed=8412324;
RX PubMed=25894527;
CC Omics: Cell surface proteome.
DI NCIt; C5051; AIDS-related non-Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HBL-1 [Human diffuse large B-cell lymphoma]
AC CVCL_4213
SY HBL1
DR BTO; BTO:0002522
DR Cosmic; 1486586
DR Cosmic; 1487545
DR Cosmic; 1517652
DR Cosmic; 2129634
DR Cosmic; 2437308
DR GEO; GSM1059804
DR GEO; GSM1374489
DR GEO; GSM1890017
DR GEO; GSM1890018
DR GEO; GSM1890019
DR GEO; GSM1890020
DR GEO; GSM2037050
DR GEO; GSM2037051
RX PubMed=3338018;
RX PubMed=15028022;
CC Characteristics: Has lost chromosome Y.
CC Doubling time: ~48 hours (PubMed=3338018).
CC Omics: Transcriptome analysis.
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HBL-10
AC CVCL_4214
DR BTO; BTO:0002531
RX PubMed=15028022;
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HBL-100
AC CVCL_4362
SY HBL 100; HBL100
DR BTO; BTO:0004734
DR CLO; CLO_0003626
DR EFO; EFO_0001167
DR CLDB; cl1571
DR ATCC; HTB-124
DR BioSample; SAMN03152011
DR BioSample; SAMN03471101
DR BioSample; SAMN03472914
DR CCRID; 3111C0001CCC000374
DR CCRID; 3131C0001000200010
DR ChEMBL-Cells; CHEMBL3307713
DR ChEMBL-Targets; CHEMBL614811
DR CLS; 300178/p775_HBL-100
DR Cosmic; 687471
DR Cosmic; 877447
DR Cosmic; 934533
DR Cosmic; 979722
DR Cosmic; 991323
DR Cosmic; 1010933
DR Cosmic; 1136364
DR Cosmic; 1176632
DR Cosmic; 1434949
DR Cosmic; 1524348
DR Cosmic; 1609469
DR RCB; RCB0460
DR TOKU-E; 3589
RX CelloPub=CLPUB00368;
RX PubMed=2547730;
RX PubMed=2995096;
RX PubMed=6500159;
RX PubMed=6891286;
RX PubMed=9671407;
RX PubMed=12661003;
RX PubMed=16643607;
RX PubMed=17157791;
RX PubMed=20143388;
RX PubMed=25485619;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-297.html
WW http://www.atcc.org/Products/Cells_and_Microorganisms/Cell_Lines/Misidentified_Cell_Lines.aspx
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
WW http://www.rccc.cytspb.rssi.ru/ecellbank/human/hHBL-100.htm
CC Problematic cell line: Misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (PubMed=16643607, PubMed=20143388). Originally thought to originate from a casein-producing breast cell line. In addition contains SV40 genomic sequence while the cell line was deemed to be spontaneously immortalized.
CC Characteristics: Contains two copies of the SV40 genome, one complete the other incomplete tandemly integrated in the cell line genome.
CC Doubling time: 1.5 days (PubMed=9671407).
CC Microsatellite instability: Stable (MSS) (PubMed=12661003).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Discontinued: ATCC; HTB-124; true.
CC Discontinued: RCB; RCB0460; true.
ST Source(s): ATCC; CLS; PubMed=25877200
ST Amelogenin: X,Y (ATCC; CLS; PubMed=11416159)
ST Amelogenin: X (PubMed=25877200)
ST CSF1PO: 10
ST D13S317: 12
ST D16S539: 9,12
ST D18S51: 16
ST D19S433: 15
ST D21S11: 28,30
ST D2S1338: 18,24
ST D3S1358: 14,16
ST D5S818: 11,12
ST D7S820: 8,12
ST D8S1179: 12,15
ST FGA: 25
ST Penta D: 12
ST Penta E: 7
ST TH01: 6,8
ST TPOX: 8
ST vWA: 16
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID HBL-11
AC CVCL_4215
DR BTO; BTO:0002533
RX PubMed=15028022;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HBL-2 [Human AIDS-related non-Hodgkin lymphoma]
AC CVCL_M574
DR Cosmic; 1086335
DR Cosmic; 1515193
DR GEO; GSM115801
RX PubMed=8412324;
DI NCIt; C5051; AIDS-related non-Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HBL-2 [Human B-cell lymphoma]
AC CVCL_M573
RX PubMed=3899542;
DI NCIt; C3457; B-cell non-Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HBL-2 [Human mantle cell lymphoma]
AC CVCL_4216
SY HBL2
DR BTO; BTO:0002523
DR Cosmic; 1047112
DR Cosmic; 2296990
RX PubMed=3338018;
RX PubMed=15028022;
RX PubMed=16183118;
RX PubMed=16960149;
CC Characteristics: Has lost chromosome Y.
CC Doubling time: 36 hours (PubMed=3338018).
DI NCIt; C4337; Mantle cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HBL-3 [Human AIDS-related non-Hodgkin lymphoma]
AC CVCL_M575
DR Cosmic; 1086336
DR Cosmic; 1515194
RX PubMed=8412324;
DI NCIt; C5051; AIDS-related non-Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HBL-3 [Human leukemia]
AC CVCL_4217
DR BTO; BTO:0002534
RX PubMed=1977232;
RX PubMed=2486608;
RX PubMed=15028022;
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HBL-4
AC CVCL_4218
DR BTO; BTO:0002526
DR Cosmic; 1515195
RX PubMed=1309680;
RX PubMed=9454894;
RX PubMed=15028022;
CC Characteristics: EBV-negative.
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HBL-5
AC CVCL_4219
DR BTO; BTO:0002527
RX PubMed=1309680;
RX PubMed=2486609;
RX PubMed=9454894;
RX PubMed=12967475;
RX PubMed=15028022;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HBL-52
AC CVCL_4220
SY HBL 52
DR BTO; BTO:0004430
DR CLS; 300188/p692_HBL-52
ST Source(s): CLS
ST Amelogenin: X
ST CSF1PO: 10,13
ST D13S317: 11,12
ST D16S539: 11,13
ST D18S51: 15,16
ST D21S11: 30,31
ST D3S1358: 15
ST D5S818: 12,13
ST D7S820: 10,11
ST D8S1179: 13
ST FGA: 23,26
ST Penta D: 9,10
ST Penta E: 11,12
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 16,20
DI NCIt; C3230; Meningioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HBL-6
AC CVCL_4221
SY HBL6
DR BTO; BTO:0002723
DR Cosmic; 1515189
RX PubMed=15028022;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=HBL-6
DI NCIt; C6915; Primary effusion lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HBL-7
AC CVCL_4222
DR BTO; BTO:0002528
RX PubMed=8905871;
RX PubMed=15028022;
CC Characteristics: EBV-negative.
CC Doubling time: ~84 hours (PubMed=8905871).
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HBL-8
AC CVCL_4223
DR BTO; BTO:0002529
RX PubMed=8905871;
RX PubMed=15028022;
CC Characteristics: EBV-negative.
CC Doubling time: ~58 hours (PubMed=8905871).
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HBL-9
AC CVCL_4224
DR BTO; BTO:0002530
RX PubMed=15028022;
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HBME-1
AC CVCL_U718
SY Human Bone Marrow Epithelial-1
DR ATCC; CRL-2767
RX PubMed=9450571;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Discontinued: ATCC; CRL-2767; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID HBMEC-2
AC CVCL_AT91
DR ATCC; CRL-3023
CC Problematic cell line: Probably contaminated. The STR profile is identical to that of the T24 cell line.
CC Discontinued: ATCC; CRL-3023; probable.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 9
ST D5S818: 10
ST D7S820: 10,11
ST TH01: 6
ST TPOX: 8,11
ST vWA: 17
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0554 ! T24
SX Female
CA Cancer cell line
//
ID HBMEC-3
AC CVCL_AT92
DR ATCC; CRL-3024
CC Discontinued: ATCC; CRL-3024; probable.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 9,12
ST D16S539: 9,11
ST D5S818: 9,13
ST D7S820: 9,11
ST TH01: 6
ST TPOX: 8,11
ST vWA: 15,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Undefined cell line type
//
ID HBMEC-4
AC CVCL_AT93
DR ATCC; CRL-3025
CC Discontinued: ATCC; CRL-3025; probable.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 9,11
ST D16S539: 11,12
ST D5S818: 11,13
ST D7S820: 9,10
ST TH01: 7
ST TPOX: 9,11
ST vWA: 15,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Undefined cell line type
//
ID HBMEC/cibeta
AC CVCL_4U95
SY HBMEC/cib; Human BMEC/conditionally immortalized, clone beta
RX PubMed=23041702;
RX PubMed=25763180;
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Conditionally immortalized cell line
//
ID HBMF-SPH
AC CVCL_9V44
DR NCBI_Iran; C171
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID hBRIE 380
AC CVCL_GZ57
SY hybrid Berkeley Rat Intestinal Epithelial clone 380
RX PubMed=1711225;
RX PubMed=7943338;
RX PubMed=9487140;
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Breed/subspecies: Sprague-Dawley.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_GZ56 ! BRIE 291
CA Hybrid cell line
//
ID hBRIE 380i
AC CVCL_GZ58
RX PubMed=7943338;
RX PubMed=9487140;
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Breed/subspecies: Sprague-Dawley.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_GZ57 ! hBRIE 380
CA Hybrid cell line
//
ID hBRIE 380i-neg
AC CVCL_GZ59
DR TOKU-E; 4034
RX PubMed=9487140;
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Breed/subspecies: Sprague-Dawley.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_GZ57 ! hBRIE 380
CA Hybrid cell line
//
ID HBs128
AC CVCL_8534
DR JCRB; JCRB1381
CC Monoclonal antibody target: Hepatitis B surface antigen.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID HBs320
AC CVCL_8535
DR JCRB; JCRB1380
CC Monoclonal antibody target: Hepatitis B surface antigen.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID hBSM
AC CVCL_9T95
SY human Bladder wall Smooth Muscle
RX PubMed=22259013;
CC Doubling time: ~72 hours (PubMed=22259013).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Spontaneously immortalized cell line
//
ID HBT-3
AC CVCL_D281
SY HBT3
DR BioSample; SAMN03151699
RX CelloPub=CLPUB00262;
RX DOI=10.1007/978-1-4757-1647-4_13;
RX PubMed=1246601;
RX PubMed=4344270;
RX PubMed=4469665;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=1246601, PubMed=4469665, PubMed=20143388). Originally thought to originate from a breast carcinoma.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HBT-39b
AC CVCL_J652
SY HBT-39B; HBT39B; HBT39b; HBT-39; HT-39
DR BioSample; SAMN03151700
RX CelloPub=CLPUB00262;
RX DOI=10.1007/978-1-4757-1647-4_13;
RX PubMed=884688;
RX PubMed=1000504;
RX PubMed=1000506;
RX PubMed=1246601;
RX PubMed=4122211;
RX PubMed=4469665;
RX PubMed=6451928;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=884688, PubMed=1246601, PubMed=4469665, PubMed=6451928, PubMed=20143388). Originally thought to originate from a breast carcinoma.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HBT-E
AC CVCL_M746
SY HBTE; 16c
DR BioSample; SAMN03151701
RX PubMed=1246601;
RX PubMed=4469665;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Parent cell line (HBT-3) has been shown to be a HeLa derivative (PubMed=1246601, PubMed=4469665, PubMed=20143388).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D281 ! HBT-3
SX Female
CA Cancer cell line
//
ID HBZY-1
AC CVCL_7213
SY HBZY 1; HBZY1
DR CCRID; 3111C0001CCC000375
DR CCRID; 3142C0001000000124
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Undefined cell line type
//
ID HC-04
AC CVCL_Z631
SY HC04; HCO4
DR ATCC; PTA-3441
RX Patent=US7015036;
RX PubMed=16687667;
RX PubMed=22990793;
RX PubMed=24532842;
WW http://www.mr4.org/MR4ReagentsSearch/hybridomaCellLines/MRA-975.aspx
CC Problematic cell line: Probably contaminated. Indicated (PubMed=24532842) to have a near genetic identity with Hep-G2 cells. But they are functionally different from Hep-G2 cells since they support sporozoite invasion and liver stage exoerythrocytic development of Plasmodium falciparum and Plasmodium vivax.
CC Registration: BEI Resources Repository, Malaria Research and Reference Reagent Resource Center; MRA-975.
CC Omics: Deep proteome analysis.
CC Discontinued: ATCC; PTA-3441; true.
DI NCIt; C3728; Hepatoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0027 ! Hep-G2
SX Male
CA Cancer cell line
//
ID HC-1
AC CVCL_1243
SY HC1
DR CLO; CLO_0003627
DR BioSample; SAMN03473346
DR ChEMBL-Cells; CHEMBL3308522
DR ChEMBL-Targets; CHEMBL2366299
DR Cosmic; 907044
DR Cosmic; 1809512
DR Cosmic-CLP; 907044
DR DSMZ; ACC-301
DR GDSC; 907044
DR GEO; GSM1669840
RX PubMed=1851909;
RX PubMed=22653958;
RX PubMed=27397505;
CC Problematic cell line: Possibly misidentified. It is not certain that this cell line originate from a hairy cell leukemia (PubMed=22653958).
CC Doubling time: ~45 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP; DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11,12
ST D16S539: 10,11
ST D5S818: 11,12
ST D7S820: 10,12
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 15,18
DI NCIt; C7402; Hairy cell leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HC-2
AC CVCL_X173
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=2914273;
DI NCIt; C6064; Maxillary sinus squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_X211 ! HC-3
OI CVCL_X212 ! HC-4
OI CVCL_X213 ! HC-7
OI CVCL_X214 ! HC-9
SX Female
CA Cancer cell line
//
ID HC-3
AC CVCL_X211
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=2914273;
DI NCIt; C6064; Maxillary sinus squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_X173 ! HC-2
OI CVCL_X212 ! HC-4
OI CVCL_X213 ! HC-7
OI CVCL_X214 ! HC-9
SX Female
CA Cancer cell line
//
ID HC-4
AC CVCL_X212
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=2914273;
DI NCIt; C6064; Maxillary sinus squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_X173 ! HC-2
OI CVCL_X211 ! HC-3
OI CVCL_X213 ! HC-7
OI CVCL_X214 ! HC-9
SX Female
CA Cancer cell line
//
ID HC-7
AC CVCL_X213
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=2914273;
DI NCIt; C6064; Maxillary sinus squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_X173 ! HC-2
OI CVCL_X211 ! HC-3
OI CVCL_X212 ! HC-4
OI CVCL_X214 ! HC-9
SX Female
CA Cancer cell line
//
ID HC-7-5
AC CVCL_X215
RX PubMed=2914273;
DI NCIt; C6064; Maxillary sinus squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_X213 ! HC-7
SX Female
CA Cancer cell line
//
ID HC-7-5/VCR
AC CVCL_X216
RX PubMed=2568984;
RX PubMed=2914273;
CC Selected for resistance to: ChEBI; CHEBI:28445; Vincristine (VCR).
DI NCIt; C6064; Maxillary sinus squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_X215 ! HC-7-5
SX Female
CA Cancer cell line
//
ID HC-9
AC CVCL_X214
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=2914273;
DI NCIt; C6064; Maxillary sinus squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_X173 ! HC-2
OI CVCL_X211 ! HC-3
OI CVCL_X212 ! HC-4
OI CVCL_X213 ! HC-7
SX Female
CA Cancer cell line
//
ID HC-AFW1
AC CVCL_M172
SY HCAFW1
DR GEO; GSE29283
RX PubMed=22666492;
RX PubMed=26310804;
CC Doubling time: 40 hours (PubMed=22666492).
CC Omics: CNV analysis.
DI NCIt; C7955; Childhood hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HC030101,F.G.
AC CVCL_6G69
SY HC030101
DR IMGT/HLA; 12648
RX PubMed=11782282;
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID HC11
AC CVCL_0288
SY HC-11; HC11 Mammary Epithelium
DR BTO; BTO:0003892
DR EFO; EFO_0006414
DR MCCL; MCC:0000178
DR ATCC; CRL-3062
DR DSMZ; ACC-780
DR Lonza; 967
RX PubMed=3416834;
RX PubMed=19523745;
WW http://faculty.sites.uci.edu/xdai/files/2014/03/HC11-Culture-KW-BG.pdf
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-143.html
CC Doubling time: ~50-80 hours (DSMZ).
CC Transfected with: UniProtKB; P00557; E.coli hygromycin-B 4-O-kinase (hph).
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_5731 ! COMMA-D
SX Female
CA Spontaneously immortalized cell line
//
ID HC11-BC20
AC CVCL_5G41
SY BC20
RX PubMed=10198285;
CC Transfected with: UniProtKB; P00557; E.coli hygromycin-B 4-O-kinase (hph).
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0288 ! HC11
SX Female
CA Spontaneously immortalized cell line
//
ID HC11-BC44
AC CVCL_5G42
SY BC44
RX PubMed=10198285;
CC Transfected with: UniProtKB; P00557; E.coli hygromycin-B 4-O-kinase (hph).
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0288 ! HC11
SX Female
CA Spontaneously immortalized cell line
//
ID HC11-C24
AC CVCL_0R13
DR BTO; BTO:0004015
RX PubMed=18767115;
CC Transfected with: UniProtKB; P00557; E.coli hygromycin-B 4-O-kinase (hph).
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0288 ! HC11
SX Female
CA Spontaneously immortalized cell line
//
ID HC11-C4
AC CVCL_0R14
RX PubMed=18767115;
CC Transfected with: UniProtKB; P00557; E.coli hygromycin-B 4-O-kinase (hph).
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0288 ! HC11
SX Female
CA Spontaneously immortalized cell line
//
ID HC2S2
AC CVCL_6A80
RX PubMed=8643664;
RX PubMed=9634594;
CC Transfected with: UniProtKB; P01110; Avian myelocytomatosis virus MC29 v-Myc.
CC Transformant: v-Myc.
CC Breed/subspecies: Fischer.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Conditionally immortalized cell line
//
ID HC2SPEx
AC CVCL_1G90
WW http://mail.nbfgr.res.in/nrfc/celldetail.php?id=38
CC Group: Fish cell line.
CC Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC038.
OX NCBI_TaxID=215346; ! Epinephelus merra
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID HC45
AC CVCL_S962
RX PubMed=18247165;
CC Transformant: Ad5-SV40 (AD-SVR4).
DI NCIt; C6422; Midgut carcinoid tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID HC49
AC CVCL_S963
RX PubMed=18247165;
CC Transformant: Ad5-SV40 (AD-SVR4).
DI NCIt; C6423; Hindgut carcinoid tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID Hca-F
AC CVCL_D015
SY HcaF; HCa/16A3-F
DR BTO; BTO:0003642
RX CelloPub=CLPUB00046;
RX PubMed=15633228;
RX PubMed=19562801;
CC Omics: Mitochondrial genome sequenced (partial).
CC Omics: Proteome analysis by 2D-DE/MS.
DI NCIt; C38756; Hepatocellular carcinoma of the mouse
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_H613 ! H22
CA Cancer cell line
//
ID Hca-P
AC CVCL_D016
SY HcaP; Hca/A2-P
RX CelloPub=CLPUB00046;
RX PubMed=15633228;
RX PubMed=19562801;
CC Omics: Mitochondrial genome sequenced (partial).
CC Omics: Proteome analysis by 2D-DE/MS.
DI NCIt; C38756; Hepatocellular carcinoma of the mouse
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_H613 ! H22
CA Cancer cell line
//
ID HCA1
AC CVCL_2916
SY HCA-1
DR BioSample; SAMN03470914
DR BioSample; SAMN03472467
DR JCRB; JCRB1153
DR JCRB; NIHS0406
CC Discontinued: JCRB; NIHS0406; true.
ST Source(s): JCRB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 11
ST D18S51: 15
ST D19S433: 14
ST D21S11: 32.2
ST D2S1338: 24
ST D3S1358: 17
ST D5S818: 11
ST D7S820: 10,11
ST D8S1179: 11,14
ST FGA: 23
ST Penta D: 10
ST Penta E: 18,21
ST TH01: 7
ST TPOX: 8,11
ST vWA: 18
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCA2
AC CVCL_2056
SY HCA-2
DR ECACC; 06061901
DR Ximbio; 152461
RX PubMed=3718830;
DI NCIt; C43584; Rectosigmoid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCA24
AC CVCL_2467
SY HCA-24
DR ECACC; 06061903
DR GEO; GSM1448109
DR Ximbio; 152462
RX PubMed=3718830;
RX PubMed=25926053;
CC Microsatellite instability: Stable (MSS) (PubMed=25926053).
CC Omics: Transcriptome analysis.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCA46
AC CVCL_2468
SY HCA-46
DR Cosmic; 876708
DR Cosmic; 948844
DR Cosmic; 986013
DR Cosmic; 995411
DR Cosmic; 1043812
DR Cosmic; 1223139
DR Cosmic; 1312300
DR Cosmic; 2301975
DR ECACC; 07031601
DR GEO; GSM1346836
DR GEO; GSM1374490
DR GEO; GSM1448177
DR Ximbio; 152463
RX PubMed=3718830;
RX PubMed=10737795;
RX PubMed=20606684;
RX PubMed=24755471;
RX PubMed=25926053;
CC Microsatellite instability: Stable (MSS) (PubMed=25926053).
CC Omics: Transcriptome analysis.
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 10,11
ST D16S539: 11,13
ST D5S818: 11,12
ST D7S820: 10,14
ST TH01: 6,9.3
ST TPOX: 8,9
ST vWA: 17
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCA7
AC CVCL_0289
SY HCA-7
DR BTO; BTO:0003031
DR EFO; EFO_0006415
DR MCCL; MCC:0000179
DR BioSample; SAMN03471988
DR Cosmic; 876722
DR Cosmic; 948860
DR Cosmic; 985995
DR Cosmic; 995407
DR Cosmic; 1043813
DR Cosmic; 1223140
DR Cosmic; 1312301
DR Cosmic; 1479629
DR Cosmic; 1486131
DR Cosmic; 1805252
DR Cosmic; 1933017
DR Cosmic; 2301976
DR ECACC; 06061902
DR GEO; GSM741260
DR GEO; GSM1346872
DR GEO; GSM1374491
DR GEO; GSM1374492
DR GEO; GSM1448125
DR Lonza; 641
DR Ximbio; 152451
RX PubMed=3718830;
RX PubMed=4016751;
RX PubMed=8410493;
RX PubMed=10737795;
RX PubMed=11226274;
RX PubMed=20606684;
RX PubMed=24755471;
RX PubMed=25485619;
RX PubMed=25926053;
WW http://www.pawefish.path.cam.ac.uk/ColonCellLineDescriptions/HCA7.html
WW http://www.addexbio.com/productdetail?pid=40
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-584.html
CC Part of: KuDOS 95 cell line panel.
CC Microsatellite instability: Instable (MSI) (PubMed=25926053).
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ECACC; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,14
ST D13S317: 9
ST D16S539: 10,11 (ECACC)
ST D16S539: 11 (PubMed=25877200)
ST D18S51: 19
ST D21S11: 26,28.2
ST D3S1358: 15,19
ST D5S818: 8,12
ST D7S820: 11,12
ST D8S1179: 12,14
ST FGA: 18.2,22
ST Penta D: 9
ST Penta E: 12,18
ST TH01: 6,7
ST TPOX: 8,10
ST vWA: 14,16
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCA7 colony 1
AC CVCL_2469
SY HCA-7 Colony 1; HCA-7 Colony1; Colony-1; Col-1; Col 1
DR BTO; BTO:0003258
DR ECACC; 09071501
DR Ximbio; 152452
RX PubMed=8410493;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0289 ! HCA7
SX Female
CA Cancer cell line
//
ID HCA7 colony 11
AC CVCL_2470
SY HCA-7 Colony 11; HCA-7 Colony11; Col-11; Col 11
DR ECACC; 09071506
DR Ximbio; 152455
RX PubMed=8410493;
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 11,14
ST D13S317: 9
ST D16S539: 10,12
ST D5S818: 9,12
ST D7S820: 11,12
ST TH01: 6,7
ST TPOX: 8,10
ST vWA: 14,16
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0289 ! HCA7
SX Female
CA Cancer cell line
//
ID HCA7 colony 24
AC CVCL_2471
SY HCA-7 Colony 24; Colony-24; Col-24; Col 24
DR BTO; BTO:0003259
DR ECACC; 09071509
DR Ximbio; 152456
RX PubMed=8410493;
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 11,14
ST D13S317: 9
ST D16S539: 10,11
ST D5S818: 8,12
ST D7S820: 11,12
ST TH01: 6,7
ST TPOX: 8,10
ST vWA: 14,16
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0289 ! HCA7
SX Female
CA Cancer cell line
//
ID HCA7 colony 26
AC CVCL_2472
SY HCA-7 Colony 26; HCA-7 Colony26; Col 26
DR ECACC; 09071511
DR Ximbio; 152457
RX PubMed=8410493;
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 11,14
ST D13S317: 9
ST D16S539: 10,11
ST D5S818: 8,12
ST D7S820: 11,12
ST TH01: 6,7
ST TPOX: 8,10
ST vWA: 14,16
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0289 ! HCA7
SX Female
CA Cancer cell line
//
ID HCA7 colony 27
AC CVCL_2473
SY HCA-7 Colony 27; HCA-7 Colony27; Col 27
DR ECACC; 09071513
DR Ximbio; 152458
RX PubMed=8410493;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0289 ! HCA7
SX Female
CA Cancer cell line
//
ID HCA7 colony 29
AC CVCL_2474
SY HCA-7 Colony 29; HCA-7 Colony29; Col 29
DR ECACC; 02091238
DR Ximbio; 152459
RX PubMed=8410493;
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 11,14
ST D13S317: 9
ST D16S539: 10,11
ST D5S818: 8,12
ST D7S820: 11,12
ST TH01: 6,7
ST TPOX: 8,10
ST vWA: 14,16
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0289 ! HCA7
SX Female
CA Cancer cell line
//
ID HCA7 colony 3
AC CVCL_2475
SY HCA-7 Colony 3; HCA-7 Colony3; Col 3
DR ECACC; 09071502
DR Ximbio; 152453
RX PubMed=8410493;
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 11,14
ST D13S317: 9
ST D16S539: 10,11
ST D5S818: 9,12
ST D7S820: 11,12
ST TH01: 6,7
ST TPOX: 8,10
ST vWA: 14,16
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0289 ! HCA7
SX Female
CA Cancer cell line
//
ID HCA7 colony 30
AC CVCL_2476
SY HCA-7 Colony 30; HCA-7 Colony30; Col 30
DR ECACC; 09071516
DR Ximbio; 152460
RX PubMed=8410493;
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 11,15
ST D13S317: 9
ST D16S539: 10,11
ST D5S818: 10,12
ST D7S820: 11,12
ST TH01: 6,7
ST TPOX: 8,10
ST vWA: 14,16
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0289 ! HCA7
SX Female
CA Cancer cell line
//
ID HCA7 colony 6
AC CVCL_2477
SY HCA-7 Colony 6; HCA-7 Colony6; Colony-6; Col-6; Col 6
DR BTO; BTO:0003260
DR ECACC; 09071504
DR Ximbio; 152454
RX PubMed=8410493;
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 11,14
ST D13S317: 9
ST D16S539: 10,11
ST D5S818: 8,12
ST D7S820: 11,12
ST TH01: 6,7
ST TPOX: 8,10
ST vWA: 14,16
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0289 ! HCA7
SX Female
CA Cancer cell line
//
ID HCB1-SV40
AC CVCL_6256
RX PubMed=14767565;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=HCB1-SV40
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID HCC-1.1
AC CVCL_0C52
SY HCC1.1; 3SP; 3sp
DR Cosmic; 1628381
DR Cosmic; 2162522
RX PubMed=18594539;
RX PubMed=21364009;
RX PubMed=23887712;
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0C42 ! BLC-1
OI CVCL_0C53 ! HCC-1.2
OI CVCL_0C47 ! MF-1
SX Male
CA Cancer cell line
//
ID HCC-1.2
AC CVCL_0C53
SY HCC1.2; 1.2; 3P; 3p
DR Cosmic; 1628382
DR Cosmic; 2162520
DR Cosmic; 2162521
RX PubMed=18594539;
RX PubMed=21364009;
RX PubMed=23887712;
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0C42 ! BLC-1
OI CVCL_0C52 ! HCC-1.1
OI CVCL_0C47 ! MF-1
SX Male
CA Cancer cell line
//
ID HCC-2
AC CVCL_0C54
SY HCC2
DR Cosmic; 1628383
RX PubMed=18594539;
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0C43 ! BLC-2
OI CVCL_0C48 ! MF-2
SX Male
CA Cancer cell line
//
ID HCC-3
AC CVCL_0C55
SY HCC3
DR Cosmic; 1628384
RX PubMed=18594539;
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0C49 ! MF-3
SX Male
CA Cancer cell line
//
ID HCC-48
AC CVCL_T732
SY HCC-48B2; HCC48
DR BioSample; SAMN03471646
DR JCRB; JCRB0185
RX PubMed=8242641;
CC Discontinued: JCRB; JCRB0185; probable.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 11
ST D16S539: 11,13
ST D5S818: 12
ST D7S820: 11
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 16,17,18
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HCC-50
AC CVCL_T733
SY HCC-50D3; HCC50
DR BioSample; SAMN03471647
DR JCRB; JCRB0184
RX PubMed=8242641;
CC Discontinued: JCRB; JCRB0184; probable.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 9,13
ST D13S317: 11
ST D16S539: 11,13
ST D5S818: 12
ST D7S820: 11
ST TH01: 9
ST TPOX: 8,11
ST vWA: 16,17,18
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HCC-56
AC CVCL_2917
SY HCC56
DR BioSample; SAMN03472484
DR CCLE; HCC56_LARGE_INTESTINE
DR Cosmic; 1995434
DR Cosmic-CLP; 1290907
DR GDSC; 1290907
DR GEO; GSM827288
DR GEO; GSM887057
DR GEO; GSM888127
DR GEO; GSM1669861
DR JCRB; JCRB1037
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: JCRB; JCRB1037; probable.
ST Source(s): Cosmic-CLP; JCRB
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 8,9
ST D16S539: 10,12
ST D5S818: 10,14
ST D7S820: 10,12
ST TH01: 7
ST TPOX: 8,10
ST vWA: 14
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HCC-M
AC CVCL_V641
RX PubMed=1661347;
RX PubMed=6307892;
RX PubMed=10870966;
CC Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC Omics: Proteome analysis by 2D-DE/MS.
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC-T
AC CVCL_V642
RX PubMed=1661347;
RX PubMed=2474366;
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC-S102
AC CVCL_M359
SY HCC S102; S102
RX PubMed=20069059;
WW http://www2.cri.or.th/lab/biochemistry/res_act
CC Omics: Secretome proteome analysis.
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HCC10
AC CVCL_V708
SY HCC0010
DR BioSample; SAMN03473054
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
ST Source(s): PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 8,12
ST D13S317: 11
ST D16S539: 9,10
ST D18S51: 17
ST D21S11: 28,30
ST D3S1358: 17
ST D5S818: 11,12
ST D7S820: 12
ST D8S1179: 13,15
ST FGA: 20
ST Penta D: 12
ST Penta E: 11,13
ST TH01: 7,9.3
ST TPOX: 8,11
ST vWA: 14,16
DI NCIt; C5105; Colorectal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC1007
AC CVCL_3374
SY HCC-1007
DR EFO; EFO_0001168
DR ATCC; CRL-2318
DR BioSample; SAMN03471869
DR GEO; GSM350518
DR KCLB; 9S1007
RX PubMed=9833771;
RX PubMed=9865903;
RX PubMed=11314036;
RX PubMed=17157791;
RX PubMed=19582160;
CC Omics: CNV analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: ATCC; CRL-2318; true.
ST Source(s): ATCC; KCLB
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 12
ST D16S539: 14,15
ST D3S1358: 16
ST D5S818: 13
ST D7S820: 10
ST FGA: 23
ST TH01: 7
ST TPOX: 6,11
ST vWA: 19 (ATCC)
ST vWA: 16,19 (KCLB)
DI NCIt; C4017; Ductal breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_3282 ! HCC1007 BL
OI CVCL_1244 ! HCC1008
SX Female
CA Cancer cell line
//
ID HCC1007 BL
AC CVCL_3282
SY HCC-1007BL; HCC1007BL
DR CLO; CLO_0003628
DR ATCC; CRL-2319
DR BioSample; SAMN03471870
RX PubMed=9833771;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 11,12
ST D16S539: 9,14
ST D5S818: 13
ST D7S820: 10
ST TH01: 7,8
ST TPOX: 6,11
ST vWA: 17,19
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_3374 ! HCC1007
OI CVCL_1244 ! HCC1008
SX Female
CA Transformed cell line
//
ID HCC1008
AC CVCL_1244
DR CLO; CLO_0003629
DR EFO; EFO_0002057
DR ATCC; CRL-2320
DR BioSample; SAMN03473055
DR Cosmic; 904359
DR Cosmic; 1235076
DR Cosmic; 1287883
DR Cosmic; 1430344
DR Cosmic; 1473073
DR Cosmic; 1518106
DR Cosmic; 1603197
DR GEO; GSM533399
DR GEO; GSM533406
DR GEO; GSM537969
DR GEO; GSM783931
DR GEO; GSM847318
DR GEO; GSM847472
DR IGRhCellID; HCC1008
RX PubMed=9833771;
RX PubMed=11314036;
RX PubMed=16959974;
RX PubMed=17932254;
RX PubMed=20070913;
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC Omics: Array-based CGH.
CC Omics: Deep exome analysis.
CC Omics: SNP array analysis.
CC Derived from metastatic site: Axillary lymph node.
ST Source(s): ATCC; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 12
ST D16S539: 14,15
ST D18S51: 17
ST D21S11: 29
ST D3S1358: 16
ST D5S818: 13
ST D7S820: 10
ST D8S1179: 14,16
ST FGA: 23
ST Penta D: 8,12
ST Penta E: 9,11
ST TH01: 7
ST TPOX: 6,11
ST vWA: 17,19
DI NCIt; C4017; Ductal breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_3374 ! HCC1007
OI CVCL_3282 ! HCC1007 BL
SX Female
CA Cancer cell line
//
ID HCC1010
AC CVCL_V674
DR BioSample; SAMN03470947
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
ST Source(s): PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 9,10
ST D13S317: 12
ST D16S539: 12
ST D18S51: 19
ST D19S433: 13.2
ST D21S11: 31,32.2,33.2
ST D2S1338: 17,22
ST D3S1358: 14
ST D5S818: 12,13
ST D7S820: 10,13
ST D8S1179: 13,15
ST FGA: 20
ST Penta D: 10,13
ST Penta E: 15
ST TH01: 6
ST TPOX: 8,11
ST vWA: 14,16
DI NCIt; C27893; Sarcomatoid renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC1011
AC CVCL_V675
DR EFO; EFO_0006422
DR BioSample; SAMN03473024
RX PubMed=25485619;
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 10,12
ST D16S539: 10,11
ST D18S51: 14,17
ST D21S11: 28,29
ST D3S1358: 16
ST D5S818: 11,12
ST D7S820: 11,12
ST D8S1179: 13
ST FGA: 25
ST Penta D: 10
ST Penta E: 21
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 16,18
DI NCIt; C4524; Multilocular cystic renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC103
AC CVCL_V705
SY HCC0103
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC1033
AC CVCL_V676
DR BioSample; SAMN03470837
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11
ST D16S539: 11,12
ST D18S51: 12
ST D21S11: 30
ST D3S1358: 15,17
ST D5S818: 12
ST D7S820: 9.3,12
ST D8S1179: 12,14
ST FGA: 22
ST Penta D: 11
ST Penta E: 11,19
ST TH01: 9,9.3
ST TPOX: 9
ST vWA: 17
DI NCIt; C5105; Colorectal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC1042
AC CVCL_V677
DI NCIt; C4182; Serous surface papillary carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC1054
AC CVCL_V678
DR BioSample; SAMN03470843
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 11,12
ST D18S51: 12
ST D21S11: 33.2
ST D3S1358: 15
ST D5S818: 12
ST D7S820: 8,11
ST D8S1179: 10,14
ST FGA: 20
ST Penta D: 11
ST Penta E: 12
ST TH01: 9.3
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC1057
AC CVCL_V679
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
DI NCIt; C39851; Bladder urothelial carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC1068
AC CVCL_V680
DI NCIt; C102872; Pharyngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC1106
AC CVCL_V681
DI NCIt; C6344; Cervical clear cell adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC1143
AC CVCL_1245
SY HCC-1143
DR CLO; CLO_0003630
DR EFO; EFO_0001169
DR ATCC; CRL-2321
DR BioSample; SAMN01821553
DR BioSample; SAMN01821627
DR BioSample; SAMN03471844
DR CCLE; HCC1143_BREAST
DR ChEMBL-Cells; CHEMBL3308737
DR ChEMBL-Targets; CHEMBL1075453
DR Cosmic; 749710
DR Cosmic; 904360
DR Cosmic; 1047708
DR Cosmic; 1176639
DR Cosmic; 1235079
DR Cosmic; 1287934
DR Cosmic; 1430347
DR Cosmic; 1460230
DR Cosmic; 1473032
DR Cosmic; 1518109
DR Cosmic; 1603198
DR Cosmic; 1935003
DR Cosmic; 2009509
DR Cosmic; 2164989
DR Cosmic-CLP; 749710
DR DSMZ; ACC-517
DR GDSC; 749710
DR GEO; GSM184404
DR GEO; GSM184405
DR GEO; GSM217570
DR GEO; GSM303672
DR GEO; GSM303674
DR GEO; GSM303676
DR GEO; GSM303677
DR GEO; GSM303678
DR GEO; GSM303679
DR GEO; GSM303681
DR GEO; GSM303683
DR GEO; GSM303685
DR GEO; GSM303686
DR GEO; GSM303688
DR GEO; GSM303690
DR GEO; GSM303692
DR GEO; GSM303693
DR GEO; GSM303694
DR GEO; GSM303696
DR GEO; GSM303697
DR GEO; GSM303699
DR GEO; GSM303701
DR GEO; GSM303702
DR GEO; GSM303703
DR GEO; GSM303705
DR GEO; GSM303706
DR GEO; GSM303708
DR GEO; GSM303710
DR GEO; GSM303711
DR GEO; GSM303713
DR GEO; GSM303714
DR GEO; GSM303716
DR GEO; GSM303717
DR GEO; GSM303718
DR GEO; GSM303720
DR GEO; GSM303722
DR GEO; GSM303724
DR GEO; GSM303725
DR GEO; GSM303727
DR GEO; GSM303728
DR GEO; GSM303730
DR GEO; GSM303732
DR GEO; GSM303733
DR GEO; GSM303734
DR GEO; GSM303736
DR GEO; GSM303737
DR GEO; GSM303739
DR GEO; GSM303741
DR GEO; GSM303743
DR GEO; GSM303744
DR GEO; GSM303746
DR GEO; GSM303748
DR GEO; GSM303749
DR GEO; GSM303751
DR GEO; GSM303752
DR GEO; GSM303755
DR GEO; GSM303756
DR GEO; GSM303757
DR GEO; GSM303758
DR GEO; GSM303759
DR GEO; GSM303761
DR GEO; GSM303763
DR GEO; GSM303764
DR GEO; GSM303765
DR GEO; GSM303767
DR GEO; GSM303768
DR GEO; GSM303771
DR GEO; GSM303772
DR GEO; GSM303773
DR GEO; GSM303774
DR GEO; GSM303776
DR GEO; GSM303778
DR GEO; GSM303779
DR GEO; GSM303781
DR GEO; GSM303782
DR GEO; GSM303783
DR GEO; GSM303785
DR GEO; GSM303787
DR GEO; GSM303788
DR GEO; GSM303790
DR GEO; GSM337641
DR GEO; GSM337642
DR GEO; GSM337643
DR GEO; GSM337644
DR GEO; GSM337645
DR GEO; GSM337646
DR GEO; GSM337647
DR GEO; GSM337648
DR GEO; GSM337649
DR GEO; GSM337650
DR GEO; GSM337651
DR GEO; GSM337652
DR GEO; GSM337653
DR GEO; GSM337654
DR GEO; GSM337655
DR GEO; GSM337656
DR GEO; GSM337657
DR GEO; GSM337658
DR GEO; GSM337659
DR GEO; GSM337660
DR GEO; GSM337661
DR GEO; GSM344378
DR GEO; GSM344428
DR GEO; GSM350550
DR GEO; GSM481298
DR GEO; GSM533400
DR GEO; GSM533407
DR GEO; GSM537970
DR GEO; GSM783932
DR GEO; GSM847319
DR GEO; GSM844541
DR GEO; GSM854615
DR GEO; GSM854616
DR GEO; GSM854617
DR GEO; GSM854618
DR GEO; GSM854619
DR GEO; GSM887033
DR GEO; GSM888103
DR GEO; GSM1008895
DR GEO; GSM1214576
DR GEO; GSM1215281
DR GEO; GSM1215282
DR GEO; GSM1215283
DR GEO; GSM1215287
DR GEO; GSM1215284
DR GEO; GSM1215285
DR GEO; GSM1215286
DR GEO; GSM1215288
DR GEO; GSM1374493
DR GEO; GSM1401661
DR GEO; GSM1669841
DR IGRhCellID; HCC1143
DR LINCS; 50205
DR PRIDE; PXD000309
DR PRIDE; PXD000394
DR PRIDE; PXD002486
RX DOI=10.4172/2157-7145.S2-005;
RX PubMed=9833771;
RX PubMed=9865903;
RX PubMed=11314036;
RX PubMed=16959974;
RX PubMed=17157791;
RX PubMed=17932254;
RX PubMed=19582160;
RX PubMed=22414580;
RX PubMed=22460905;
RX PubMed=23601657;
RX PubMed=24162158;
RX PubMed=25485619;
RX PubMed=25576301;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.pawefish.path.cam.ac.uk/BreastCellLineDescriptions/HCC1143.html
WW http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=HCC1143
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
WW http://tcpaportal.org/mclp/
CC Part of: AKT genetic alteration cell panel (ATCC TCP-1029).
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: KuDOS 95 cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~45-60 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: HLA class I peptidome analysis by proteomics.
CC Omics: miRNA expression profiling.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; DSMZ; DOI=10.4172/2157-7145.S2-005; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 12
ST D16S539: 11,13
ST D18S51: 14
ST D19S433: 13,16.2
ST D21S11: 30.2
ST D2S1338: 20,23
ST D3S1358: 16
ST D5S818: 11
ST D7S820: 12
ST D8S1179: 13
ST FGA: 21
ST Penta D: 8
ST Penta E: 10
ST TH01: 9.3
ST TPOX: 12
ST vWA: 16
DI NCIt; C4017; Ductal breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1246 ! HCC1143 BL
SX Female
CA Cancer cell line
//
ID HCC1143 BL
AC CVCL_1246
SY HCC1143-BL; HCC1143BL
DR CLO; CLO_0003631
DR ATCC; CRL-2362
DR BioSample; SAMN03471830
DR GEO; GSM854620
RX PubMed=9833771;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 12,13
ST D16S539: 11,13
ST D5S818: 11
ST D7S820: 10,12
ST TH01: 9.3
ST TPOX: 10,12
ST vWA: 16,20
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1245 ! HCC1143
SX Female
CA Transformed cell line
//
ID HCC1159
AC CVCL_9699
DR EFO; EFO_0003127
DR BioSample; SAMN03473057
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 10,11
ST D16S539: 13,14
ST D18S51: 14,16
ST D19S433: 13,14
ST D21S11: 29
ST D2S1338: 19
ST D3S1358: 15
ST D5S818: 12
ST D7S820: 9,10
ST D8S1179: 12,13
ST FGA: 20,22
ST Penta D: 12
ST Penta E: 10,12
ST TH01: 9
ST TPOX: 8
ST vWA: 14
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC1162
AC CVCL_V651
DR EFO; EFO_0006423
DR BioSample; SAMN03473028
RX PubMed=25485619;
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 11
ST D18S51: 15
ST D21S11: 28,30
ST D3S1358: 16
ST D5S818: 12
ST D7S820: 10,12
ST D8S1179: 11,13
ST FGA: 24.2,47.2
ST Penta D: 10,11
ST Penta E: 12
ST TH01: 9.3
ST TPOX: 8,9
ST vWA: 15
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC1171
AC CVCL_5126
SY HCC-1171
DR EFO; EFO_0003126
DR BioSample; SAMN03473217
DR CCLE; HCC1171_LUNG
DR Cosmic; 903635
DR Cosmic; 909908
DR Cosmic; 1146924
DR GEO; GSM253406
DR GEO; GSM434258
DR GEO; GSM794384
DR GEO; GSM887034
DR GEO; GSM888104
DR IGRhCellID; HCC1171GEO
DR KCLB; 71171
DR PRIDE; PXD002556
RX PubMed=10353731;
RX PubMed=10987304;
RX PubMed=20679594;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=26361996;
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): KCLB; PubMed=20679594; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 11
ST D16S539: 14
ST D18S51: 16
ST D21S11: 30,31
ST D3S1358: 14,16
ST D5S818: 11
ST D7S820: 9,12
ST D8S1179: 12,13
ST FGA: 20,25
ST Penta D: 11,12
ST Penta E: 14
ST TH01: 9.3
ST TPOX: 8,9
ST vWA: 17,19
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_S842 ! HCC1171 BL
SX Male
CA Cancer cell line
//
ID HCC1171 BL
AC CVCL_S842
SY HCC1171-BL; HCC1171BL
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5126 ! HCC1171
SX Male
CA Transformed cell line
//
ID HCC1187
AC CVCL_1247
SY HCC-1187
DR CLO; CLO_0003632
DR EFO; EFO_0001170
DR ATCC; CRL-2322
DR BioSample; SAMN03471273
DR CCLE; HCC1187_BREAST
DR ChEMBL-Cells; CHEMBL3308845
DR ChEMBL-Targets; CHEMBL2366202
DR Cosmic; 749711
DR Cosmic; 904361
DR Cosmic; 1136366
DR Cosmic; 1235080
DR Cosmic; 1287916
DR Cosmic; 1430348
DR Cosmic; 1460231
DR Cosmic; 1473100
DR Cosmic; 1518110
DR Cosmic; 1603199
DR Cosmic; 1995422
DR Cosmic-CLP; 749711
DR GDSC; 749711
DR GEO; GSM185077
DR GEO; GSM185078
DR GEO; GSM186712
DR GEO; GSM186713
DR GEO; GSM217571
DR GEO; GSM344370
DR GEO; GSM344420
DR GEO; GSM350540
DR GEO; GSM378152
DR GEO; GSM783933
DR GEO; GSM847320
DR GEO; GSM847473
DR GEO; GSM844542
DR GEO; GSM887035
DR GEO; GSM888105
DR GEO; GSM1008896
DR GEO; GSM1214579
DR GEO; GSM1374494
DR GEO; GSM1374495
DR GEO; GSM1401672
DR GEO; GSM1661979
DR GEO; GSM1669842
DR LINCS; 50578
RX PubMed=9833771;
RX PubMed=9865903;
RX PubMed=11314036;
RX PubMed=12800145;
RX PubMed=16959974;
RX PubMed=17157791;
RX PubMed=17932254;
RX PubMed=19582160;
RX PubMed=22460905;
RX PubMed=24162158;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.pawefish.path.cam.ac.uk/BreastCellLineDescriptions/HCC1187.html
WW http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=HCC1187
WW http://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
WW http://www.completegenomics.com/documents/PublicGenomes.pdf
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: ICBP43 breast cancer cell line panel.
CC Part of: KuDOS 95 cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 100 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Genome sequenced.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 13
ST D13S317: 11
ST D16S539: 10
ST D18S51: 17
ST D21S11: 29,30
ST D3S1358: 15
ST D5S818: 12
ST D7S820: 8,11
ST D8S1179: 11
ST FGA: 23
ST Penta D: 11
ST Penta E: 16
ST TH01: 6
ST TPOX: 8
ST vWA: 19
DI NCIt; C4017; Ductal breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1248 ! HCC1187 BL
SX Female
CA Cancer cell line
//
ID HCC1187 BL
AC CVCL_1248
SY HCC-1187BL; HCC1187BL
DR CLO; CLO_0003633
DR ATCC; CRL-2323
DR BioSample; SAMN03471871
DR KCLB; 9S1187BL
RX PubMed=9833771;
WW http://www.completegenomics.com/documents/PublicGenomes.pdf
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Genome sequenced.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 13
ST D13S317: 11
ST D16S539: 10,11
ST D5S818: 11,12
ST D7S820: 8,11
ST TH01: 6
ST TPOX: 8
ST vWA: 15,19
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1247 ! HCC1187
SX Female
CA Transformed cell line
//
ID HCC1192
AC CVCL_V709
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC1195
AC CVCL_5127
SY HCC-1195
DR EFO; EFO_0005371
DR CCLE; HCC1195_LUNG
DR Cosmic; 903636
DR Cosmic; 1146925
DR Cosmic; 1925842
DR GEO; GSM62337
DR GEO; GSM253429
DR GEO; GSM434298
DR GEO; GSM794385
DR GEO; GSM887036
DR GEO; GSM888106
DR IGRhCellID; HCC1195_02GEO
DR KCLB; 71195
RX PubMed=10353731;
RX PubMed=20679594;
RX PubMed=22460905;
RX PubMed=28196595;
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): KCLB; PubMed=20679594
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 9
ST D3S1358: 15,16
ST D5S818: 13
ST D7S820: 10,11
ST FGA: 21
ST TH01: 7
ST TPOX: 8,11
ST vWA: 15,17
DI NCIt; C9133; Adenosquamous lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC12
AC CVCL_V719
SY HCC0012
DR EFO; EFO_0006416
DR BioSample; SAMN03473014
RX PubMed=25485619;
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 14
ST D16S539: 9
ST D18S51: 16
ST D21S11: 32.2
ST D3S1358: 15
ST D5S818: 10
ST D7S820: 8
ST D8S1179: 14,16
ST FGA: 26
ST Penta D: 9
ST Penta E: 10
ST TH01: 6
ST TPOX: 8
ST vWA: 15
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC1205
AC CVCL_V683
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC1210
AC CVCL_V682
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC1217
AC CVCL_V684
DR BioSample; SAMN03470844
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
ST Source(s): PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 8
ST D16S539: 12,13
ST D18S51: 19
ST D21S11: 29,30
ST D3S1358: 18
ST D5S818: 11,13
ST D7S820: 9,10
ST D8S1179: 13,15
ST FGA: 20,24
ST Penta D: 13,14
ST Penta E: 5,12
ST TH01: 7
ST TPOX: 7,9
ST vWA: 14,17
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC122
AC CVCL_V704
SY HCC0122
DR BioSample; SAMN03473025
DR GEO; GSM1682811
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 8
ST D16S539: 9
ST D18S51: 12,18
ST D21S11: 31
ST D3S1358: 14
ST D5S818: 8
ST D7S820: 10,12
ST D8S1179: 14,16
ST FGA: 21,27
ST Penta D: 12
ST Penta E: 13,16
ST TH01: 7
ST TPOX: 7,11
ST vWA: 15
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC1261
AC CVCL_V685
DR BioSample; SAMN03470839
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 13,14
ST D13S317: 12
ST D16S539: 8
ST D18S51: 12,18
ST D21S11: 31,33.2
ST D3S1358: 14
ST D5S818: 11
ST D7S820: 9,10,12
ST D8S1179: 10,15
ST FGA: 23
ST Penta D: 9
ST Penta E: 12,18
ST TH01: 8,9.3
ST TPOX: 11
ST vWA: 14,15
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID HCC1263
AC CVCL_V686
DR EFO; EFO_0006424
DR BioSample; SAMN03473031
RX PubMed=25485619;
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 12
ST D16S539: 9,11
ST D18S51: 20
ST D21S11: 27,32.2
ST D3S1358: 16,17
ST D5S818: 13
ST D7S820: 10
ST D8S1179: 15
ST FGA: 22
ST Penta D: 3.2,8
ST Penta E: 17
ST TH01: 6,8
ST TPOX: 6
ST vWA: 13,15
DI NCIt; C5105; Colorectal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC1266
AC CVCL_V687
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC128
AC CVCL_V703
SY HCC0128
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC1311
AC CVCL_V688
DI NCIt; C4017; Ductal breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC1313
AC CVCL_L087
SY HCC-1313
DR Cosmic; 903637
DR GEO; GSM794386
RX PubMed=10353731;
RX PubMed=28196595;
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: Transcriptome analysis.
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC1314
AC CVCL_V670
DR BioSample; SAMN03473032
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
ST Source(s): PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 8,11
ST D16S539: 9,11
ST D18S51: 13,15
ST D21S11: 29,30
ST D3S1358: 15,17
ST D5S818: 10,13
ST D7S820: 10,12
ST D8S1179: 10,13
ST FGA: 22
ST Penta D: 9,12
ST Penta E: 20
ST TH01: 6
ST TPOX: 9,11
ST vWA: 18
DI NCIt; C39851; Bladder urothelial carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC1319
AC CVCL_V671
DR EFO; EFO_0006425
RX PubMed=25485619;
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC1323
AC CVCL_V672
DI NCIt; C4017; Ductal breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC1347
AC CVCL_V673
DR BioSample; SAMN03470911
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11
ST D16S539: 11,13
ST D18S51: 14,19
ST D21S11: 29,31.2
ST D3S1358: 17
ST D5S818: 11
ST D7S820: 8,10
ST D8S1179: 13,14
ST FGA: 20,23
ST Penta D: 12
ST Penta E: 10,11
ST TH01: 8,9
ST TPOX: 8,10
ST vWA: 15,16
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC1354
AC CVCL_V663
DR BioSample; SAMN03470852
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 8,12
ST D13S317: 11,12
ST D16S539: 9
ST D18S51: 16
ST D19S433: 11,12,13
ST D21S11: 28,29
ST D2S1338: 16,26
ST D3S1358: 14
ST D5S818: 8,12
ST D7S820: 10,11
ST D8S1179: 12
ST FGA: 23
ST Penta D: 11
ST Penta E: 7,11
ST TH01: 7
ST TPOX: 8
ST vWA: 14
DI NCIt; C7558; Endometrial carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC1359
AC CVCL_5128
SY HCC-1359
DR EFO; EFO_0003128
DR BioSample; SAMN03473015
DR CCLE; HCC1359_LUNG
DR Cosmic; 1146926
DR GEO; GSM253422
DR GEO; GSM434259
DR GEO; GSM794387
DR IGRhCellID; HCC1359GEO
DR KCLB; 71359
RX PubMed=10353731;
RX PubMed=20679594;
RX PubMed=25485619;
RX PubMed=28196595;
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Deep RNAseq analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=20679594; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 7,11
ST D13S317: 12,14
ST D16S539: 8,11
ST D18S51: 19
ST D21S11: 28,29
ST D3S1358: 16,17
ST D5S818: 11,12
ST D7S820: 10,11
ST D8S1179: 13,15
ST FGA: 21,22
ST Penta D: 11,13
ST Penta E: 8,11
ST TH01: 8,9
ST TPOX: 7,10
ST vWA: 16
DI NCIt; C4452; Lung giant cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC1360
AC CVCL_V664
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC1367
AC CVCL_V665
DR BioSample; SAMN03470853
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 10
ST D16S539: 14
ST D18S51: 14
ST D19S433: 14
ST D21S11: 33.2
ST D2S1338: 24
ST D3S1358: 15
ST D5S818: 11,12
ST D7S820: 10
ST D8S1179: 10,13
ST FGA: 23,24
ST Penta D: 9
ST Penta E: 12,13
ST TH01: 6
ST TPOX: 8,9
ST vWA: 17
DI NCIt; C2955; Colorectal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID HCC1375
AC CVCL_V666
DR BioSample; SAMN03470854
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
ST Source(s): PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 9
ST D18S51: 13,14
ST D19S433: 15,15.2
ST D21S11: 31.2
ST D2S1338: 24
ST D3S1358: 17,18
ST D5S818: 12
ST D7S820: 8,9
ST D8S1179: 12,13
ST FGA: 22
ST Penta D: 10
ST Penta E: 11,14
ST TPOX: 8,11
ST vWA: 14
DI NCIt; C7724; Small intestinal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC1385
AC CVCL_V667
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC1386
AC CVCL_V668
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC1395
AC CVCL_1249
SY HCC-1395; SCC-1395
DR BTO; BTO:0003444
DR CLO; CLO_0003634
DR EFO; EFO_0002185
DR ATCC; CRL-2324
DR BioSample; SAMN03471290
DR BioSample; SAMN03471814
DR CCLE; HCC1395_BREAST
DR ChEMBL-Cells; CHEMBL3308106
DR ChEMBL-Targets; CHEMBL1075454
DR Cosmic; 749712
DR Cosmic; 904362
DR Cosmic; 1047707
DR Cosmic; 1235081
DR Cosmic; 1287935
DR Cosmic; 1309005
DR Cosmic; 1430349
DR Cosmic; 1460232
DR Cosmic; 1473080
DR Cosmic; 1518111
DR Cosmic; 1603200
DR Cosmic; 1935004
DR Cosmic; 2164990
DR Cosmic-CLP; 749712
DR GDSC; 749712
DR GEO; GSM186714
DR GEO; GSM186715
DR GEO; GSM217572
DR GEO; GSM302884
DR GEO; GSM302885
DR GEO; GSM302886
DR GEO; GSM302887
DR GEO; GSM302888
DR GEO; GSM302889
DR GEO; GSM302890
DR GEO; GSM302891
DR GEO; GSM302892
DR GEO; GSM302893
DR GEO; GSM302894
DR GEO; GSM344377
DR GEO; GSM344427
DR GEO; GSM350539
DR GEO; GSM481302
DR GEO; GSM533401
DR GEO; GSM533408
DR GEO; GSM537971
DR GEO; GSM783934
DR GEO; GSM847321
DR GEO; GSM844543
DR GEO; GSM887037
DR GEO; GSM888107
DR GEO; GSM1008897
DR GEO; GSM1214582
DR GEO; GSM1374496
DR GEO; GSM1374497
DR GEO; GSM1669843
DR IGRhCellID; HCC1395
DR KCLB; 9S1395
DR LINCS; 50206
RX PubMed=9833771;
RX PubMed=9865903;
RX PubMed=11314036;
RX PubMed=12800145;
RX PubMed=14762065;
RX PubMed=16959974;
RX PubMed=17932254;
RX PubMed=19582160;
RX PubMed=22460905;
RX PubMed=23601657;
RX PubMed=24162158;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=HCC1395
WW http://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: ICBP43 breast cancer cell line panel.
CC Part of: KuDOS 95 cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 72 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: miRNA expression profiling.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 9
ST D16S539: 11
ST D18S51: 14
ST D21S11: 31,32.2
ST D3S1358: 15
ST D5S818: 11 (ATCC; Cosmic-CLP)
ST D5S818: 11,12 (PubMed=25877200)
ST D7S820: 10,12 (ATCC; Cosmic-CLP)
ST D7S820: 10 (PubMed=25877200)
ST D8S1179: 14
ST FGA: 21
ST Penta D: 12
ST Penta E: 7,12
ST TH01: 9.3
ST TPOX: 11
ST vWA: 15 (ATCC; Cosmic-CLP)
ST vWA: 15,16 (PubMed=25877200)
DI NCIt; C4017; Ductal breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1250 ! HCC1395 BL
SX Female
CA Cancer cell line
//
ID HCC1395 BL
AC CVCL_1250
SY HCC-1395BL; HCC1395BL; SCC-1395BL
DR CLO; CLO_0003635
DR ATCC; CRL-2325
DR BioSample; SAMN03471815
DR GEO; GSM302883
DR KCLB; 9S1395BL
RX PubMed=9833771;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 9,11
ST D16S539: 11
ST D5S818: 10,11
ST D7S820: 10,12
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 15,17
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1249 ! HCC1395
SX Female
CA Transformed cell line
//
ID HCC1419
AC CVCL_1251
SY HCC-1419
DR CLO; CLO_0003636
DR EFO; EFO_0005372
DR ATCC; CRL-2326
DR BioSample; SAMN03471438
DR CCLE; HCC1419_BREAST
DR ChEMBL-Cells; CHEMBL3308738
DR ChEMBL-Targets; CHEMBL1075455
DR Cosmic; 687475
DR Cosmic; 904363
DR Cosmic; 907045
DR Cosmic; 1287884
DR Cosmic; 1308992
DR Cosmic; 1603201
DR Cosmic; 1935005
DR Cosmic; 2165005
DR Cosmic-CLP; 907045
DR GDSC; 907045
DR GEO; GSM149984
DR GEO; GSM149992
DR GEO; GSM150000
DR GEO; GSM186716
DR GEO; GSM186717
DR GEO; GSM217573
DR GEO; GSM344371
DR GEO; GSM344421
DR GEO; GSM350553
DR GEO; GSM378145
DR GEO; GSM459729
DR GEO; GSM783940
DR GEO; GSM847322
DR GEO; GSM844544
DR GEO; GSM887038
DR GEO; GSM888108
DR GEO; GSM1374498
DR GEO; GSM1421430
DR GEO; GSM1669844
DR KCLB; 9S1419
DR LINCS; 50207
RX PubMed=9833771;
RX PubMed=9865903;
RX PubMed=11314036;
RX PubMed=19582160;
RX PubMed=22460905;
RX PubMed=23601657;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.pawefish.path.cam.ac.uk/BreastCellLineDescriptions/HCC1419.html
WW http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=HCC1419
WW http://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: ICBP43 breast cancer cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: miRNA expression profiling.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; KCLB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 9,12
ST D16S539: 11,12
ST D18S51: 14
ST D21S11: 27,30
ST D3S1358: 14,17
ST D5S818: 10,12
ST D7S820: 11
ST D8S1179: 15
ST FGA: 20,24
ST Penta D: 11,13
ST Penta E: 15,21
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C4017; Ductal breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC1419-Luc
AC CVCL_J253
SY HCC-1419-Luc
DR JCRB; JCRB1466
DR JCRB; NIHS0706
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 9,12
ST D16S539: 11,12
ST D5S818: 10,12
ST D7S820: 11
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C4017; Ductal breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1251 ! HCC1419
SX Female
CA Cancer cell line
//
ID HCC1426
AC CVCL_V689
DI NCIt; C4182; Serous surface papillary carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC1428
AC CVCL_1252
SY HCC-1428
DR CLO; CLO_0003637
DR EFO; EFO_0001171
DR ATCC; CRL-2327
DR BioSample; SAMN03472560
DR CCLE; HCC1428_BREAST
DR Cosmic; 904364
DR Cosmic; 1460233
DR Cosmic; 1603202
DR Cosmic; 1995423
DR Cosmic; 2165021
DR Cosmic-CLP; 1290905
DR GDSC; 1290905
DR GEO; GSM344373
DR GEO; GSM344423
DR GEO; GSM350510
DR GEO; GSM827277
DR GEO; GSM887039
DR GEO; GSM888109
DR GEO; GSM1008898
DR GEO; GSM1214570
DR GEO; GSM1613822
DR GEO; GSM1669845
DR KCLB; 9S1428
DR LINCS; 50208
RX PubMed=9833771;
RX PubMed=11314036;
RX PubMed=17157791;
RX PubMed=19582160;
RX PubMed=20070913;
RX PubMed=20679594;
RX PubMed=22460905;
RX PubMed=24162158;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=HCC1428
WW http://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: ICBP43 breast cancer cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Array-based CGH.
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ATCC; Cosmic-CLP; KCLB; PubMed=20679594; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 12
ST D16S539: 8,12
ST D18S51: 16
ST D21S11: 30,33.2
ST D3S1358: 16
ST D5S818: 11,12
ST D7S820: 9
ST D8S1179: 14
ST FGA: 21 (KCLB)
ST FGA: 21,22 (PubMed=25877200)
ST Penta D: 8,9
ST Penta E: 18
ST TH01: 8
ST TPOX: 8
ST vWA: 17 (ATCC; KCLB; PubMed=20679594; PubMed=25877200)
ST vWA: 17,18 (Cosmic-CLP)
DI NCIt; C5214; Breast adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1253 ! HCC1428 BL
SX Female
CA Cancer cell line
//
ID HCC1428 BL
AC CVCL_1253
SY HCC-1428BL; HCC1428BL
DR CLO; CLO_0003638
DR ATCC; CRL-2328
DR BioSample; SAMN03471816
DR KCLB; 9S1428BL
RX PubMed=9833771;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): ATCC; KCLB
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 8,12
ST D16S539: 8,12
ST D3S1358: 15,16
ST D5S818: 11,12
ST D7S820: 9
ST FGA: 21,22
ST TH01: 8,9.3
ST TPOX: 8
ST vWA: 17
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1252 ! HCC1428
SX Female
CA Transformed cell line
//
ID HCC1438
AC CVCL_L088
SY HCC-1438
DR BioSample; SAMN03470855
DR CCLE; HCC1438_LUNG
DR GEO; GSM794388
DR KCLB; 71438
RX PubMed=10353731;
RX PubMed=28196595;
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: Transcriptome analysis.
ST Source(s): KCLB; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 15
ST D18S51: 14,20
ST D19S433: 14
ST D21S11: 32.2
ST D2S1338: 19
ST D3S1358: 15
ST D5S818: 11,13
ST D7S820: 10
ST D8S1179: 14,15
ST FGA: 19,24 (KCLB)
ST FGA: 24 (PubMed=25877200)
ST Penta D: 7,11
ST Penta E: 11,13
ST TH01: 6,7
ST TPOX: 8
ST vWA: 17
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC1445
AC CVCL_V589
DR BioSample; SAMN03470856
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 11
ST D16S539: 11,12
ST D18S51: 14
ST D19S433: 13,14
ST D21S11: 31.2,32.2
ST D2S1338: 17,20
ST D3S1358: 14,15
ST D5S818: 9,13
ST D7S820: 12
ST D8S1179: 12,13
ST FGA: 21,23
ST Penta D: 12,15
ST Penta E: 16
ST TH01: 9,9.3
ST TPOX: 8,11
ST vWA: 18
DI NCIt; C4878; Lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC1448
AC CVCL_V590
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC1482
AC CVCL_V591
DR EFO; EFO_0006426
DR BioSample; SAMN03473030
RX PubMed=25485619;
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 10,12
ST D16S539: 11,13,14
ST D18S51: 11,12,13
ST D19S433: 14,16
ST D21S11: 29,33.2
ST D2S1338: 16,18
ST D3S1358: 12,16
ST D5S818: 11
ST D7S820: 10.3,12
ST D8S1179: 13
ST FGA: 18,23
ST Penta D: 12,13
ST Penta E: 10,16
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 17,20
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC149
AC CVCL_V702
SY HCC0149
DR BioSample; SAMN03470857
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 12
ST D18S51: 17,18
ST D19S433: 15.2
ST D21S11: 29,31.2
ST D2S1338: 19,23
ST D3S1358: 17
ST D5S818: 11,13
ST D7S820: 10
ST D8S1179: 13,14
ST FGA: 21,23
ST Penta D: 10,11
ST Penta E: 14,17
ST TH01: 7
ST TPOX: 6
ST vWA: 17
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC1493
AC CVCL_V592
DR EFO; EFO_0006427
DR BioSample; SAMN03473016
RX PubMed=25485619;
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 11,12
ST D16S539: 8,9
ST D18S51: 11,17
ST D21S11: 30
ST D3S1358: 15,17
ST D5S818: 11
ST D7S820: 8,11
ST D8S1179: 8,14
ST FGA: 21,23
ST Penta D: 13
ST Penta E: 11,23
ST TH01: 6,8
ST TPOX: 8,11
ST vWA: 17
DI NCIt; C5214; Breast adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC1498
AC CVCL_V706
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC15
AC CVCL_2057
SY HCC-15; HCC0015
DR EFO; EFO_0003129
DR BioSample; SAMN03473175
DR CCLE; HCC15_LUNG
DR Cosmic; 877105
DR Cosmic; 903625
DR Cosmic; 1146927
DR Cosmic; 1219058
DR Cosmic; 1239908
DR Cosmic; 1518094
DR Cosmic; 1802314
DR Cosmic; 1925846
DR Cosmic; 2060531
DR Cosmic; 2125188
DR Cosmic-CLP; 1240143
DR DSMZ; ACC-496
DR GDSC; 1240143
DR GEO; GSM62968
DR GEO; GSM253336
DR GEO; GSM434318
DR GEO; GSM784212
DR GEO; GSM784277
DR GEO; GSM794372
DR GEO; GSM827364
DR GEO; GSM887043
DR GEO; GSM888113
DR GEO; GSM1374499
DR GEO; GSM1669846
DR IGRhCellID; HCC15GEO
DR KCLB; 70015
RX PubMed=10987304;
RX PubMed=11314036;
RX PubMed=19472407;
RX PubMed=20679594;
RX PubMed=22460905;
RX PubMed=23381221;
RX PubMed=25120651;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~30-40 hours (DSMZ).
CC Microsatellite instability: Instable (MSI-low) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; KCLB; PubMed=20679594; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 11
ST D16S539: 11,13
ST D18S51: 17
ST D21S11: 28
ST D3S1358: 16
ST D5S818: 13
ST D7S820: 8,11
ST D8S1179: 13,14
ST FGA: 20.2 (KCLB)
ST FGA: 47.2 (PubMed=25877200)
ST Penta D: 10
ST Penta E: 5,8
ST TH01: 7
ST TPOX: 8,11
ST vWA: 16,20
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L062 ! HCC15 BL
SX Male
CA Cancer cell line
//
ID HCC15 BL
AC CVCL_L062
SY HCC15BL; C-15BL
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2057 ! HCC15
SX Male
CA Transformed cell line
//
ID HCC1500
AC CVCL_1254
DR CLO; CLO_0003639
DR EFO; EFO_0001172
DR ATCC; CRL-2329
DR BioSample; SAMN03471865
DR CCLE; HCC1500_BREAST
DR Cosmic; 687476
DR Cosmic; 904365
DR Cosmic; 1018471
DR Cosmic; 1047709
DR Cosmic; 1136374
DR Cosmic; 1287885
DR Cosmic; 1603203
DR Cosmic; 1935006
DR Cosmic; 1995424
DR Cosmic; 2165022
DR Cosmic-CLP; 1303900
DR GDSC; 1303900
DR GEO; GSM217574
DR GEO; GSM344376
DR GEO; GSM344426
DR GEO; GSM350538
DR GEO; GSM459706
DR GEO; GSM783971
DR GEO; GSM887040
DR GEO; GSM888110
DR GEO; GSM1008899
DR GEO; GSM1214571
DR GEO; GSM1374500
DR GEO; GSM1669847
DR LINCS; 50579
RX PubMed=9833771;
RX PubMed=9865903;
RX PubMed=11314036;
RX PubMed=12800145;
RX PubMed=17157791;
RX PubMed=19582160;
RX PubMed=22460905;
RX PubMed=23601657;
RX PubMed=24162158;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.pawefish.path.cam.ac.uk/BreastCellLineDescriptions/HCC1500.html
WW http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=HCC1500
WW http://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: ICBP43 breast cancer cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Instable (MSI-low) (Sanger).
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: miRNA expression profiling.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 10
ST D16S539: 9,10
ST D18S51: 13
ST D21S11: 27,30
ST D3S1358: 15
ST D5S818: 11,13
ST D7S820: 11
ST D8S1179: 13,14
ST FGA: 23
ST Penta D: 2.2,5
ST Penta E: 7
ST TH01: 9
ST TPOX: 8
ST vWA: 13,16
DI NCIt; C4017; Ductal breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC1501
AC CVCL_V594
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID HCC1534
AC CVCL_V595
DR EFO; EFO_0006428
DR BioSample; SAMN03472977
RX PubMed=25485619;
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 9,12
ST D16S539: 11
ST D18S51: 18,19,20
ST D21S11: 28
ST D3S1358: 15,16
ST D5S818: 12,13
ST D7S820: 10
ST D8S1179: 14
ST FGA: 21,22
ST Penta D: 11,12
ST Penta E: 15
ST TH01: 9,9.3
ST TPOX: 8,9
ST vWA: 17
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID HCC1561
AC CVCL_V596
DR BioSample; SAMN03470858
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
ST Source(s): PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 11,12
ST D16S539: 11,12
ST D18S51: 15
ST D19S433: 15,15.2
ST D21S11: 30.2,32.2
ST D2S1338: 17,19
ST D3S1358: 16
ST D5S818: 12,13
ST D7S820: 9,10
ST D8S1179: 13,14
ST FGA: 19,22
ST Penta D: 9
ST Penta E: 5,7
ST TH01: 7,9.3
ST TPOX: 8,11
ST vWA: 17,18
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC1569
AC CVCL_1255
SY HCC-1569
DR CLO; CLO_0003640
DR EFO; EFO_0001173
DR ATCC; CRL-2330
DR BioSample; SAMN03471817
DR BioSample; SAMN03473137
DR CCLE; HCC1569_BREAST
DR ChEMBL-Cells; CHEMBL3308497
DR ChEMBL-Targets; CHEMBL1075456
DR Cosmic; 687477
DR Cosmic; 907046
DR Cosmic; 1136354
DR Cosmic; 1176644
DR Cosmic; 1287886
DR Cosmic; 1603204
DR Cosmic; 1935007
DR Cosmic; 1995425
DR Cosmic; 2165006
DR Cosmic-CLP; 907046
DR GDSC; 907046
DR GEO; GSM186718
DR GEO; GSM186719
DR GEO; GSM217575
DR GEO; GSM344381
DR GEO; GSM344431
DR GEO; GSM350503
DR GEO; GSM481315
DR GEO; GSM783966
DR GEO; GSM847323
DR GEO; GSM847474
DR GEO; GSM844545
DR GEO; GSM887041
DR GEO; GSM888111
DR GEO; GSM1374501
DR GEO; GSM1374502
DR GEO; GSM1401674
DR GEO; GSM1669848
DR KCLB; 71569
DR KCLB; 9S1569
DR LINCS; 50210
RX PubMed=9833771;
RX PubMed=9865903;
RX PubMed=11314036;
RX PubMed=17157791;
RX PubMed=19582160;
RX PubMed=20679594;
RX PubMed=22460905;
RX PubMed=23601657;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.pawefish.path.cam.ac.uk/BreastCellLineDescriptions/HCC1569.html
WW http://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: ICBP43 breast cancer cell line panel.
CC Part of: KuDOS 95 cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Instable (MSI-high) (Sanger).
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: miRNA expression profiling.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; PubMed=20679594; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,12 (ATCC; PubMed=20679594)
ST CSF1PO: 10,11,12 (Cosmic-CLP; PubMed=25877200)
ST D13S317: 12
ST D16S539: 11,12,13 (ATCC; PubMed=25877200)
ST D16S539: 12,13 (Cosmic-CLP)
ST D16S539: 11,12 (PubMed=20679594)
ST D18S51: 17,18,19
ST D21S11: 28
ST D3S1358: 15,16
ST D5S818: 11,12
ST D7S820: 8,8.3,9 (ATCC)
ST D7S820: 8,9 (Cosmic-CLP; PubMed=20679594; PubMed=25877200)
ST D8S1179: 12,14,15
ST FGA: 19.2,24
ST Penta D: 8
ST Penta E: 16,17
ST TH01: 7
ST TPOX: 6,11
ST vWA: 17
DI NCIt; C4017; Ductal breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC1576
AC CVCL_V597
DR EFO; EFO_0006429
DR BioSample; SAMN03473033
RX PubMed=25485619;
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
ST Source(s): PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 12
ST D16S539: 12
ST D18S51: 17
ST D21S11: 28
ST D3S1358: 16,18
ST D5S818: 12,13
ST D7S820: 10
ST D8S1179: 13
ST FGA: 22
ST Penta D: 9
ST Penta E: 12,13
ST TH01: 7,9.3
ST TPOX: 11,12
ST vWA: 14,17
DI NCIt; C9325; Adrenal cortex carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC1581
AC CVCL_V598
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC1588
AC CVCL_A351
SY HCC-1588
DR BioSample; SAMN03473071
DR CCLE; HCC1588_LUNG
DR Cosmic; 903638
DR GEO; GSM1374503
DR KCLB; 71588
RX PubMed=10353731;
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: Transcriptome analysis.
ST Source(s): KCLB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 13
ST D13S317: 11 (KCLB)
ST D13S317: 10,11 (PubMed=25877200)
ST D16S539: 10
ST D18S51: 15,20
ST D21S11: 27,28
ST D3S1358: 17
ST D5S818: 8
ST D7S820: 10,11
ST D8S1179: 14
ST FGA: 22
ST Penta D: 12
ST Penta E: 7,13
ST TH01: 7,9
ST TPOX: 8,12
ST vWA: 16,19
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC1599
AC CVCL_1256
SY HCC-1599
DR CLO; CLO_0003641
DR EFO; EFO_0002186
DR ATCC; CRL-2331
DR BioSample; SAMN01821554
DR BioSample; SAMN01821628
DR BioSample; SAMN03471818
DR CCLE; HCC1599_BREAST
DR ChEMBL-Cells; CHEMBL3308262
DR ChEMBL-Targets; CHEMBL2366063
DR Cosmic; 749713
DR Cosmic; 904366
DR Cosmic; 1047710
DR Cosmic; 1235082
DR Cosmic; 1287887
DR Cosmic; 1430350
DR Cosmic; 1518112
DR Cosmic; 1603205
DR Cosmic; 1995426
DR Cosmic; 2009510
DR Cosmic-CLP; 749713
DR DSMZ; ACC-503
DR GDSC; 749713
DR GEO; GSM186720
DR GEO; GSM186721
DR GEO; GSM186722
DR GEO; GSM217612
DR GEO; GSM350526
DR GEO; GSM533402
DR GEO; GSM533409
DR GEO; GSM537972
DR GEO; GSM783935
DR GEO; GSM847324
DR GEO; GSM847481
DR GEO; GSM887042
DR GEO; GSM888112
DR GEO; GSM1401655
DR GEO; GSM1669849
DR IGRhCellID; HCC1599
DR LINCS; 50580
DR PRIDE; PXD000309
RX PubMed=9833771;
RX PubMed=11314036;
RX PubMed=16959974;
RX PubMed=17932254;
RX PubMed=19582160;
RX PubMed=22414580;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.pawefish.path.cam.ac.uk/BreastCellLineDescriptions/HCC1599.html
WW http://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: ICBP43 breast cancer cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~4-5 days (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 12,13
ST D18S51: 19
ST D21S11: 29
ST D3S1358: 15,17
ST D5S818: 12
ST D7S820: 10,11
ST D8S1179: 13
ST FGA: 24
ST Penta D: 13
ST Penta E: 13
ST TH01: 9.3
ST TPOX: 8
ST vWA: 17
DI NCIt; C4017; Ductal breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1257 ! HCC1599 BL
SX Female
CA Cancer cell line
//
ID HCC1599 BL
AC CVCL_1257
SY HCC-1599BL; HCC1599BL
DR CLO; CLO_0003642
DR ATCC; CRL-2332
DR BioSample; SAMN03471819
DR KCLB; 9S1599BL
RX PubMed=9833771;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 8,11
ST D16S539: 12,13
ST D5S818: 12
ST D7S820: 10,11
ST TH01: 9.3
ST TPOX: 8
ST vWA: 17
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1256 ! HCC1599
SX Female
CA Transformed cell line
//
ID HCC1623
AC CVCL_V657
DR BioSample; SAMN03470998
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11,14
ST D16S539: 9
ST D18S51: 18,19
ST D19S433: 14,16.2
ST D21S11: 28,31
ST D2S1338: 19,23
ST D3S1358: 15,18
ST D5S818: 12,13
ST D7S820: 9,11
ST D8S1179: 13,15
ST FGA: 21.2,27
ST Penta D: 10,13
ST Penta E: 8,10
ST TH01: 8
ST TPOX: 8,11
ST vWA: 13,17
DI NCIt; C5105; Colorectal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC1629
AC CVCL_V656
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC1637
AC CVCL_9Y85
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HCC1671
AC CVCL_V655
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC1685
AC CVCL_V658
RX PubMed=9865903;
DI NCIt; C4017; Ductal breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC1686
AC CVCL_V659
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC1688
AC CVCL_V660
DI NCIt; C6340; Uterine corpus leiomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC1705
AC CVCL_V654
DR BioSample; SAMN03470859
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 12,13
ST D16S539: 12
ST D18S51: 13
ST D19S433: 14,15
ST D21S11: 29,30
ST D2S1338: 16,17
ST D3S1358: 18,19
ST D5S818: 13
ST D7S820: 9
ST D8S1179: 12,13
ST FGA: 21,23
ST Penta D: 13
ST Penta E: 10,12
ST TH01: 9.3
ST TPOX: 9,11
ST vWA: 17
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID HCC1719
AC CVCL_L089
SY HCC-1719
DR BioSample; SAMN03470840
DR KCLB; 71719
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
ST Source(s): PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 13
ST D16S539: 9
ST D18S51: 14,17
ST D21S11: 30,31
ST D3S1358: 19
ST D5S818: 13
ST D7S820: 9,13
ST D8S1179: 11
ST FGA: 22
ST Penta D: 2.2,11
ST Penta E: 16
ST TH01: 7
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC1739
AC CVCL_9877
SY HCC-1739
DR ATCC; CRL-2333
RX PubMed=9833771;
RX PubMed=9865903;
RX PubMed=11314036;
CC Discontinued: ATCC; CRL-2333; true.
DI NCIt; C4017; Ductal breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_3280 ! HCC1739 BL
SX Female
CA Cancer cell line
//
ID HCC1739 BL
AC CVCL_3280
SY HCC-1739BL; HCC1739BL
DR CLO; CLO_0003643
DR ATCC; CRL-2334
DR BioSample; SAMN03471820
DR KCLB; 9S1739BL
RX PubMed=9833771;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11,13
ST D16S539: 12,13
ST D5S818: 11,13
ST D7S820: 11,13
ST TH01: 6,9.3
ST TPOX: 8,10
ST vWA: 17,19
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9877 ! HCC1739
SX Female
CA Transformed cell line
//
ID HCC1772
AC CVCL_V653
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC1806
AC CVCL_1258
SY Hcc1806; HCC-1806
DR CLO; CLO_0003644
DR EFO; EFO_0005373
DR ATCC; CRL-2335
DR BioSample; SAMN03472709
DR CCLE; HCC1806_BREAST
DR ChEMBL-Cells; CHEMBL3308135
DR ChEMBL-Targets; CHEMBL1075457
DR Cosmic; 687479
DR Cosmic; 904367
DR Cosmic; 907047
DR Cosmic; 1047705
DR Cosmic; 1287888
DR Cosmic; 1460234
DR Cosmic; 1603206
DR Cosmic; 1935008
DR Cosmic-CLP; 907047
DR GDSC; 907047
DR GEO; GSM217576
DR GEO; GSM344339
DR GEO; GSM344389
DR GEO; GSM350528
DR GEO; GSM378147
DR GEO; GSM783942
DR GEO; GSM847325
DR GEO; GSM847482
DR GEO; GSM844547
DR GEO; GSM844546
DR GEO; GSM887044
DR GEO; GSM888114
DR GEO; GSM1374504
DR GEO; GSM1374505
DR GEO; GSM1669850
DR KCB; KCB 2014032YJ
DR LINCS; 50211
RX PubMed=9833771;
RX PubMed=9865903;
RX PubMed=11314036;
RX PubMed=12353263;
RX PubMed=12800145;
RX PubMed=19582160;
RX PubMed=20070913;
RX PubMed=20679594;
RX PubMed=22460905;
RX PubMed=23601657;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.pawefish.path.cam.ac.uk/BreastCellLineDescriptions/HCC1806.html
WW http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=HCC1806
WW http://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: ICBP43 breast cancer cell line panel.
CC Part of: KuDOS 95 cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Array-based CGH.
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: miRNA expression profiling.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; PubMed=20679594; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 10
ST D18S51: 16
ST D19S433: 14
ST D21S11: 29
ST D2S1338: 17
ST D3S1358: 16
ST D5S818: 13
ST D7S820: 10,12
ST D8S1179: 14,15
ST FGA: 25
ST Penta D: 15
ST Penta E: 12
ST TH01: 8
ST TPOX: 8,9
ST vWA: 16,18
DI NCIt; C40359; Squamous cell breast carcinoma, acantholytic variant
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC1820
AC CVCL_V652
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID HCC1833
AC CVCL_5129
SY HCC-1833
DR BioSample; SAMN03470860
DR CCLE; HCC1833_LUNG
DR Cosmic; 903639
DR Cosmic; 1146928
DR GEO; GSM62338
DR GEO; GSM253423
DR GEO; GSM434312
DR GEO; GSM794389
DR IGRhCellID; HCC1833_02GEO
DR KCLB; 71833
DR PRIDE; PXD002556
RX PubMed=10353731;
RX PubMed=20679594;
RX PubMed=26361996;
RX PubMed=28196595;
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Deep proteome analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: Transcriptome analysis.
ST Source(s): KCLB; PubMed=20679594; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8,11
ST D16S539: 11 (PubMed=20679594)
ST D16S539: 9,11 (PubMed=25877200)
ST D18S51: 17
ST D19S433: 13,14
ST D21S11: 28
ST D2S1338: 19,23
ST D3S1358: 16
ST D5S818: 9
ST D7S820: 11,12
ST D8S1179: 13,15
ST FGA: 20
ST Penta D: 7
ST Penta E: 12
ST TH01: 8,9.3 (KCLB; PubMed=20679594)
ST TH01: 9.3 (PubMed=25877200)
ST TPOX: 8
ST vWA: 19
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC1897
AC CVCL_V578
SY HCC-1897
DR BioSample; SAMN03470862
DR CCLE; HCC1897_LUNG
DR GEO; GSM794390
RX PubMed=20679594;
RX PubMed=28196595;
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=20679594; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 12,13
ST D18S51: 15
ST D19S433: 13.2
ST D21S11: 28
ST D2S1338: 19
ST D3S1358: 17
ST D5S818: 9
ST D7S820: 10,11
ST D8S1179: 13,14
ST FGA: 24,25
ST Penta D: 9,10
ST Penta E: 15
ST TH01: 9
ST TPOX: 8,11
ST vWA: 20
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC19
AC CVCL_V720
SY HCC0019
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC1908
AC CVCL_V639
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC193
AC CVCL_5130
SY HCC0193
DR EFO; EFO_0003130
DR BioSample; SAMN03472990
DR Cosmic; 877256
DR Cosmic; 903629
DR Cosmic; 1146929
DR Cosmic; 1239872
DR Cosmic; 1518093
DR Cosmic; 2125260
DR GEO; GSM62334
DR GEO; GSM253372
DR GEO; GSM434260
DR GEO; GSM794377
DR IGRhCellID; HCC193GEO
RX PubMed=10987304;
RX PubMed=11314036;
RX PubMed=19472407;
RX PubMed=20679594;
RX PubMed=25485619;
RX PubMed=28196595;
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Deep RNAseq analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=20679594; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 9,12
ST D13S317: 11
ST D16S539: 12,13
ST D18S51: 12,18
ST D21S11: 30,31.2
ST D3S1358: 16
ST D5S818: 12
ST D7S820: 10,11
ST D8S1179: 13,14
ST FGA: 25,26
ST Penta D: 9,13
ST Penta E: 14,18
ST TH01: 6
ST TPOX: 9,11
ST vWA: 16
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_S838 ! HCC193 BL
SX Female
CA Cancer cell line
//
ID HCC193 BL
AC CVCL_S838
SY HCC193-BL; HCC193BL
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5130 ! HCC193
SX Female
CA Transformed cell line
//
ID HCC1937
AC CVCL_0290
SY HCC-1937
DR BTO; BTO:0003323
DR CLO; CLO_0003645
DR EFO; EFO_0001174
DR MCCL; MCC:0000180
DR ATCC; CRL-2336
DR BioSample; SAMN01821555
DR BioSample; SAMN01821629
DR BioSample; SAMN03473202
DR CCLE; HCC1937_BREAST
DR CCRID; 3131C0001000700148
DR ChEMBL-Cells; CHEMBL3308371
DR ChEMBL-Targets; CHEMBL1075458
DR Cosmic; 749714
DR Cosmic; 904368
DR Cosmic; 1007153
DR Cosmic; 1046927
DR Cosmic; 1047704
DR Cosmic; 1176626
DR Cosmic; 1235083
DR Cosmic; 1287892
DR Cosmic; 1289389
DR Cosmic; 1309007
DR Cosmic; 1430351
DR Cosmic; 1460235
DR Cosmic; 1472999
DR Cosmic; 1518113
DR Cosmic; 1603207
DR Cosmic; 1995427
DR Cosmic; 2009511
DR Cosmic; 2164992
DR Cosmic-CLP; 749714
DR DSMZ; ACC-513
DR GDSC; 749714
DR GEO; GSM155209
DR GEO; GSM185079
DR GEO; GSM185080
DR GEO; GSM186723
DR GEO; GSM217577
DR GEO; GSM344367
DR GEO; GSM344417
DR GEO; GSM350544
DR GEO; GSM378151
DR GEO; GSM459723
DR GEO; GSM481301
DR GEO; GSM533403
DR GEO; GSM533410
DR GEO; GSM537973
DR GEO; GSM783936
DR GEO; GSM783943
DR GEO; GSM847340
DR GEO; GSM887045
DR GEO; GSM888115
DR GEO; GSM1008900
DR GEO; GSM1214588
DR GEO; GSM1374506
DR GEO; GSM1374507
DR GEO; GSM1401668
DR GEO; GSM1669851
DR IGRhCellID; HCC1937
DR KCB; KCB 200944YJ
DR KCLB; 9S1937
DR LINCS; 50212
DR Lonza; 905
DR PRIDE; PXD000309
DR PRIDE; PXD000394
DR TOKU-E; 1402
RX PubMed=9833771;
RX PubMed=9865903;
RX PubMed=11314036;
RX PubMed=12353263;
RX PubMed=12800145;
RX PubMed=14762065;
RX PubMed=16959974;
RX PubMed=17157791;
RX PubMed=17932254;
RX PubMed=19582160;
RX PubMed=20070913;
RX PubMed=22414580;
RX PubMed=22460905;
RX PubMed=23601657;
RX PubMed=24162158;
RX PubMed=25485619;
RX PubMed=25576301;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.pawefish.path.cam.ac.uk/BreastCellLineDescriptions/HCC1937.html
WW http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=HCC1937
WW http://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: ICBP43 breast cancer cell line panel.
CC Part of: KuDOS 95 cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~50 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Array-based CGH.
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: HLA class I peptidome analysis by proteomics.
CC Omics: miRNA expression profiling.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; DSMZ; KCLB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 13
ST D16S539: 13,14
ST D18S51: 12
ST D21S11: 28
ST D3S1358: 18
ST D5S818: 12
ST D7S820: 9,10
ST D8S1179: 12,13
ST FGA: 20,22
ST Penta D: 9
ST Penta E: 13
ST TH01: 6,8 (KCLB)
ST TH01: 6 (PubMed=25877200)
ST TPOX: 11
ST vWA: 16,17
DI NCIt; C4017; Ductal breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_3281 ! HCC1937 BL
SX Female
CA Cancer cell line
//
ID HCC1937 BL
AC CVCL_3281
SY HCC-1937BL; HCC1937BL
DR CLO; CLO_0003646
DR ATCC; CRL-2337
DR BioSample; SAMN03471821
DR KCLB; 9S1937BL
RX PubMed=9833771;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 13
ST D16S539: 13,14
ST D5S818: 12
ST D7S820: 9,10
ST TH01: 6
ST TPOX: 8,11
ST vWA: 16,17
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0290 ! HCC1937
SX Female
CA Transformed cell line
//
ID HCC1937/CMV-Luc
AC CVCL_4W92
SY HCC-1937/CMV-Luc
DR JCRB; JCRB1508
DR JCRB; NIHS0707
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
DI NCIt; C4017; Ductal breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0290 ! HCC1937
SX Female
CA Cancer cell line
//
ID HCC1943
AC CVCL_V661
DR BioSample; SAMN03470863
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 11,12
ST D18S51: 16,19
ST D19S433: 15
ST D21S11: 30,32.2
ST D2S1338: 24
ST D3S1358: 15,17
ST D5S818: 11,12
ST D7S820: 12,13
ST D8S1179: 10
ST FGA: 19,21
ST Penta D: 11,12
ST Penta E: 12
ST TH01: 9
ST TPOX: 8
ST vWA: 15,17
DI NCIt; C39851; Bladder urothelial carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC1944
AC CVCL_V603
DR BioSample; SAMN03470845
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
ST Source(s): PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 11,14
ST D16S539: 11,13
ST D18S51: 16
ST D21S11: 29,30
ST D3S1358: 17
ST D5S818: 11
ST D7S820: 11
ST D8S1179: 13,14
ST FGA: 21,24
ST Penta D: 11,12
ST Penta E: 7,15
ST TH01: 7
ST TPOX: 10,11
ST vWA: 16,17
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC1945
AC CVCL_V604
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC1954
AC CVCL_1259
SY HCC-1954
DR BTO; BTO:0005368
DR CLO; CLO_0003647
DR EFO; EFO_0001175
DR ATCC; CRL-2338
DR BCRJ; 0280
DR BioSample; SAMN03473018
DR CCLE; HCC1954_BREAST
DR ChEMBL-Cells; CHEMBL3308107
DR ChEMBL-Targets; CHEMBL1075459
DR Cosmic; 749709
DR Cosmic; 904369
DR Cosmic; 1136367
DR Cosmic; 1235077
DR Cosmic; 1287889
DR Cosmic; 1308993
DR Cosmic; 1430345
DR Cosmic; 1473150
DR Cosmic; 1518107
DR Cosmic; 1603208
DR Cosmic; 1717243
DR Cosmic; 1935009
DR Cosmic; 1995428
DR Cosmic; 2165007
DR Cosmic-CLP; 749709
DR GDSC; 749709
DR GEO; GSM185081
DR GEO; GSM185082
DR GEO; GSM186724
DR GEO; GSM217578
DR GEO; GSM303673
DR GEO; GSM303675
DR GEO; GSM303680
DR GEO; GSM303682
DR GEO; GSM303684
DR GEO; GSM303687
DR GEO; GSM303689
DR GEO; GSM303691
DR GEO; GSM303695
DR GEO; GSM303698
DR GEO; GSM303700
DR GEO; GSM303704
DR GEO; GSM303707
DR GEO; GSM303709
DR GEO; GSM303712
DR GEO; GSM303715
DR GEO; GSM303719
DR GEO; GSM303721
DR GEO; GSM303723
DR GEO; GSM303726
DR GEO; GSM303729
DR GEO; GSM303731
DR GEO; GSM303735
DR GEO; GSM303738
DR GEO; GSM303740
DR GEO; GSM303742
DR GEO; GSM303745
DR GEO; GSM303747
DR GEO; GSM303750
DR GEO; GSM303753
DR GEO; GSM303754
DR GEO; GSM303760
DR GEO; GSM303762
DR GEO; GSM303766
DR GEO; GSM303769
DR GEO; GSM303770
DR GEO; GSM303775
DR GEO; GSM303777
DR GEO; GSM303780
DR GEO; GSM303784
DR GEO; GSM303786
DR GEO; GSM303789
DR GEO; GSM337683
DR GEO; GSM337684
DR GEO; GSM337685
DR GEO; GSM337686
DR GEO; GSM337687
DR GEO; GSM337688
DR GEO; GSM337689
DR GEO; GSM337690
DR GEO; GSM337691
DR GEO; GSM337692
DR GEO; GSM337693
DR GEO; GSM337694
DR GEO; GSM337695
DR GEO; GSM344374
DR GEO; GSM344424
DR GEO; GSM350499
DR GEO; GSM481299
DR GEO; GSM718290
DR GEO; GSM783937
DR GEO; GSM847341
DR GEO; GSM847483
DR GEO; GSM887046
DR GEO; GSM888116
DR GEO; GSM1008901
DR GEO; GSM1215272
DR GEO; GSM1374508
DR GEO; GSM1374509
DR GEO; GSM1401665
DR GEO; GSM1669852
DR IGRhCellID; HCC1954
DR KCLB; 9S1954
DR LINCS; 50213
DR Lonza; 1357
DR PRIDE; PXD002486
RX PubMed=9833771;
RX PubMed=11314036;
RX PubMed=16959974;
RX PubMed=17157791;
RX PubMed=17932254;
RX PubMed=19582160;
RX PubMed=20070913;
RX PubMed=21378333;
RX PubMed=22460905;
RX PubMed=23601657;
RX PubMed=24162158;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.pawefish.path.cam.ac.uk/BreastCellLineDescriptions/HCC1954.html
WW http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=HCC1954
WW http://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: ICBP43 breast cancer cell line panel.
CC Part of: KuDOS 95 cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 45 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Array-based CGH.
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: miRNA expression profiling.
CC Omics: shRNA library screening.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 8,9
ST D16S539: 9,11
ST D18S51: 14,18
ST D21S11: 28,32.2
ST D3S1358: 15,16
ST D5S818: 11
ST D7S820: 10,11
ST D8S1179: 12,15
ST FGA: 22,23
ST Penta D: 9,12
ST Penta E: 12,16
ST TH01: 6,7
ST TPOX: 8,9
ST vWA: 18,19
DI NCIt; C4017; Ductal breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1260 ! HCC1954 BL
SX Female
CA Cancer cell line
//
ID HCC1954 BL
AC CVCL_1260
SY HCC-1954BL; HCC1954BL
DR CLO; CLO_0003648
DR ATCC; CRL-2339
DR BioSample; SAMN03471822
DR KCLB; 9S1954BL
RX PubMed=9833771;
RX PubMed=14762065;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 8,9
ST D16S539: 9,11
ST D5S818: 11,12
ST D7S820: 10,11
ST TH01: 6,7
ST TPOX: 8,9
ST vWA: 18,19
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1259 ! HCC1954
SX Female
CA Transformed cell line
//
ID HCC1954-Luc
AC CVCL_4W93
SY HCC-1954-Luc
DR JCRB; JCRB1476
DR JCRB; NIHS0708
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 8,9
ST D16S539: 9,11
ST D5S818: 11
ST D7S820: 10,11
ST TH01: 6,7
ST TPOX: 8,9
ST vWA: 18,19
DI NCIt; C4017; Ductal breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1259 ! HCC1954
SX Female
CA Cancer cell line
//
ID HCC1963
AC CVCL_V614
DR Cosmic; 903640
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC1972
AC CVCL_V739
DR BioSample; SAMN03470864
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11,13
ST D16S539: 10,13
ST D18S51: 11,12
ST D19S433: 12,14
ST D21S11: 30,31.2
ST D2S1338: 19,24
ST D3S1358: 14,17
ST D5S818: 11,13
ST D7S820: 12
ST D8S1179: 12,15
ST FGA: 21,22
ST Penta D: 13,14
ST Penta E: 7,13
ST TH01: 6
ST TPOX: 10,11
ST vWA: 14,18
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC1974
AC CVCL_V615
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID HCC202
AC CVCL_2062
SY HCC-202; HCC0202
DR CLO; CLO_0003649
DR EFO; EFO_0001176
DR ATCC; CRL-2316
DR BioSample; SAMN03471302
DR CCLE; HCC202_BREAST
DR Cosmic; 687482
DR Cosmic; 904358
DR Cosmic; 1018461
DR Cosmic; 1047702
DR Cosmic; 1136360
DR Cosmic; 1287882
DR Cosmic; 1603209
DR Cosmic; 1935002
DR Cosmic; 1995429
DR Cosmic; 2165008
DR Cosmic-CLP; 1290906
DR GDSC; 1290906
DR GEO; GSM186725
DR GEO; GSM186726
DR GEO; GSM344369
DR GEO; GSM344419
DR GEO; GSM350515
DR GEO; GSM783972
DR GEO; GSM827455
DR GEO; GSM847342
DR GEO; GSM847484
DR GEO; GSM844089
DR GEO; GSM887047
DR GEO; GSM888117
DR GEO; GSM1374510
DR GEO; GSM1669853
DR KCLB; 9S0202
DR LINCS; 50214
DR PRIDE; PXD000309
RX PubMed=9833771;
RX PubMed=11314036;
RX PubMed=17157791;
RX PubMed=19582160;
RX PubMed=22414580;
RX PubMed=22460905;
RX PubMed=23601657;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: ICBP43 breast cancer cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: miRNA expression profiling.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; KCLB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 8,9
ST D16S539: 13
ST D18S51: 17
ST D21S11: 26
ST D3S1358: 16
ST D5S818: 11,13
ST D7S820: 8,12
ST D8S1179: 15
ST FGA: 24
ST Penta D: 12,15
ST Penta E: 8
ST TH01: 6
ST TPOX: 8,9
ST vWA: 16
DI NCIt; C4017; Ductal breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC2036
AC CVCL_9Y86
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HCC2041
AC CVCL_V619
DI NCIt; C9119; Medullary breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC2108
AC CVCL_A352
SY HCC-2108
DR BioSample; SAMN03470865
DR CCLE; HCC2108_LUNG
DR Cosmic; 903641
DR GEO; GSM794391
DR KCLB; 72108
RX PubMed=10353731;
RX PubMed=28196595;
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: Transcriptome analysis.
ST Source(s): KCLB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11
ST D16S539: 12
ST D18S51: 16
ST D19S433: 13
ST D21S11: 28,30
ST D2S1338: 19
ST D3S1358: 15
ST D5S818: 11,13
ST D7S820: 9,11
ST D8S1179: 12,13
ST FGA: 22
ST Penta D: 10,13
ST Penta E: 12
ST TH01: 7,9 (KCLB)
ST TH01: 9 (PubMed=25877200)
ST TPOX: 10,11
ST vWA: 16
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC2157
AC CVCL_1261
DR CLO; CLO_0003650
DR EFO; EFO_0001177
DR ATCC; CRL-2340
DR BioSample; SAMN03470829
DR BioSample; SAMN03471823
DR CCLE; HCC2157_BREAST
DR ChEMBL-Cells; CHEMBL3308891
DR ChEMBL-Targets; CHEMBL2366126
DR Cosmic; 749715
DR Cosmic; 904370
DR Cosmic; 1018472
DR Cosmic; 1235084
DR Cosmic; 1430341
DR Cosmic; 1460236
DR Cosmic; 1473033
DR Cosmic; 1518114
DR Cosmic; 1603210
DR Cosmic; 1995430
DR Cosmic-CLP; 749715
DR GDSC; 749715
DR GEO; GSM350525
DR GEO; GSM783938
DR GEO; GSM847343
DR GEO; GSM847485
DR GEO; GSM887048
DR GEO; GSM888118
DR GEO; GSM1669854
DR IGRhCellID; HCC2157
DR LINCS; 50581
RX PubMed=9833771;
RX PubMed=9865903;
RX PubMed=11314036;
RX PubMed=16959974;
RX PubMed=17157791;
RX PubMed=17932254;
RX PubMed=19582160;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
WW http://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: ICBP43 breast cancer cell line panel.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 12
ST D16S539: 11 (ATCC; Cosmic-CLP)
ST D16S539: 11,12 (PubMed=25877200)
ST D18S51: 15
ST D21S11: 28,29
ST D3S1358: 16,18
ST D5S818: 13
ST D7S820: 9,10,12 (ATCC)
ST D7S820: 10,12 (Cosmic-CLP; PubMed=25877200)
ST D8S1179: 13
ST FGA: 21
ST Penta D: 8,10
ST Penta E: 12,15
ST TH01: 8,9
ST TPOX: 9,11
ST vWA: 14,18
DI NCIt; C4017; Ductal breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1262 ! HCC2157 BL
SX Female
CA Cancer cell line
//
ID HCC2157 BL
AC CVCL_1262
SY HCC-2157BL; HCC2157BL
DR CLO; CLO_0003651
DR ATCC; CRL-2341
DR BioSample; SAMN03471825
DR KCLB; 9S2157BL
RX PubMed=9833771;
RX PubMed=14762065;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): ATCC; KCLB
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 12
ST D16S539: 11,12
ST D3S1358: 16,18
ST D5S818: 12,13
ST D7S820: 10,12
ST TH01: 8,9
ST TPOX: 9,11
ST vWA: 14,18
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1261 ! HCC2157
SX Female
CA Transformed cell line
//
ID HCC2185
AC CVCL_3375
SY HCC-2185; HCC 2185
DR EFO; EFO_0001178
DR ATCC; CRL-2342
DR BioSample; SAMN03472913
DR Cosmic; 1136368
DR GEO; GSM350519
DR KCLB; 9S2185
DR LINCS; 51093
RX PubMed=9833771;
RX PubMed=11314036;
RX PubMed=17157791;
RX PubMed=19582160;
RX PubMed=20679594;
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC Omics: CNV analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: ATCC; CRL-2342; true.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): PubMed=20679594; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 8,10
ST D13S317: 12
ST D16S539: 10
ST D18S51: 15
ST D19S433: 13
ST D21S11: 32.2
ST D2S1338: 20
ST D3S1358: 15,16
ST D5S818: 11,12
ST D7S820: 12,13
ST D8S1179: 14
ST FGA: 23
ST Penta D: 11
ST Penta E: 10
ST TH01: 9.3
ST TPOX: 11
ST vWA: 18,19
DI NCIt; C76328; Metastatic lobular breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC2218
AC CVCL_1263
SY HCC-2218
DR CLO; CLO_0003652
DR EFO; EFO_0002187
DR ATCC; CRL-2343
DR BioSample; SAMN03471426
DR BioSample; SAMN03471824
DR CCLE; HCC2218_BREAST
DR ChEMBL-Cells; CHEMBL3308869
DR ChEMBL-Targets; CHEMBL2366221
DR Cosmic; 749716
DR Cosmic; 904371
DR Cosmic; 1047711
DR Cosmic; 1235085
DR Cosmic; 1287915
DR Cosmic; 1430342
DR Cosmic; 1473120
DR Cosmic; 1518115
DR Cosmic; 1603211
DR Cosmic; 1995431
DR Cosmic; 2165009
DR Cosmic-CLP; 749716
DR GDSC; 749716
DR GEO; GSM155211
DR GEO; GSM185083
DR GEO; GSM185084
DR GEO; GSM186727
DR GEO; GSM344375
DR GEO; GSM344425
DR GEO; GSM350520
DR GEO; GSM533404
DR GEO; GSM533411
DR GEO; GSM537974
DR GEO; GSM783939
DR GEO; GSM847344
DR GEO; GSM847486
DR GEO; GSM844548
DR GEO; GSM887049
DR GEO; GSM888119
DR GEO; GSM1661980
DR GEO; GSM1669855
DR IGRhCellID; HCC2218
DR KCLB; 9S2218
DR LINCS; 50582
DR PRIDE; PXD000309
RX PubMed=9833771;
RX PubMed=9865903;
RX PubMed=11314036;
RX PubMed=16959974;
RX PubMed=17932254;
RX PubMed=19582160;
RX PubMed=20070913;
RX PubMed=20679594;
RX PubMed=22414580;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW http://www.completegenomics.com/documents/PublicGenomes.pdf
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: ICBP43 breast cancer cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 120 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Array-based CGH.
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Genome sequenced.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; KCLB; PubMed=20679594; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11,12
ST D16S539: 9
ST D18S51: 10,13,14
ST D21S11: 28
ST D3S1358: 16
ST D5S818: 11
ST D7S820: 10,14 (ATCC; PubMed=20679594)
ST D7S820: 14 (Cosmic-CLP; KCLB; PubMed=25877200)
ST D8S1179: 13,14
ST FGA: 24
ST Penta D: 12,14
ST Penta E: 15,18
ST TH01: 8,9.3
ST TPOX: 8,11 (ATCC; Cosmic-CLP; PubMed=20679594; PubMed=25877200)
ST TPOX: 8 (KCLB)
ST vWA: 14,18
DI NCIt; C4017; Ductal breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1264 ! HCC2218 BL
SX Female
CA Cancer cell line
//
ID HCC2218 BL
AC CVCL_1264
SY HCC-2218BL; HCC 2218 BL; HCC2218BL
DR CLO; CLO_0003653
DR ATCC; CRL-2363
DR BioSample; SAMN03471831
RX PubMed=9833771;
RX PubMed=14762065;
WW http://www.completegenomics.com/documents/PublicGenomes.pdf
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Genome sequenced.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11,12
ST D16S539: 9,13
ST D5S818: 11
ST D7S820: 10,14
ST TH01: 8,9.3
ST TPOX: 8,11
ST vWA: 14,18
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1263 ! HCC2218
SX Female
CA Transformed cell line
//
ID HCC2270
AC CVCL_V635
DR EFO; EFO_0006430
DR BioSample; SAMN03473069
RX PubMed=25485619;
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,14
ST D13S317: 8,11
ST D16S539: 13
ST D18S51: 14
ST D21S11: 29,30
ST D3S1358: 15
ST D5S818: 11
ST D7S820: 10,12
ST D8S1179: 10,12
ST FGA: 18,24
ST Penta D: 12,14
ST Penta E: 5,13
ST TH01: 9
ST TPOX: 10,11
ST vWA: 17,18
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC2279
AC CVCL_5131
SY HCC-2279
DR EFO; EFO_0005374
DR EFO; EFO_0006431
DR ATCC; CRL-2870
DR BioSample; SAMN03472992
DR CCLE; HCC2279_LUNG
DR Cosmic; 903642
DR Cosmic; 1128248
DR Cosmic; 1146930
DR GEO; GSM63348
DR GEO; GSM253421
DR GEO; GSM434283
DR GEO; GSM794392
DR GEO; GSM887050
DR GEO; GSM888120
DR IGRhCellID; HCC2279GEO
DR KCLB; 72279
RX PubMed=10353731;
RX PubMed=20679594;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=28196595;
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Deep RNAseq analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'HCC227' in EFO EFO_0005374.
CC Discontinued: ATCC; CRL-2870; true.
ST Source(s): ATCC; KCLB; PubMed=20679594; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 11
ST D18S51: 20
ST D21S11: 29,32.2
ST D3S1358: 17,18
ST D5S818: 10,11
ST D7S820: 11
ST D8S1179: 16
ST FGA: 19,25 (KCLB)
ST FGA: 19 (PubMed=25877200)
ST Penta D: 10,12
ST Penta E: 12,14
ST TH01: 9
ST TPOX: 11
ST vWA: 14,17
DI NCIt; C9133; Adenosquamous lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC229
AC CVCL_V721
SY HCC0229
DI NCIt; C4028; Cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC2302
AC CVCL_V636
DR EFO; EFO_0006432
DR BioSample; SAMN03473005
DR GEO; GSM1682812
RX PubMed=25485619;
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 8,12
ST D16S539: 11
ST D18S51: 12,18
ST D21S11: 30
ST D3S1358: 15
ST D5S818: 11,12
ST D7S820: 9,12
ST D8S1179: 12,13
ST FGA: 20,21
ST Penta D: 12
ST Penta E: 14
ST TH01: 9.3
ST TPOX: 8,12
ST vWA: 16,17
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC2308
AC CVCL_V662
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC2312
AC CVCL_V669
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC2344
AC CVCL_V638
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC2352
AC CVCL_V637
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
DI NCIt; C9133; Adenosquamous lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC2373
AC CVCL_L090
SY HCC-2373
DR KCLB; 72373
DI NCIt; C4878; Lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC2374
AC CVCL_A353
SY HCC-2374
DR BioSample; SAMN03470866
DR Cosmic; 903643
DR GEO; GSM794393
RX PubMed=20679594;
RX PubMed=28196595;
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=20679594; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 7
ST D13S317: 11,14 (PubMed=20679594)
ST D13S317: 14 (PubMed=25877200)
ST D16S539: 11
ST D18S51: 18
ST D19S433: 13,15
ST D21S11: 28,30
ST D2S1338: 22,24
ST D3S1358: 16
ST D5S818: 10
ST D7S820: 10,11
ST D8S1179: 14
ST FGA: 18.2
ST Penta D: 8
ST Penta E: 7
ST TH01: 8,9.3 (PubMed=20679594)
ST TH01: 8 (PubMed=25877200)
ST TPOX: 8,9
ST vWA: 17,19
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC2389
AC CVCL_V600
RX PubMed=9865903;
DI NCIt; C4017; Ductal breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC2393
AC CVCL_V601
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID HCC2414
AC CVCL_V602
DI NCIt; C4017; Ductal breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC242
AC CVCL_V722
SY HCC0242
DI NCIt; C39851; Bladder urothelial carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC2429
AC CVCL_5132
DR Cosmic; 903644
DR Cosmic; 1146931
DR Cosmic; 1340147
DR Cosmic; 1518099
DR GEO; GSM253412
DR GEO; GSM434319
DR GEO; GSM794394
DR IGRhCellID; HCC2429GEO
RX PubMed=15994877;
RX PubMed=20679594;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=20679594
ST Amelogenin: X
ST CSF1PO: 10,13
ST D13S317: 11
ST D16S539: 11,13
ST D5S818: 12,14
ST D7S820: 10,11
ST TH01: 6,9
ST TPOX: 8
ST vWA: 16
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_V989 ! HCC2429 BL
SX Female
CA Cancer cell line
//
ID HCC2429 BL
AC CVCL_V989
SY HCC2429BL; BL2429
RX PubMed=15994877;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5132 ! HCC2429
SX Female
CA Transformed cell line
//
ID HCC2433
AC CVCL_V599
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC2450
AC CVCL_5133
DR Cosmic; 903645
DR Cosmic; 1146932
DR GEO; GSM62970
DR GEO; GSM253431
DR GEO; GSM434320
DR GEO; GSM794395
DR IGRhCellID; HCC2450GEO
RX PubMed=10353731;
RX PubMed=20679594;
RX PubMed=28196595;
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=20679594
ST Amelogenin: X,Y
ST CSF1PO: 13
ST D13S317: 11
ST D16S539: 11,13
ST D5S818: 12
ST D7S820: 9
ST TH01: 6
ST TPOX: 8
ST vWA: 16
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC267
AC CVCL_V723
SY HCC0267
DI NCIt; C4017; Ductal breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC2677
AC CVCL_V584
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC2688
AC CVCL_3376
DR EFO; EFO_0006433
DR BioSample; SAMN03473199
DR GEO; GSM350545
RX PubMed=19582160;
RX PubMed=20679594;
RX PubMed=25485619;
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC Omics: CNV analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=20679594; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 8
ST D16S539: 12
ST D18S51: 13
ST D21S11: 27,31.2
ST D3S1358: 15
ST D5S818: 13
ST D7S820: 9
ST D8S1179: 13
ST FGA: 20
ST Penta D: 11,13
ST Penta E: 12
ST TH01: 6
ST TPOX: 8
ST vWA: 14,15
DI NCIt; C4017; Ductal breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC2713
AC CVCL_A350
SY HCC-2713
DR Cosmic; 1235087
RX PubMed=16959974;
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
DI NCIt; C4017; Ductal breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC2771
AC CVCL_V583
DI NCIt; C4017; Ductal breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC2783
AC CVCL_V585
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC2814
AC CVCL_V586
SY HCC-2814
DR BioSample; SAMN03470867
DR CCLE; HCC2814_LUNG
DR GEO; GSM794396
RX PubMed=20679594;
RX PubMed=25984343;
RX PubMed=28196595;
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 24 hours (PubMed=25984343).
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=20679594; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 13
ST D13S317: 10,11
ST D16S539: 11,13 (PubMed=20679594)
ST D16S539: 10,11,13 (PubMed=25877200)
ST D18S51: 12
ST D19S433: 13,14
ST D21S11: 29
ST D2S1338: 24
ST D3S1358: 17
ST D5S818: 12
ST D7S820: 10
ST D8S1179: 15
ST FGA: 24
ST Penta D: 9
ST Penta E: 10
ST TH01: 6,8 (PubMed=20679594)
ST TH01: 8 (PubMed=25877200)
ST TPOX: 11
ST vWA: 16,17
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC2846
AC CVCL_V587
DR BioSample; SAMN03470868
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 13
ST D16S539: 11,12
ST D18S51: 14
ST D19S433: 13
ST D21S11: 29,32.2
ST D2S1338: 22,24
ST D3S1358: 15,19
ST D5S818: 12
ST D7S820: 10
ST D8S1179: 12,13
ST FGA: 23,25
ST Penta D: 13
ST Penta E: 7,11
ST TH01: 6
ST TPOX: 10,11
ST vWA: 14,17
DI NCIt; C39851; Bladder urothelial carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC2858
AC CVCL_9Y87
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HCC2879
AC CVCL_9Y88
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HCC2885
AC CVCL_V588
DR EFO; EFO_0006434
DR BioSample; SAMN03473013
RX PubMed=25485619;
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
ST Source(s): PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 10
ST D16S539: 9,11
ST D18S51: 12
ST D21S11: 32
ST D3S1358: 14
ST D5S818: 7,11
ST D7S820: 8,11
ST D8S1179: 10,13
ST FGA: 20,23
ST Penta D: 13
ST Penta E: 5,10
ST TH01: 7,9.3
ST TPOX: 8
ST vWA: 18
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC2911
AC CVCL_0V16
DR EFO; EFO_0006435
DR BioSample; SAMN03473200
RX PubMed=25485619;
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 8,13
ST D13S317: 12,13
ST D16S539: 11,13
ST D18S51: 15
ST D21S11: 30,32.2
ST D3S1358: 17,18
ST D5S818: 11,12
ST D7S820: 8
ST D8S1179: 12,14
ST FGA: 21
ST Penta D: 9,10
ST Penta E: 7
ST TH01: 6,9.3
ST TPOX: 9,12
ST vWA: 16,18
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC2935
AC CVCL_1265
SY HCC-2935
DR BTO; BTO:0004083
DR CLO; CLO_0003654
DR EFO; EFO_0005375
DR ATCC; CRL-2869
DR BioSample; SAMN03471880
DR CCLE; HCC2935_LUNG
DR Cosmic; 903646
DR Cosmic; 1128249
DR Cosmic; 1146933
DR GEO; GSM253407
DR GEO; GSM434284
DR GEO; GSM794397
DR GEO; GSM844549
DR GEO; GSM887051
DR GEO; GSM888121
DR IGRhCellID; HCC2935GEO
DR PRIDE; PXD002556
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=26361996;
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 12
ST D18S51: 14
ST D21S11: 28
ST D3S1358: 15
ST D5S818: 13
ST D7S820: 12,13
ST D8S1179: 12
ST FGA: 24
ST Penta D: 12
ST Penta E: 7,12
ST TH01: 7,9
ST TPOX: 8
ST vWA: 17
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC2962
AC CVCL_9Y89
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HCC2974
AC CVCL_9Y90
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HCC2998
AC CVCL_1266
SY HCC-2998; HCC.2998; HCC 2998
DR BTO; BTO:0003322
DR EFO; EFO_0005370
DR ChEMBL-Cells; CHEMBL3308074
DR ChEMBL-Targets; CHEMBL613855
DR Cosmic; 875899
DR Cosmic; 905971
DR Cosmic; 974245
DR Cosmic; 1092599
DR Cosmic; 1305352
DR Cosmic; 1312337
DR Cosmic; 1436017
DR Cosmic; 1479602
DR Cosmic; 1676741
DR Cosmic; 1803942
DR Cosmic; 1998441
DR Cosmic; 2301977
DR Cosmic-CLP; 905971
DR GDSC; 905971
DR GEO; GSM50187
DR GEO; GSM50251
DR GEO; GSM750796
DR GEO; GSM799330
DR GEO; GSM799393
DR GEO; GSM846354
DR GEO; GSM844550
DR GEO; GSM844551
DR GEO; GSM1153401
DR GEO; GSM1181249
DR GEO; GSM1181265
DR GEO; GSM1346873
DR GEO; GSM1448169
DR GEO; GSM1669856
DR SKY/M-FISH/CGH; 2794
RX PubMed=2041050;
RX PubMed=17088437;
RX PubMed=19372543;
RX PubMed=20606684;
RX PubMed=22336246;
RX PubMed=23856246;
RX PubMed=23933261;
RX PubMed=24755471;
RX PubMed=25926053;
RX PubMed=27397505;
RX PubMed=27807467;
RX PubMed=28196595;
WW https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=16
WW http://tcpaportal.org/mclp/
CC Part of: JFCR39 cancer cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: NCI60 cancer cell line panel.
CC Doubling time: 31.5 hours (DTP).
CC Microsatellite instability: Stable (MSS) (PubMed=25926053; Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; PubMed=19372543
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 11,12
ST D16S539: 9,12
ST D18S51: 12,15
ST D19S433: 12,15
ST D21S11: 29,30
ST D2S1338: 18,23
ST D3S1358: 17,19
ST D5S818: 12
ST D7S820: 10,11
ST D8S1179: 11,14
ST FGA: 25
ST TH01: 7,9.3
ST TPOX: 8,11
ST vWA: 18,19
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID HCC3051
AC CVCL_V582
DR BioSample; SAMN03470869
DR GEO; GSM794398
RX PubMed=28196595;
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 7,9
ST D13S317: 12
ST D16S539: 10,11
ST D18S51: 15
ST D19S433: 13
ST D21S11: 31
ST D2S1338: 22,23
ST D3S1358: 15
ST D5S818: 10,11
ST D7S820: 10,12
ST D8S1179: 13,17
ST FGA: 21,23
ST Penta D: 9
ST Penta E: 5,7
ST TH01: 7,9.3
ST TPOX: 6,9
ST vWA: 17,18
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC31
AC CVCL_V724
SY HCC0031
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC3153
AC CVCL_3377
SY HCC 3153
DR EFO; EFO_0001179
DR BioSample; SAMN03470870
DR Cosmic; 1136375
DR Cosmic; 1176634
DR GEO; GSM350507
DR LINCS; 51094
RX PubMed=17157791;
RX PubMed=19582160;
RX PubMed=20679594;
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC Omics: CNV analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=20679594; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 9
ST D16S539: 11
ST D18S51: 17
ST D19S433: 12,14.2
ST D21S11: 28,32
ST D2S1338: 20
ST D3S1358: 16
ST D5S818: 11
ST D7S820: 9,10
ST D8S1179: 13
ST FGA: 19
ST Penta D: 2.2,5
ST Penta E: 7,13
ST TH01: 9
ST TPOX: 8
ST vWA: 13,16
DI NCIt; C4017; Ductal breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC317
AC CVCL_V725
SY HCC0317
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC3172
AC CVCL_9Y91
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HCC3212
AC CVCL_0V17
DR BioSample; SAMN03470875
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,13
ST D16S539: 9,13
ST D18S51: 13
ST D19S433: 14
ST D21S11: 28,30
ST D2S1338: 19
ST D3S1358: 15,17
ST D5S818: 11
ST D7S820: 10,11
ST D8S1179: 12
ST FGA: 22
ST Penta D: 9,13
ST Penta E: 13,14
ST TH01: 7,8
ST TPOX: 8,9
ST vWA: 16,18
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID HCC3270
AC CVCL_9Y92
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HCC33
AC CVCL_2058
SY HCC-33; HCC0033
DR EFO; EFO_0006417
DR BioSample; SAMN03473100
DR CCLE; HCC33_LUNG
DR Cosmic; 877235
DR Cosmic; 1219093
DR Cosmic; 1239927
DR Cosmic; 1320184
DR Cosmic; 1518101
DR Cosmic; 2125212
DR Cosmic-CLP; 1303901
DR DSMZ; ACC-487
DR GDSC; 1303901
DR GEO; GSM794373
DR GEO; GSM887052
DR GEO; GSM888122
DR GEO; GSM1669857
DR KCLB; 70033
RX PubMed=10987304;
RX PubMed=11314036;
RX PubMed=19472407;
RX PubMed=20679594;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~40 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=20679594; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11,13
ST D16S539: 11,12
ST D18S51: 12,17
ST D21S11: 30,32
ST D3S1358: 16
ST D5S818: 11
ST D7S820: 11
ST D8S1179: 13,14
ST FGA: 20,23
ST Penta D: 10,12
ST Penta E: 14
ST TH01: 9
ST TPOX: 8,11
ST vWA: 16,18
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L063 ! HCC33 BL
SX Male
CA Cancer cell line
//
ID HCC33 BL
AC CVCL_L063
SY HCC-33BL; HCC33BL
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2058 ! HCC33
SX Male
CA Transformed cell line
//
ID HCC3303
AC CVCL_0V18
DR BioSample; SAMN03470876
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 14
ST D16S539: 13
ST D18S51: 18,19
ST D19S433: 14,17
ST D21S11: 35
ST D2S1338: 20,24
ST D3S1358: 15
ST D5S818: 8
ST D7S820: 8,11
ST D8S1179: 13
ST FGA: 24
ST Penta D: 11
ST Penta E: 7,9
ST TH01: 7
ST TPOX: 6,8
ST vWA: 15,16
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HCC3321
AC CVCL_9Y93
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HCC3335
AC CVCL_9Y94
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HCC3350
AC CVCL_9Y95
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HCC3369
AC CVCL_9Y96
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HCC3388
AC CVCL_9Y97
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HCC3410
AC CVCL_9Y98
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HCC3418
AC CVCL_9Y99
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HCC3440
AC CVCL_9Z00
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HCC345
AC CVCL_V726
SY HCC0345
DR BioSample; SAMN03470838
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
ST Source(s): PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11,12
ST D16S539: 9
ST D18S51: 18
ST D21S11: 29
ST D3S1358: 15
ST D5S818: 11,12
ST D7S820: 9,10
ST D8S1179: 13
ST FGA: 20,23
ST Penta D: 2.2
ST Penta E: 11,13
ST TH01: 7
ST TPOX: 8,11
ST vWA: 16,18
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC3498
AC CVCL_9Z01
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HCC3524
AC CVCL_9Z02
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HCC3531
AC CVCL_9Z03
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HCC364
AC CVCL_5134
SY HCC0364
DR EFO; EFO_0006420
DR BioSample; SAMN03473003
DR CCLE; HCC364_LUNG
DR Cosmic; 903630
DR Cosmic; 1146934
DR Cosmic; 1209733
DR Cosmic; 2472917
DR GEO; GSM434285
DR GEO; GSM794378
DR IGRhCellID; HCC364GEO
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=28196595;
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 24 hours (PubMed=25984343).
CC Omics: Deep RNAseq analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 11
ST D18S51: 13
ST D19S433: 13
ST D21S11: 29
ST D2S1338: 25
ST D3S1358: 14,16
ST D5S818: 12,13
ST D7S820: 10,12
ST D8S1179: 12,14
ST FGA: 20,24
ST Penta D: 13
ST Penta E: 12,18
ST TH01: 9.3
ST TPOX: 8,11
ST vWA: 16,18
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC366
AC CVCL_2059
SY HCC-366; HCC0366
DR EFO; EFO_0003131
DR BioSample; SAMN03473079
DR CCLE; HCC366_LUNG
DR Cosmic; 877261
DR Cosmic; 903631
DR Cosmic; 1146935
DR Cosmic; 1239916
DR Cosmic; 1518096
DR Cosmic; 2125184
DR Cosmic-CLP; 1240144
DR DSMZ; ACC-492
DR GDSC; 1240144
DR GEO; GSM62335
DR GEO; GSM253363
DR GEO; GSM434261
DR GEO; GSM784223
DR GEO; GSM794379
DR GEO; GSM827365
DR GEO; GSM887053
DR GEO; GSM888123
DR GEO; GSM1669858
DR IGRhCellID; HCC366_02GEO
DR KCLB; 70366
RX PubMed=10987304;
RX PubMed=11314036;
RX PubMed=19472407;
RX PubMed=20679594;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~60-70 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; KCLB; PubMed=20679594; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11,13 (Cosmic-CLP; DSMZ; PubMed=25877200)
ST D13S317: 13 (KCLB; PubMed=20679594)
ST D16S539: 11
ST D18S51: 19
ST D21S11: 28
ST D3S1358: 15,17
ST D5S818: 12
ST D7S820: 10,11
ST D8S1179: 15
ST FGA: 19,21
ST Penta D: 9
ST Penta E: 12
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 16
DI NCIt; C9133; Adenosquamous lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_M077 ! HCC366 BL
SX Female
CA Cancer cell line
//
ID HCC366 BL
AC CVCL_M077
SY HCC-366BL; HCC366-BL; HCC366BL
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2059 ! HCC366
SX Female
CA Transformed cell line
//
ID HCC374
AC CVCL_V727
SY HCC00374
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
DI NCIt; C3539; Malignant splenic neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC379
AC CVCL_V728
SY HCC0379
DI NCIt; C4017; Ductal breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC38
AC CVCL_1267
SY Hcc38; HCC-38; HCC 38; HCC0038
DR BTO; BTO:0005295
DR CLO; CLO_0003655
DR EFO; EFO_0001180
DR ATCC; CRL-2314
DR BioSample; SAMN03471264
DR CCLE; HCC38_BREAST
DR CCRID; 3111C0001CCC000220
DR ChEMBL-Cells; CHEMBL3308578
DR ChEMBL-Targets; CHEMBL1075460
DR Cosmic; 749717
DR Cosmic; 904356
DR Cosmic; 1018475
DR Cosmic; 1047706
DR Cosmic; 1136365
DR Cosmic; 1235078
DR Cosmic; 1287932
DR Cosmic; 1430346
DR Cosmic; 1460229
DR Cosmic; 1518108
DR Cosmic; 1603212
DR Cosmic; 1935000
DR Cosmic; 1995432
DR Cosmic; 2009508
DR Cosmic; 2164993
DR Cosmic-CLP; 749717
DR GDSC; 749717
DR GEO; GSM149979
DR GEO; GSM149987
DR GEO; GSM149995
DR GEO; GSM185085
DR GEO; GSM185086
DR GEO; GSM217579
DR GEO; GSM344382
DR GEO; GSM344432
DR GEO; GSM350536
DR GEO; GSM378150
DR GEO; GSM533398
DR GEO; GSM533405
DR GEO; GSM537968
DR GEO; GSM783968
DR GEO; GSM827244
DR GEO; GSM847390
DR GEO; GSM847487
DR GEO; GSM844013
DR GEO; GSM854621
DR GEO; GSM854622
DR GEO; GSM854623
DR GEO; GSM854624
DR GEO; GSM854625
DR GEO; GSM887054
DR GEO; GSM888124
DR GEO; GSM1008902
DR GEO; GSM1214580
DR GEO; GSM1215289
DR GEO; GSM1215291
DR GEO; GSM1215293
DR GEO; GSM1215294
DR GEO; GSM1215292
DR GEO; GSM1215290
DR GEO; GSM1215295
DR GEO; GSM1215296
DR GEO; GSM1374511
DR GEO; GSM1401651
DR GEO; GSM1669859
DR IGRhCellID; HCC38
DR KCLB; 9S0038
DR LINCS; 50216
RX DOI=10.4172/2157-7145.S2-005;
RX PubMed=9833771;
RX PubMed=9865903;
RX PubMed=11314036;
RX PubMed=12800145;
RX PubMed=14762065;
RX PubMed=16959974;
RX PubMed=17157791;
RX PubMed=17932254;
RX PubMed=19582160;
RX PubMed=20070913;
RX PubMed=22460905;
RX PubMed=23601657;
RX PubMed=24162158;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.pawefish.path.cam.ac.uk/BreastCellLineDescriptions/HCC38.html
WW http://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: ICBP43 breast cancer cell line panel.
CC Part of: KuDOS 95 cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Array-based CGH.
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: miRNA expression profiling.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; KCLB; DOI=10.4172/2157-7145.S2-005; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12,14
ST D16S539: 10,14
ST D18S51: 15
ST D19S433: 13,15
ST D21S11: 27,28
ST D2S1338: 17,19
ST D3S1358: 18
ST D5S818: 9
ST D7S820: 10
ST D8S1179: 8,10
ST FGA: 24
ST Penta D: 9
ST Penta E: 5,11
ST TH01: 9.3
ST TPOX: 9,12
ST vWA: 16,17
DI NCIt; C4017; Ductal breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1268 ! HCC38 BL
SX Female
CA Cancer cell line
//
ID HCC38 BL
AC CVCL_1268
SY HCC38-BL; HCC-38BL; HCC 38BL; HCC38BL
DR CLO; CLO_0003656
DR ATCC; CRL-2346
DR BioSample; SAMN03471826
DR GEO; GSM854626
DR KCLB; 9S0038BL
RX PubMed=9833771;
RX PubMed=14762065;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): ATCC; KCLB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12,14
ST D16S539: 10,14
ST D5S818: 9,12
ST D7S820: 10
ST FGA: 21,24
ST TH01: 7,9.3 (ATCC)
ST TH01: 8,9.3 (KCLB)
ST TPOX: 9,12
ST vWA: 16,17
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1267 ! HCC38
SX Female
CA Transformed cell line
//
ID HCC4000
AC CVCL_9Z04
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HCC4001
AC CVCL_9Z05
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HCC4002
AC CVCL_9Z06
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HCC4003
AC CVCL_9Z07
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HCC4004
AC CVCL_9Z08
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HCC4005
AC CVCL_9Z09
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HCC4006
AC CVCL_1269
SY HCC-4006
DR BTO; BTO:0004081
DR CLO; CLO_0003657
DR EFO; EFO_0003132
DR ATCC; CRL-2871
DR BioSample; SAMN03471807
DR BioSample; SAMN03473288
DR CCLE; HCC4006_LUNG
DR Cosmic; 903602
DR Cosmic; 1028938
DR Cosmic; 1128250
DR Cosmic; 1146936
DR Cosmic; 1802302
DR Cosmic; 2015233
DR GEO; GSM63351
DR GEO; GSM253408
DR GEO; GSM434286
DR GEO; GSM794399
DR GEO; GSM844552
DR GEO; GSM887055
DR GEO; GSM888125
DR IGRhCellID; HCC4006GEO
DR PRIDE; PXD002556
RX PubMed=20679594;
RX PubMed=22460905;
RX PubMed=23733853;
RX PubMed=25485619;
RX PubMed=26361996;
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: EGFR genetic alteration cell panel (ATCC TCP-1027).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ATCC; PubMed=20679594; PubMed=25877200
ST Amelogenin: X (ATCC; PubMed=25877200)
ST Amelogenin: X,Y (PubMed=20679594)
ST CSF1PO: 10
ST D13S317: 11,12
ST D16S539: 11,12 (ATCC; PubMed=20679594)
ST D16S539: 12 (PubMed=25877200)
ST D18S51: 19
ST D21S11: 31
ST D3S1358: 18
ST D5S818: 12
ST D7S820: 9,12
ST D8S1179: 10,14
ST FGA: 21,22
ST Penta D: 9,14
ST Penta E: 7,13
ST TH01: 7
ST TPOX: 8,9
ST vWA: 16,17
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC4006-GR-high
AC CVCL_S698
DR Cosmic; 1896431
RX PubMed=23542356;
CC Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1269 ! HCC4006
SX Male
CA Cancer cell line
//
ID HCC4006-GR-step
AC CVCL_S699
DR Cosmic; 1896430
RX PubMed=23542356;
CC Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1269 ! HCC4006
SX Male
CA Cancer cell line
//
ID HCC4006/R
AC CVCL_S746
SY HCC4006R; HCC4006/ER; HCC4006ER
DR Cosmic; 1890457
DR Cosmic; 2015232
RX PubMed=22773810;
RX PubMed=23733853;
CC Selected for resistance to: ChEBI; CHEBI:114785; Erlotinib.
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1269 ! HCC4006
SX Male
CA Cancer cell line
//
ID HCC4011
AC CVCL_S700
DR EFO; EFO_0006436
DR BioSample; SAMN03473004
DR GEO; GSM794400
RX PubMed=20679594;
RX PubMed=25485619;
RX PubMed=28196595;
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Deep RNAseq analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=20679594; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 12,14
ST D13S317: 12
ST D16S539: 8,11
ST D18S51: 19,20
ST D21S11: 31,31.2
ST D3S1358: 18
ST D5S818: 12,13
ST D7S820: 9,10
ST D8S1179: 11,13
ST FGA: 19,20
ST Penta D: 12,14
ST Penta E: 17
ST TH01: 6
ST TPOX: 11
ST vWA: 16,17
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC4011-GR-high
AC CVCL_S701
DR Cosmic; 1896433
RX PubMed=23542356;
CC Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_S700 ! HCC4011
SX Male
CA Cancer cell line
//
ID HCC4011-GR-step
AC CVCL_S702
DR Cosmic; 1896432
RX PubMed=23542356;
CC Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_S700 ! HCC4011
SX Male
CA Cancer cell line
//
ID HCC4011/R
AC CVCL_S747
SY HCC4011/ER; HCC4011R
DR Cosmic; 1890458
RX PubMed=22773810;
CC Selected for resistance to: ChEBI; CHEBI:114785; Erlotinib.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_S700 ! HCC4011
SX Male
CA Cancer cell line
//
ID HCC4012
AC CVCL_IT30
SY HCC-4012
DR PRIDE; PXD000589
RX PubMed=24207061;
RX PubMed=24926545;
RX PubMed=25894527;
CC Transfected with: HGNC; 11730; TERT.
CC Omics: Cell surface proteome.
CC Omics: SNP array analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Telomerase immortalized cell line
//
ID HCC4017
AC CVCL_V579
DR EFO; EFO_0006437
DR BioSample; SAMN03473218
DR GEO; GSM794401
RX PubMed=20679594;
RX PubMed=25485619;
RX PubMed=28196595;
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Deep RNAseq analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=20679594; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 12
ST D16S539: 11
ST D18S51: 16
ST D21S11: 28,30
ST D3S1358: 16
ST D5S818: 11
ST D7S820: 8,9
ST D8S1179: 13,14
ST FGA: 20
ST Penta D: 9,13
ST Penta E: 10
ST TH01: 9.3
ST TPOX: 8,9
ST vWA: 13,16 (PubMed=20679594)
ST vWA: 16 (PubMed=25877200)
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC4018
AC CVCL_V580
DR GEO; GSM794402
RX PubMed=20679594;
RX PubMed=28196595;
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=20679594
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11
ST D16S539: 9
ST D5S818: 12
ST D7S820: 10
ST TH01: 9.3
ST TPOX: 8
ST vWA: 18
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC4019
AC CVCL_V581
DR BioSample; SAMN03472973
DR GEO; GSM794403
RX PubMed=28196595;
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 12
ST D16S539: 11
ST D18S51: 12,18
ST D21S11: 25.2,31
ST D3S1358: 16
ST D5S818: 12,13
ST D7S820: 9,10
ST D8S1179: 13,14
ST FGA: 24,25
ST Penta D: 12,13
ST Penta E: 17
ST TH01: 9
ST TPOX: 8,11
ST vWA: 17,18
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC4021
AC CVCL_9Z10
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HCC4034
AC CVCL_9Z11
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HCC4037
AC CVCL_9Z12
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HCC4038
AC CVCL_9Z13
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HCC4047
AC CVCL_9Z14
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HCC4054
AC CVCL_9Z15
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HCC4058
AC CVCL_9Z16
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HCC4059
AC CVCL_9Z17
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HCC407
AC CVCL_V707
SY HCC0407
DR BioSample; SAMN03473027
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
ST Source(s): PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 12
ST D16S539: 9
ST D18S51: 13,15
ST D21S11: 28,29
ST D3S1358: 15,16
ST D5S818: 10,12
ST D7S820: 8,11
ST D8S1179: 14
ST FGA: 21,24,25
ST Penta D: 9,11
ST Penta E: 7,12
ST TH01: 7,9.3
ST TPOX: 8
ST vWA: 17,18
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC4087
AC CVCL_9Z18
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HCC41
AC CVCL_V733
SY HCC0041
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC420
AC CVCL_V734
SY HCC0420
DI NCIt; C5169; Breast neuroendocrine neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC435
AC CVCL_V735
SY HCC0435
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC44
AC CVCL_2060
SY HCC-44; HCC0044
DR EFO; EFO_0003133
DR BioSample; SAMN03473080
DR BioSample; SAMN03473528
DR CCLE; HCC44_LUNG
DR Cosmic; 877254
DR Cosmic; 903626
DR Cosmic; 1146937
DR Cosmic; 1239870
DR Cosmic; 1995433
DR Cosmic; 2125202
DR Cosmic-CLP; 1240145
DR DSMZ; ACC-534
DR GDSC; 1240145
DR GEO; GSM253314
DR GEO; GSM434321
DR GEO; GSM794374
DR GEO; GSM827372
DR GEO; GSM887056
DR GEO; GSM888126
DR GEO; GSM1669860
DR IGRhCellID; HCC44GEO
DR KCLB; 70044
RX PubMed=10987304;
RX PubMed=11314036;
RX PubMed=19472407;
RX PubMed=20679594;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=27397505;
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 29 hours (PubMed=25984343); ~30 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; KCLB; PubMed=20679594; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 9,11
ST D13S317: 11
ST D16S539: 9,13
ST D18S51: 17
ST D21S11: 28,32.2,33.2
ST D3S1358: 14,15
ST D5S818: 11,13
ST D7S820: 8,10
ST D8S1179: 14,15
ST FGA: 24
ST Penta D: 12
ST Penta E: 10,12
ST TH01: 9
ST TPOX: 8,12 (Cosmic-CLP; DSMZ; KCLB; PubMed=20679594)
ST TPOX: 12 (PubMed=25877200)
ST vWA: 15
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L065 ! HCC44 BL
SX Female
CA Cancer cell line
//
ID HCC44 BL
AC CVCL_L065
SY HCC-44BL; HCC44-BL; HCC44BL
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2060 ! HCC44
SX Female
CA Transformed cell line
//
ID HCC446
AC CVCL_V736
SY HCC0446
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC461
AC CVCL_5135
SY HCC0461
DR EFO; EFO_0003134
DR BioSample; SAMN03471006
DR Cosmic; 903632
DR Cosmic; 1146938
DR GEO; GSM62336
DR GEO; GSM253392
DR GEO; GSM434262
DR GEO; GSM794380
DR IGRhCellID; HCC461GEO
RX PubMed=10353731;
RX PubMed=20679594;
RX PubMed=25485619;
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=20679594; PubMed=25877200
ST Amelogenin: X (PubMed=20679594)
ST Amelogenin: X,Y (PubMed=25877200)
ST CSF1PO: 10,12
ST D13S317: 10,11
ST D16S539: 11,12
ST D18S51: 12,14
ST D21S11: 30
ST D3S1358: 15,18
ST D5S818: 10,13
ST D7S820: 9,11
ST D8S1179: 13,14
ST FGA: 21,22
ST Penta D: 10,13
ST Penta E: 13
ST TH01: 7,9
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC4977
AC CVCL_E050
RX PubMed=22460906;
CC Miscellaneous: Only mentioned as a hepatocellular carcinoma cell line in PubMed=22460906.
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HCC515
AC CVCL_5136
SY HCC0515
DR EFO; EFO_0003135
DR BioSample; SAMN03473216
DR Cosmic; 877257
DR Cosmic; 903633
DR Cosmic; 1146939
DR Cosmic; 1239873
DR Cosmic; 1518097
DR Cosmic; 2125261
DR GEO; GSM253364
DR GEO; GSM434263
DR GEO; GSM794381
DR IGRhCellID; HCC515_02v
RX PubMed=10987304;
RX PubMed=11314036;
RX PubMed=19472407;
RX PubMed=20679594;
RX PubMed=25485619;
RX PubMed=28196595;
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Deep RNAseq analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=20679594; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 8
ST D16S539: 11,13
ST D18S51: 9,20
ST D21S11: 29,30
ST D3S1358: 15,16
ST D5S818: 11
ST D7S820: 7,8
ST D8S1179: 14,15
ST FGA: 20,22
ST Penta D: 11,15
ST Penta E: 9,16
ST TH01: 7
ST TPOX: 8,11
ST vWA: 15,17
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_S839 ! HCC515 BL
SX Female
CA Cancer cell line
//
ID HCC515 BL
AC CVCL_S839
SY HCC515-BL; HCC515BL
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5136 ! HCC515
SX Female
CA Transformed cell line
//
ID HCC590
AC CVCL_V700
SY HCC0590
DI NCIt; C9231; Merkel cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC597
AC CVCL_V701
SY HCC0597
DR BioSample; SAMN03470871
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11
ST D16S539: 11
ST D18S51: 18
ST D19S433: 17.2
ST D21S11: 29,30
ST D2S1338: 20,26
ST D3S1358: 16
ST D5S818: 11
ST D7S820: 9,11
ST D8S1179: 13
ST FGA: 19
ST Penta D: 9,11
ST Penta E: 15
ST TH01: 8
ST TPOX: 8
ST vWA: 17
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC60
AC CVCL_G002
SY HCC0060
DR EFO; EFO_0006418
DR BioSample; SAMN03473068
DR Cosmic; 1113279
RX PubMed=12429618;
RX PubMed=25485619;
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 12
ST D16S539: 11
ST D18S51: 14
ST D21S11: 30
ST D3S1358: 15
ST D5S818: 12,13
ST D7S820: 9,10
ST D8S1179: 15
ST FGA: 24
ST Penta D: 8
ST Penta E: 7,17
ST TH01: 6
ST TPOX: 8,9
ST vWA: 16,17
DI NCIt; C5228; Ovarian cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC630
AC CVCL_V729
SY HCC0630
DR EFO; EFO_0006421
DR BioSample; SAMN03472978
RX PubMed=25485619;
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC Problematic cell line: Possibly misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (STR profile).
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
ST Source(s): PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 11,12,13
ST D16S539: 11,12
ST D18S51: 15,16
ST D21S11: 30,33.2
ST D3S1358: 13,16
ST D5S818: 12
ST D7S820: 8,12
ST D8S1179: 13,16
ST FGA: 20.2,21
ST Penta D: 15
ST Penta E: 7
ST TH01: 7,9
ST TPOX: 8,9
ST vWA: 15,16,17,18
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC653
AC CVCL_V730
SY HCC0653
DI NCIt; C9325; Adrenal cortex carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC70
AC CVCL_1270
SY HCC-70; HCC 70; HCC0070
DR BTO; BTO:0005963
DR CLO; CLO_0003658
DR EFO; EFO_0001181
DR ATCC; CRL-2315
DR BioSample; SAMN03471365
DR BioSample; SAMN03471868
DR CCLE; HCC70_BREAST
DR ChEMBL-Cells; CHEMBL3308739
DR ChEMBL-Targets; CHEMBL1075461
DR Cosmic; 687486
DR Cosmic; 904357
DR Cosmic; 907048
DR Cosmic; 1018474
DR Cosmic; 1047703
DR Cosmic; 1136352
DR Cosmic; 1287933
DR Cosmic; 1603213
DR Cosmic; 1935001
DR Cosmic; 1995435
DR Cosmic; 2164994
DR Cosmic-CLP; 907048
DR GDSC; 907048
DR GEO; GSM217580
DR GEO; GSM344372
DR GEO; GSM344422
DR GEO; GSM350500
DR GEO; GSM718288
DR GEO; GSM783941
DR GEO; GSM847391
DR GEO; GSM844014
DR GEO; GSM844015
DR GEO; GSM887058
DR GEO; GSM888128
DR GEO; GSM1401660
DR GEO; GSM1374512
DR GEO; GSM1669862
DR IGRhCellID; HCC70
DR KCLB; 9S0070
DR LINCS; 50219
RX PubMed=9833771;
RX PubMed=9865903;
RX PubMed=11314036;
RX PubMed=17157791;
RX PubMed=19582160;
RX PubMed=20679594;
RX PubMed=22460905;
RX PubMed=23601657;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.pawefish.path.cam.ac.uk/BreastCellLineDescriptions/HCC70.html
WW http://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: ICBP43 breast cancer cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 93 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: miRNA expression profiling.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; KCLB; PubMed=20679594; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,14 (ATCC; Cosmic-CLP; PubMed=20679594; PubMed=25877200)
ST CSF1PO: 10 (KCLB)
ST D13S317: 12
ST D16S539: 9,13 (ATCC; Cosmic-CLP)
ST D16S539: 13 (PubMed=20679594; PubMed=25877200)
ST D18S51: 13,16
ST D19S433: 12.2,15.2
ST D21S11: 30
ST D2S1338: 23,25
ST D3S1358: 16 (KCLB)
ST D3S1358: 16,17 (PubMed=25877200)
ST D5S818: 12,13 (ATCC; Cosmic-CLP; KCLB; PubMed=20679594)
ST D5S818: 13 (PubMed=25877200)
ST D7S820: 10,11
ST D8S1179: 13
ST FGA: 24 (KCLB)
ST FGA: 19.2,24 (PubMed=25877200)
ST Penta D: 10
ST Penta E: 9,16
ST TH01: 9
ST TPOX: 10 (ATCC; Cosmic-CLP; KCLB)
ST TPOX: 9,10 (PubMed=20679594; PubMed=25877200)
ST vWA: 13,15
DI NCIt; C4017; Ductal breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC711
AC CVCL_V698
SY HCC0711
DI NCIt; C5105; Colorectal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC712
AC CVCL_3378
SY HCC0712
DR ATCC; CRL-2317
DR GEO; GSM350512
DR GEO; GSM378144
RX PubMed=9833771;
RX PubMed=9865903;
RX PubMed=11314036;
RX PubMed=19582160;
RX PubMed=20679594;
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC Omics: CNV analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: ATCC; CRL-2317; true.
ST Source(s): PubMed=20679594
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,11
ST D16S539: 10,11
ST D5S818: 12,14
ST D7S820: 10,11
ST TH01: 9
ST TPOX: 8,9
ST vWA: 14,19
DI NCIt; C4017; Ductal breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC78
AC CVCL_2061
SY HCC-78; HCC0078
DR EFO; EFO_0003136
DR BioSample; SAMN03473081
DR CCLE; HCC78_LUNG
DR Cosmic; 877255
DR Cosmic; 903627
DR Cosmic; 1146940
DR Cosmic; 1239871
DR Cosmic; 1518095
DR Cosmic; 1612230
DR Cosmic; 2125262
DR Cosmic-CLP; 1290908
DR DSMZ; ACC-563
DR GDSC; 1290908
DR GEO; GSM62333
DR GEO; GSM253403
DR GEO; GSM434264
DR GEO; GSM784275
DR GEO; GSM794375
DR GEO; GSM827373
DR GEO; GSM887059
DR GEO; GSM888129
DR GEO; GSM1669863
DR IGRhCellID; HCC78GEO
RX PubMed=10987304;
RX PubMed=11314036;
RX PubMed=19472407;
RX PubMed=20679594;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~60-70 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=20679594; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 8,12
ST D16S539: 11,13
ST D18S51: 12,16
ST D21S11: 29,30
ST D3S1358: 16,17
ST D5S818: 11,12
ST D7S820: 9
ST D8S1179: 13,14
ST FGA: 21,22
ST Penta D: 7,11
ST Penta E: 11,12
ST TH01: 7,9.3
ST TPOX: 8,11
ST vWA: 15,18
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L064 ! HCC78 BL
SX Male
CA Cancer cell line
//
ID HCC78 BL
AC CVCL_L064
SY HCC-78BL; HCC78BL
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2061 ! HCC78
SX Male
CA Transformed cell line
//
ID HCC815
AC CVCL_V699
SY HCC0815
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC824
AC CVCL_V738
SY HCC0824
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC826
AC CVCL_V593
SY HCC0826
DR BioSample; SAMN03470842
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 7,11
ST D13S317: 11,12
ST D16S539: 13
ST D18S51: 18
ST D21S11: 30,30.2
ST D3S1358: 15,17
ST D5S818: 12,13
ST D7S820: 8,12
ST D8S1179: 14
ST FGA: 24
ST Penta D: 2.2,10
ST Penta E: 14
ST TH01: 7,10
ST TPOX: 8,9
ST vWA: 15,17
DI NCIt; C2955; Colorectal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC827
AC CVCL_2063
SY HCC-827; HCC0827
DR BTO; BTO:0004082
DR CLO; CLO_0003659
DR EFO; EFO_0003137
DR ATCC; CRL-2868
DR BCRJ; 0351
DR BioSample; SAMN03472697
DR CCLE; HCC827_LUNG
DR CCRID; 3131C0001000700153
DR Cosmic; 903634
DR Cosmic; 1028936
DR Cosmic; 1128251
DR Cosmic; 1146941
DR Cosmic; 1219071
DR Cosmic; 1352407
DR Cosmic; 1802300
DR Cosmic; 1995436
DR Cosmic; 2125263
DR Cosmic-CLP; 1240146
DR DSMZ; ACC-566
DR GDSC; 1240146
DR GEO; GSM63350
DR GEO; GSM183436
DR GEO; GSM183437
DR GEO; GSM253425
DR GEO; GSM434274
DR GEO; GSM466319
DR GEO; GSM513969
DR GEO; GSM514323
DR GEO; GSM784276
DR GEO; GSM794382
DR GEO; GSM827206
DR GEO; GSM844553
DR GEO; GSM887060
DR GEO; GSM888130
DR GEO; GSM1557132
DR GEO; GSM1669864
DR IGRhCellID; HCC827GEO
DR KCLB; 70827
DR PRIDE; PXD002556
RX PubMed=10987304;
RX PubMed=11314036;
RX PubMed=20679594;
RX PubMed=22460905;
RX PubMed=23733853;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=26361996;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 71 hours (PubMed=25984343); ~50-60 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; DSMZ; KCLB; PubMed=20679594; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 9
ST D16S539: 12
ST D18S51: 13
ST D21S11: 31
ST D3S1358: 17
ST D5S818: 12
ST D7S820: 11,12
ST D8S1179: 12
ST FGA: 22,24
ST Penta D: 14
ST Penta E: 20
ST TH01: 6
ST TPOX: 8
ST vWA: 18
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_S840 ! HCC827 BL
SX Female
CA Cancer cell line
//
ID HCC827 BL
AC CVCL_S840
SY HCC-827BL; HCC827-BL; HCC827BL
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2063 ! HCC827
SX Female
CA Transformed cell line
//
ID HCC827 ER1
AC CVCL_EJ07
SY ER1
DR Cosmic; 1716792
RX PubMed=22751098;
CC Selected for resistance to: ChEBI; CHEBI:114785; Erlotinib.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2063 ! HCC827
SX Female
CA Cancer cell line
//
ID HCC827 ER2
AC CVCL_EJ08
SY ER2
DR Cosmic; 1716793
RX PubMed=22751098;
CC Selected for resistance to: ChEBI; CHEBI:114785; Erlotinib.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2063 ! HCC827
SX Female
CA Cancer cell line
//
ID HCC827 ER3
AC CVCL_EJ09
SY ER3
DR Cosmic; 1716794
RX PubMed=22751098;
CC Selected for resistance to: ChEBI; CHEBI:114785; Erlotinib.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2063 ! HCC827
SX Female
CA Cancer cell line
//
ID HCC827 ER4
AC CVCL_EJ10
SY ER4
DR Cosmic; 1716795
RX PubMed=22751098;
CC Selected for resistance to: ChEBI; CHEBI:114785; Erlotinib.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2063 ! HCC827
SX Female
CA Cancer cell line
//
ID HCC827 ER5
AC CVCL_EJ11
SY ER5
DR Cosmic; 1716796
RX PubMed=22751098;
CC Selected for resistance to: ChEBI; CHEBI:114785; Erlotinib.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2063 ! HCC827
SX Female
CA Cancer cell line
//
ID HCC827 GR1
AC CVCL_V620
DR GEO; GSM466320
RX PubMed=17463250;
CC Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2063 ! HCC827
SX Female
CA Cancer cell line
//
ID HCC827 GR2
AC CVCL_V621
DR GEO; GSM466321
RX PubMed=17463250;
CC Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2063 ! HCC827
SX Female
CA Cancer cell line
//
ID HCC827 GR5
AC CVCL_V622
SY HCC-827-GR5; HCC827GR5
DR CCLE; HCC827GR5_LUNG
DR GEO; GSM466322
RX PubMed=17463250;
RX PubMed=25984343;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 48 hours (PubMed=25984343).
CC Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).
CC Omics: shRNA library screening.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2063 ! HCC827
SX Female
CA Cancer cell line
//
ID HCC827 GR6
AC CVCL_V623
DR GEO; GSM466323
RX PubMed=17463250;
CC Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2063 ! HCC827
SX Female
CA Cancer cell line
//
ID HCC827 GR7
AC CVCL_V624
DR GEO; GSM466324
RX PubMed=17463250;
CC Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2063 ! HCC827
SX Female
CA Cancer cell line
//
ID HCC827 GR8
AC CVCL_V625
DR GEO; GSM466325
RX PubMed=17463250;
CC Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2063 ! HCC827
SX Female
CA Cancer cell line
//
ID HCC827 PFR1
AC CVCL_DH92
SY HCC827 PFR-1
DR GEO; GSM466326
RX PubMed=20129249;
CC Selected for resistance to: ChEBI; CHEBI:132268; Dacomitinib (PF-00299804).
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2063 ! HCC827
SX Female
CA Cancer cell line
//
ID HCC827 PFR3
AC CVCL_DH93
SY HCC827 PFR-3
DR GEO; GSM466327
RX PubMed=20129249;
CC Selected for resistance to: ChEBI; CHEBI:132268; Dacomitinib (PF-00299804).
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2063 ! HCC827
SX Female
CA Cancer cell line
//
ID HCC827 PFR4
AC CVCL_DH94
SY HCC827 PFR-4
DR GEO; GSM466328
RX PubMed=20129249;
CC Selected for resistance to: ChEBI; CHEBI:132268; Dacomitinib (PF-00299804).
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2063 ! HCC827
SX Female
CA Cancer cell line
//
ID HCC827 PFR5
AC CVCL_DH95
SY HCC827 PFR-5
DR GEO; GSM466329
RX PubMed=20129249;
CC Selected for resistance to: ChEBI; CHEBI:132268; Dacomitinib (PF-00299804).
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2063 ! HCC827
SX Female
CA Cancer cell line
//
ID HCC827 PFR6
AC CVCL_DH96
SY HCC827 PFR-6
DR GEO; GSM466330
RX PubMed=20129249;
CC Selected for resistance to: ChEBI; CHEBI:132268; Dacomitinib (PF-00299804).
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2063 ! HCC827
SX Female
CA Cancer cell line
//
ID HCC827-GR-high1
AC CVCL_S703
DR Cosmic; 1896426
RX PubMed=23542356;
CC Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2063 ! HCC827
SX Female
CA Cancer cell line
//
ID HCC827-GR-high2
AC CVCL_S704
DR Cosmic; 1896427
RX PubMed=23542356;
CC Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2063 ! HCC827
SX Female
CA Cancer cell line
//
ID HCC827-GR-step
AC CVCL_S705
DR Cosmic; 1896425
RX PubMed=23542356;
CC Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2063 ! HCC827
SX Female
CA Cancer cell line
//
ID HCC827-Luc
AC CVCL_4W94
SY HCC-827-Luc
DR JCRB; JCRB1516
DR JCRB; NIHS0709
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 9
ST D16S539: 12
ST D5S818: 12
ST D7S820: 11,12
ST TH01: 6
ST TPOX: 8
ST vWA: 18
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2063 ! HCC827
SX Female
CA Cancer cell line
//
ID HCC827-PR
AC CVCL_EQ68
SY HCC827 PR
DR GEO; GSM183438
DR GEO; GSM183439
RX PubMed=17560336;
CC Knockout cell: Method=shRNA knockdown; HGNC; 9588; PTEN.
CC Omics: Transcriptome analysis.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2063 ! HCC827
SX Female
CA Cancer cell line
//
ID HCC827/R1
AC CVCL_S748
SY HCC827R1
DR Cosmic; 1890455
DR Cosmic; 2015228
DR Cosmic; 2015230
RX PubMed=22773810;
RX PubMed=23733853;
CC Selected for resistance to: ChEBI; CHEBI:114785; Erlotinib.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2063 ! HCC827
SX Female
CA Cancer cell line
//
ID HCC827/R2
AC CVCL_S749
SY HCC827R2
DR Cosmic; 1890456
DR Cosmic; 2015229
DR Cosmic; 2015231
RX PubMed=22773810;
RX PubMed=23733853;
CC Selected for resistance to: ChEBI; CHEBI:114785; Erlotinib.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2063 ! HCC827
SX Female
CA Cancer cell line
//
ID HCC827/WR
AC CVCL_DG26
RX PubMed=26980747;
CC Selected for resistance to: ChEBI; CHEBI:61400; WZ4002.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2063 ! HCC827
SX Female
CA Cancer cell line
//
ID HCC827CLR
AC CVCL_V406
DR Cosmic; 1604992
RX PubMed=22133747;
CC Selected for resistance to: ChEBI; CHEBI:90180; CL-387785 (EKI-785).
CC Selected for resistance to: ChEBI; CHEBI:114785; Erlotinib.
CC Selected for resistance to: ChEBI; CHEBI:90197; PHA-665752.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_V407 ! HCC827EPR
SX Female
CA Cancer cell line
//
ID HCC827EPR
AC CVCL_V407
RX PubMed=21062933;
CC Selected for resistance to: ChEBI; CHEBI:114785; Erlotinib.
CC Selected for resistance to: ChEBI; CHEBI:90197; PHA-665752.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2063 ! HCC827
SX Female
CA Cancer cell line
//
ID HCC827ER
AC CVCL_V408
RX PubMed=21062933;
CC Selected for resistance to: ChEBI; CHEBI:114785; Erlotinib.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2063 ! HCC827
SX Female
CA Cancer cell line
//
ID HCC845
AC CVCL_V693
SY HCC0845
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC850
AC CVCL_V694
SY HCC0850
DR BioSample; SAMN03473026
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 12
ST D16S539: 9
ST D18S51: 16,17
ST D21S11: 28,33.2
ST D3S1358: 16
ST D5S818: 11,12
ST D7S820: 11
ST D8S1179: 14
ST FGA: 24
ST Penta D: 2.2,9
ST Penta E: 8,13
ST TH01: 7,9.3
ST TPOX: 8,9
ST vWA: 15,18
DI NCIt; C27390; Ovarian small cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC853
AC CVCL_V695
SY HCC0853
DI NCIt; C4752; T-cell prolymphocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC880
AC CVCL_V691
SY HCC0880
DR BioSample; SAMN03470873
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,13
ST D13S317: 8,13
ST D16S539: 10,12
ST D18S51: 14
ST D19S433: 14,15
ST D21S11: 29
ST D2S1338: 17,20
ST D3S1358: 15
ST D5S818: 13
ST D7S820: 10,12
ST D8S1179: 10
ST FGA: 20,23
ST Penta D: 10,12
ST Penta E: 7,10
ST TH01: 7,8
ST TPOX: 11,12
ST vWA: 15
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC889
AC CVCL_V692
SY HCC0889
DR BioSample; SAMN03473070
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11
ST D16S539: 8
ST D18S51: 13,18
ST D21S11: 31.2,33.2
ST D3S1358: 16
ST D5S818: 12
ST D7S820: 8,9
ST D8S1179: 10
ST FGA: 22
ST Penta D: 10,15
ST Penta E: 7
ST TH01: 8,9.3
ST TPOX: 8,9
ST vWA: 17
DI NCIt; C4035; Thyroid gland papillary carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC89
AC CVCL_V731
SY HCC0089
DR EFO; EFO_0006419
DR BioSample; SAMN03473012
RX PubMed=25485619;
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 8,10
ST D13S317: 11,13
ST D16S539: 9,11
ST D18S51: 14
ST D21S11: 28
ST D3S1358: 18
ST D5S818: 10,11
ST D7S820: 10,11
ST D8S1179: 13,14
ST FGA: 22
ST Penta D: 10,13
ST Penta E: 12,16
ST TH01: 6
ST TPOX: 8,11
ST vWA: 14,17
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC90
AC CVCL_V732
SY HCC0090
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC9204
AC CVCL_A605
SY HCC-9204
DR Cosmic; 1060082
RX PubMed=10766346;
CC Misspelling: 'SMMC-9204' in Cosmic 1060082.
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC94
AC CVCL_6945
SY HCC-94; HCC 94
DR CCRID; 3111C0001CCC000277
DR CCRID; 3131C0001000700081
RX PubMed=9596902;
DI NCIt; C4028; Cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC95
AC CVCL_5137
SY HCC-95; HCC0095
DR EFO; EFO_0003138
DR BioSample; SAMN03470831
DR CCLE; HCC95_LUNG
DR Cosmic; 877260
DR Cosmic; 903628
DR Cosmic; 1146942
DR Cosmic; 1219070
DR Cosmic; 1239909
DR Cosmic; 1608838
DR Cosmic; 2060521
DR Cosmic; 2125264
DR GEO; GSM62969
DR GEO; GSM253404
DR GEO; GSM434322
DR GEO; GSM794376
DR GEO; GSM887061
DR GEO; GSM888131
DR GEO; GSM1374513
DR IGRhCellID; HCC95_GEO
DR KCLB; 70095
DR PRIDE; PXD002556
RX PubMed=10353731;
RX PubMed=10987304;
RX PubMed=19472407;
RX PubMed=20679594;
RX PubMed=22460905;
RX PubMed=26361996;
RX PubMed=28196595;
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Deep proteome analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): KCLB; PubMed=20679594; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12 (KCLB)
ST CSF1PO: 10,12 (PubMed=20679594; PubMed=25877200)
ST D13S317: 11 (KCLB; PubMed=20679594)
ST D13S317: 11,12 (PubMed=25877200)
ST D16S539: 9
ST D18S51: 16,20
ST D21S11: 29,30
ST D3S1358: 17
ST D5S818: 10,11 (KCLB)
ST D5S818: 11,12 (PubMed=25877200)
ST D5S818: 11 (PubMed=20679594)
ST D7S820: 10
ST D8S1179: 14,16
ST FGA: 22
ST Penta D: 9
ST Penta E: 12,17
ST TH01: 8,9
ST TPOX: 8,11
ST vWA: 14,17
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_S841 ! HCC95 BL
SX Male
CA Cancer cell line
//
ID HCC95 BL
AC CVCL_S841
SY HCC-95BL; HCC95-BL; HCC95BL
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5137 ! HCC95
SX Male
CA Transformed cell line
//
ID HCC954
AC CVCL_V697
SY HCC0954
DR BioSample; SAMN03473017
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8,11
ST D16S539: 9,12
ST D18S51: 18
ST D21S11: 30,31.2
ST D3S1358: 14
ST D5S818: 9
ST D7S820: 10
ST D8S1179: 13
ST FGA: 19,20
ST Penta D: 11,12
ST Penta E: 7
ST TH01: 8
ST TPOX: 8,11
ST vWA: 17,18
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCC966
AC CVCL_L086
SY HCC-966
DR KCLB; 70966
ST Source(s): KCLB
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 13
ST D3S1358: 15,17
ST D5S818: 12
ST D7S820: 10,11
ST FGA: 19,21
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 16
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HCC970
AC CVCL_A354
SY HCC-970; HCC0970
DR Cosmic; 877236
DR Cosmic; 1518102
DR GEO; GSM794383
RX PubMed=10987304;
RX PubMed=20679594;
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=20679594
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 10
ST D16S539: 12
ST D5S818: 10
ST D7S820: 10
ST TH01: 7
ST TPOX: 8
ST vWA: 15,19
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_S843 ! HCC970 BL
SX Male
CA Cancer cell line
//
ID HCC970 BL
AC CVCL_S843
SY HCC-970BL; HCC970-BL; HCC970BL
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A354 ! HCC970
SX Male
CA Transformed cell line
//
ID HCC9724
AC CVCL_A606
SY HCC-9724
DR Cosmic; 1060083
CC Misspelling: 'SMMC-9724' in Cosmic 1060083.
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HCC973
AC CVCL_V696
SY HCC0973
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
DI NCIt; C9231; Merkel cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCC985
AC CVCL_V690
SY HCC0985
DR BioSample; SAMN03470874
WW http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/cell-lines.pdf
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 9
ST D16S539: 14
ST D18S51: 14
ST D19S433: 14
ST D21S11: 33.2
ST D2S1338: 24
ST D3S1358: 15
ST D5S818: 11,12
ST D7S820: 10
ST D8S1179: 10
ST FGA: 23,24
ST Penta D: 9
ST Penta E: 12
ST TH01: 8
ST TPOX: 8,9
ST vWA: 17,18
DI NCIt; C5105; Colorectal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCCC-9810
AC CVCL_6908
SY HCCC9810; Hccc9810
DR CCRID; 3111C0001CCC000278
DR CCRID; 3131C0001000700017
DR GEO; GSM936756
DR GEO; GSM1374514
RX CelloPub=CLPUB00275;
RX PubMed=23505090;
WW http://www.growth-media.net/Product/661/#B
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C35417; Intrahepatic cholangiocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HCCLM3
AC CVCL_6832
AS CVCL_7679
SY LM3
DR BTO; BTO:0004469
DR CCRID; 3131C0001000700094
DR GEO; GSM1374515
DR PRIDE; PXD000529
RX PubMed=12133480;
RX PubMed=12618900;
RX PubMed=15796966;
RX PubMed=19335983;
CC Characteristics: Has lost chromosome Y.
CC Doubling time: 34.9 hours (PubMed=12133480).
CC Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC Omics: Transcriptome analysis.
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4972 ! MHCC97-H
SX Male
CA Cancer cell line
//
ID HCCLM6
AC CVCL_7680
SY LM6
DR BTO; BTO:0004470
RX PubMed=15146329;
RX PubMed=19335983;
CC Characteristics: Has lost chromosome Y.
CC Doubling time: 32 hours (PubMed=15146329).
CC Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4972 ! MHCC97-H
SX Male
CA Cancer cell line
//
ID HCCM-5
AC CVCL_M687
RX DOI=10.1111/j.1447-0756.1980.tb00508.x;
RX PubMed=4039287;
CC Doubling time: ~72 hours (PubMed=4039287).
DI NCIt; C4646; Gestational choriocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCCM-5MTXr
AC CVCL_W857
RX PubMed=4039287;
CC Doubling time: ~72 hours (PubMed=4039287).
CC Selected for resistance to: ChEBI; CHEBI:44185; Methotrexate (MTX).
DI NCIt; C4646; Gestational choriocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_M687 ! HCCM-5
SX Female
CA Cancer cell line
//
ID HCD-57
AC CVCL_5289
SY HCD57; HC-D57
DR TOKU-E; 3596
RX CelloPub=CLPUB00343;
RX PubMed=2154592;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=HCD57
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-544.html
CC Characteristics: EPO dependent.
CC Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC Breed/subspecies: NIH Swiss.
DI NCIt; C21895; Mouse erythroid leukemia
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID hCD40L-M90
AC CVCL_L522
SY M90
DR CLO; CLO_0003660
DR ATCC; HB-12055
RX Patent=US5961974;
CC Monoclonal antibody target: UniProtKB; P29965; Human CD40LG/CD154.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID hCD40L-M91
AC CVCL_L523
SY M91
DR CLO; CLO_0003661
DR ATCC; HB-12056
RX Patent=US5961974;
CC Monoclonal antibody target: UniProtKB; P29965; Human CD40LG/CD154.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID HCDB-1
AC CVCL_A343
SY HBP Carcinoma induced by DMBA/BQ extract treatment-1
RX PubMed=10943946;
CC Characteristics: Buccal pouch carcinoma cell line induced by DMBA and betel quid (BQ).
CC Characteristics: Has a TP53 p.Ala141Val mutation.
CC Doubling time: 19 hours (PubMed=10943946).
CC Transformant: ChEBI; CHEBI:59032; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
OX NCBI_TaxID=10036; ! Mesocricetus auratus
SX Male
CA Cancer cell line
//
ID HCE
AC CVCL_M619
DR BioSample; SAMN03151702
RX PubMed=1246601;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=1246601, PubMed=20143388).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HCE-2
AC CVCL_3316
SY 50.B1
DR CLO; CLO_0003662
DR ATCC; CRL-11135
DR BioSample; SAMN03471330
RX Patent=US5672498;
CC Transformant: Ad12-SV40.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,13
ST D13S317: 8,11
ST D16S539: 9,11
ST D5S818: 11,12
ST D7S820: 8,10
ST TH01: 6,9
ST TPOX: 10,11
ST vWA: 15,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID HCE-3
AC CVCL_A355
DR Cosmic; 932974
RX PubMed=2415247;
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HCE-4
AC CVCL_1271
SY HCE4
DR BTO; BTO:0005572
DR ChEMBL-Cells; CHEMBL3308199
DR ChEMBL-Targets; CHEMBL2366207
DR Cosmic; 753559
DR Cosmic; 923186
DR Cosmic; 934539
DR Cosmic; 1394519
DR Cosmic-CLP; 753559
DR GDSC; 753559
DR GEO; GSM482501
DR GEO; GSM1669865
RX PubMed=2415247;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 9
ST D5S818: 10
ST D7S820: 8,11
ST TH01: 8
ST TPOX: 7,8
ST vWA: 16,20
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HCE-5
AC CVCL_A356
RX PubMed=2415247;
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HCE-6
AC CVCL_A357
DR BTO; BTO:0005573
DR Cosmic; 1394514
RX PubMed=2415247;
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HCE-7
AC CVCL_5138
SY HCE7; HCE-7 (NM)
DR BTO; BTO:0002818
DR Cosmic; 923187
DR Cosmic; 932975
DR GEO; GSM827169
DR GEO; GSM1669866
RX PubMed=2415247;
CC Omics: DNA methylation analysis.
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HCE-8
AC CVCL_A358
RX PubMed=2415247;
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HCE-9
AC CVCL_S846
RX PubMed=2415247;
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HCe-8693
AC CVCL_6909
SY Hce-8693; HCE-8693; Hce8693; HCE8693
DR CCRID; 3131C0001000700070
RX PubMed=2634537;
RX PubMed=7954969;
DI NCIt; C5543; Cecum adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCE-T
AC CVCL_1272
SY HCET; Human Corneal Epithelial cells-Transformed
DR CLO; CLO_0050405
DR CLO; CLO_0050406
DR BCRJ; 0349
DR BioSample; SAMN03472134
DR ChEMBL-Cells; CHEMBL3308200
DR ChEMBL-Targets; CHEMBL2366139
DR Cosmic; 907049
DR GEO; GSM1669867
DR RCB; RCB1384
DR RCB; RCB2280
RX PubMed=7534282;
CC Transformant: Ad-SV40.
CC Omics: DNA methylation analysis.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8
ST D16S539: 9,11
ST D5S818: 13
ST D7S820: 10,13
ST TH01: 7,8
ST TPOX: 8,11
ST vWA: 18,19
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID HCEC 1CT
AC CVCL_AQ45
SY hCEC-1CT; Human Colonic Epithelial Cells 1 transduced with CDK4 and Telomerase; 1CT
RX DOI=10.3389/fcimb.2016.00034;
RX PubMed=19962984;
RX PubMed=21527559;
RX PubMed=21472139;
RX PubMed=25923178;
WW http://www.evercyte.com/hcec-1ct-110.html
CC Transfected with: HGNC; 1773; CDK4.
CC Transfected with: HGNC; 11730; TERT.
CC Omics: Deep exome analysis.
ST Source(s): DOI=10.3389/fcimb.2016.00034
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 12,13
ST D16S539: 10,11
ST D21S11: 28
ST D5S818: 11,14
ST D7S820: 9,11
ST TH01: 9.3
ST TPOX: 11
ST vWA: 16,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Telomerase immortalized cell line
//
ID HCEC 1CTA
AC CVCL_AV01
RX DOI=10.3389/fcimb.2016.00034;
CC Knockout cell: Method=shRNA knockdown; HGNC; 583; APC.
CC Transfected with: HGNC; 1773; CDK4.
CC Transfected with: HGNC; 11730; TERT.
ST Source(s): DOI=10.3389/fcimb.2016.00034
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 12,13
ST D16S539: 10,11
ST D21S11: 28
ST D5S818: 11,14
ST D7S820: 9,11
ST TH01: 9.3
ST TPOX: 11
ST vWA: 16,18
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_AQ45 ! HCEC 1CT
SX Male
CA Telomerase immortalized cell line
//
ID HCEC 1CTP
AC CVCL_AV02
SY HCEC 1CT + KrasV12; 1CTP
RX DOI=10.3389/fcimb.2016.00034;
RX PubMed=21527559;
CC Transfected with: HGNC; 1773; CDK4.
CC Transfected with: HGNC; 6407; KRAS (with V-12).
CC Transfected with: HGNC; 11730; TERT.
ST Source(s): DOI=10.3389/fcimb.2016.00034
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 12,13
ST D16S539: 10,11
ST D21S11: 28
ST D5S818: 11,14
ST D7S820: 9,11
ST TH01: 9.3
ST TPOX: 11
ST vWA: 16,18
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_AQ45 ! HCEC 1CT
SX Male
CA Telomerase immortalized cell line
//
ID HCEC 1CTR
AC CVCL_AV03
SY HCEC 1CT + shTP53; 1CTR
RX DOI=10.3389/fcimb.2016.00034;
RX PubMed=21527559;
CC Knockout cell: Method=shRNA knockdown; HGNC; 11998; TP53.
CC Transfected with: HGNC; 1773; CDK4.
CC Transfected with: HGNC; 11730; TERT.
ST Source(s): DOI=10.3389/fcimb.2016.00034
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 12,13
ST D16S539: 10,11
ST D21S11: 28
ST D5S818: 11,14
ST D7S820: 9,11
ST TH01: 9.3
ST TPOX: 11
ST vWA: 16,18
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_AQ45 ! HCEC 1CT
SX Male
CA Telomerase immortalized cell line
//
ID HCEC 1CT+7
AC CVCL_AQ46
SY HCEC 1CT7; 1CT7
RX PubMed=21472139;
RX PubMed=25923178;
CC Characteristics: Has acquired a chromosome 7 trisomy.
CC Transfected with: HGNC; 1773; CDK4.
CC Transfected with: HGNC; 11730; TERT.
CC Omics: Deep exome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_AQ45 ! HCEC 1CT
SX Male
CA Telomerase immortalized cell line
//
ID HCEC 2CT
AC CVCL_AQ47
SY Human Colonic Epithelial Cells 2 transduced with CDK4 and Telomerase; 2CT
RX PubMed=19962984;
RX PubMed=21527559;
CC Transfected with: HGNC; 1773; CDK4.
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Telomerase immortalized cell line
//
ID HCEC-12
AC CVCL_2064
SY Human Corneal Endothelial Cells-12
DR BioSample; SAMN03473460
DR DSMZ; ACC-646
RX PubMed=10794243;
CC Doubling time: ~40-50 hours (DSMZ).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 8,11
ST D16S539: 11,14
ST D5S818: 11,12
ST D7S820: 10,11
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 14,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID HCEC-B4G12
AC CVCL_2065
SY B4G12
DR DSMZ; ACC-647
RX PubMed=18196893;
CC Doubling time: ~40-50 hours (DSMZ).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 8,11
ST D16S539: 11,14
ST D5S818: 11,12
ST D7S820: 10,11
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 14,17
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2064 ! HCEC-12
SX Female
CA Transformed cell line
//
ID HCEC-H9C1
AC CVCL_2066
SY H9C1
DR BioSample; SAMN03473462
DR DSMZ; ACC-649
RX PubMed=18196893;
CC Doubling time: ~50-60 hours (DSMZ).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8,11
ST D16S539: 11
ST D5S818: 11
ST D7S820: 10,11
ST TH01: 9
ST TPOX: 8
ST vWA: 14,17
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2064 ! HCEC-12
SX Female
CA Transformed cell line
//
ID HCEnT-21T
AC CVCL_S876
RX PubMed=23284695;
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Telomerase immortalized cell line
//
ID HCFMK-1
AC CVCL_5762
SY HCFMK1
DR BTO; BTO:0004017
RX PubMed=8561821;
DI NCIt; C4041; Floor of mouth squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCH-1
AC CVCL_DF05
RX PubMed=27259990;
CC Doubling time: 66.4 hours (at 6th passage), 48.7 hours (at 25th passage) (PubMed=27259990).
DI NCIt; C40078; Ovarian clear cell adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HChol-Y1
AC CVCL_M256
RX CelloPub=CLPUB00275;
RX PubMed=2989602;
DI NCIt; C35417; Intrahepatic cholangiocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HCjE
AC CVCL_9700
SY ConjEp-1/p53DD/cdk4R/TERT
DR EFO; EFO_0003139
RX PubMed=12766048;
CC Transfected with: HGNC; 1773; CDK4 (with C-24).
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Telomerase immortalized cell line
//
ID HCK
AC CVCL_6F04
SY Human Corneal Keratocytes
RX PubMed=15813699;
RX PubMed=19326031;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID HCL BMF-PI 51
AC CVCL_9V72
DR NCBI_Iran; C489
RX PubMed=17254797;
ST Source(s): PubMed=17254797
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11,12
ST D16S539: 9,12
ST D18S51: 13,16
ST D21S11: 27,32
ST D3S1358: 15
ST D5S818: 11,13
ST D7S820: 8
ST D8S1179: 13,15
ST FGA: 20,24
ST TH01: 9,10
ST TPOX: 9,11
ST vWA: 16,18
DI NCIt; C84663; Cutis laxa
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9V46 ! LCL CL-PI 50
SX Female
CA Finite cell line
//
ID HCLL-7876
AC CVCL_0B40
DR Cosmic; 1809513
RX PubMed=3495441;
RX PubMed=7686949;
DI NCIt; C7402; Hairy cell leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HCLO
AC CVCL_M353
DR ChEMBL-Cells; CHEMBL3308659
DR ChEMBL-Targets; CHEMBL614814
RX PubMed=7779711;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HCLv-07
AC CVCL_EI72
SY Hairy Cell Leukemia variant-07
DR Cosmic; 1809514
RX PubMed=19332987;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C7402; Hairy cell leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCM HJ 1-i
AC CVCL_T925
SY HCM HJ; HCM 3
DR SKIP; SKIP000213
DR SKIP; SKIP000583
RX PubMed=25389285;
CC Discontinued: SKIP; SKIP000213; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T926 ! HCM HJ 1-n
SX Female
CA Induced pluripotent stem cell
//
ID HCM HJ 1-n
AC CVCL_T926
DR SKIP; SKIP000212
CC Discontinued: SKIP; SKIP000212; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T925 ! HCM HJ 1-i
SX Female
CA Induced pluripotent stem cell
//
ID HCM090909-3F2
AC CVCL_T909
SY HCM 090909-3F2; HCM 090909; HCM 1
DR SKIP; SKIP000208
DR SKIP; SKIP000581
RX PubMed=25389285;
CC Discontinued: SKIP; SKIP000208; probable.
DI NCIt; C34449; Hypertrophic cardiomyopathy
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T910 ! HCM090909-3G1
SX Male
CA Induced pluripotent stem cell
//
ID HCM090909-3G1
AC CVCL_T910
SY HCM 090909-3G1
DR SKIP; SKIP000209
CC Discontinued: SKIP; SKIP000209; probable.
DI NCIt; C34449; Hypertrophic cardiomyopathy
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T909 ! HCM090909-3F2
SX Male
CA Induced pluripotent stem cell
//
ID HCM512519-b3
AC CVCL_T911
SY HCM 512519; HCM 2
DR SKIP; SKIP000210
DR SKIP; SKIP000582
RX PubMed=25389285;
CC Discontinued: SKIP; SKIP000210; probable.
DI NCIt; C34449; Hypertrophic cardiomyopathy
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T912 ! HCM512519-c1
SX Female
CA Induced pluripotent stem cell
//
ID HCM512519-c1
AC CVCL_T912
DR SKIP; SKIP000211
CC Discontinued: SKIP; SKIP000211; probable.
DI NCIt; C34449; Hypertrophic cardiomyopathy
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T911 ! HCM512519-b3
SX Female
CA Induced pluripotent stem cell
//
ID HCMC
AC CVCL_0084
SY Human Colonic Mucosal Cells
DR ATCC; CCL-239
WW http://www.atcc.org/support/faqs/2e91a/HCMC%20ATCC%20CCL239-1090.aspx
CC Discontinued: ATCC; CCL-239; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID hCMEC/D3
AC CVCL_U985
SY HCMEC/D3; CMEC/D3
DR BTO; BTO:0003339
DR Millipore; SCC066
DR PRIDE; PXD002292
RX PubMed=16141364;
RX PubMed=23531482;
RX PubMed=26718731;
WW https://www.cedarlanelabs.com/Products/Detail/CLU512?lob=Cellutions
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Omics: Secretome proteome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID HCN-1
AC CVCL_4T79
SY Human Cortical Neuronal cells-1
RX Patent=US5196315;
RX PubMed=7700510;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID HCN-1A
AC CVCL_3283
SY HCN1A; Human Cortical Neuronal cells-1A
DR BTO; BTO:0003261
DR CLO; CLO_0003663
DR ATCC; CRL-10442
DR BioSample; SAMN03471301
RX Patent=US5196315;
RX PubMed=8779309;
WW http://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/hcn/hcncells.html
WW https://www.atcc.org/support/faqs/d04e3/ATCC%20normal%20brain%20cell%20lines-476.aspx
CC Miscellaneous: Cell line no longer available due to depletion of the original seed stock.
CC Discontinued: ATCC; CRL-10442; true.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11,12
ST D16S539: 12
ST D5S818: 11,12
ST D7S820: 11,12
ST TH01: 9.3
ST TPOX: 11
ST vWA: 17
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4T79 ! HCN-1
SX Female
CA Finite cell line
//
ID HCN-2
AC CVCL_3284
SY HCN2; Human Cortical Neuronal cells-2
DR BTO; BTO:0003262
DR CLO; CLO_0003664
DR ATCC; CRL-10742
DR BioSample; SAMN03471304
RX Patent=US5196315;
RX PubMed=7700510;
RX PubMed=14615026;
CC Omics: Proteome analysis by 2D-DE/MS.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,15
ST D13S317: 11,12
ST D16S539: 8,11
ST D5S818: 13
ST D7S820: 9,11
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 14,20
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID HCRL-ATO10
AC CVCL_Z692
SY HCRL-ATO-10; AT10
RX DOI=10.1016/0022-2011(90)90038-8;
CC Group: Insect cell line.
CC Doubling time: 34 hours (DOI=10.1016/0022-2011(90)90038-8).
OX NCBI_TaxID=680683; ! Amyelois transitella
SX Female
CA Spontaneously immortalized cell line
//
ID HCRL-ATO20
AC CVCL_Z693
SY HCRL-ATO-20; AT20
RX DOI=10.1016/0022-2011(90)90038-8;
CC Group: Insect cell line.
CC Doubling time: 35 hours (DOI=10.1016/0022-2011(90)90038-8).
OX NCBI_TaxID=680683; ! Amyelois transitella
SX Female
CA Spontaneously immortalized cell line
//
ID HCS-2
AC CVCL_2918
DR BioSample; SAMN03470913
DR JCRB; JCRB1203
DR JCRB; NIHS0405
RX PubMed=2979208;
CC Discontinued: JCRB; NIHS0405; true.
ST Source(s): JCRB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11
ST D16S539: 9,10
ST D18S51: 13,14
ST D19S433: 12,13
ST D21S11: 31.2
ST D2S1338: 24
ST D3S1358: 16,18
ST D5S818: 11,12
ST D7S820: 10,12
ST D8S1179: 13,14
ST FGA: 23,24
ST Penta D: 11,13
ST Penta E: 5,21
ST TH01: 6
ST TPOX: 9,11
ST vWA: 18
DI NCIt; C4028; Cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCS-2/8
AC CVCL_E261
SY HCS2/8
RX PubMed=2736538;
RX PubMed=8200849;
RX PubMed=15087127;
RX PubMed=15501409;
CC Omics: ESTs sequenced.
CC Omics: Transcriptome analysis.
DI NCIt; C2946; Chondrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_E262 ! HCS-2/A
SX Male
CA Cancer cell line
//
ID HCS-2/A
AC CVCL_E262
RX PubMed=2071232;
DI NCIt; C2946; Chondrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_E261 ! HCS-2/8
SX Male
CA Cancer cell line
//
ID HCSC-1
AC CVCL_2919
DR BioSample; SAMN03470912
DR JCRB; JCRB1205
RX CelloPub=CLPUB00373;
CC Doubling time: 24.3 hours (CelloPub=CLPUB00373).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC Derived from metastatic site: Ascites.
ST Source(s): JCRB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,9
ST D16S539: 9,13
ST D18S51: 14
ST D19S433: 13,15.2,16.2
ST D21S11: 28
ST D2S1338: 22,24
ST D3S1358: 15,16
ST D5S818: 12
ST D7S820: 11,12
ST D8S1179: 11
ST FGA: 22,26
ST Penta D: 12
ST Penta E: 16,18
ST TH01: 9
ST TPOX: 9
ST vWA: 16,18
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HCT 116
AC CVCL_0291
SY HCT-116; HCT.116; HCT116
DR BTO; BTO:0001109
DR BTO; BTO:0004743
DR CLO; CLO_0003665
DR EFO; EFO_0002824
DR MCCL; MCC:0000181
DR CLDB; cl1574
DR CLDB; cl1575
DR CLDB; cl5198
DR ATCC; CCL-247
DR BCRC; 60349
DR BCRJ; 0288
DR BioSample; SAMN03470980
DR BioSample; SAMN03471481
DR BioSample; SAMN03473487
DR CCLE; HCT116_LARGE_INTESTINE
DR CCRID; 3111C0001CCC000158
DR CCRID; 3111C0001CCC000331
DR CCRID; 3131C0001000700099
DR ChEMBL-Cells; CHEMBL3308372
DR ChEMBL-Targets; CHEMBL394
DR Cosmic; 711257
DR Cosmic; 720329
DR Cosmic; 724840
DR Cosmic; 869794
DR Cosmic; 870449
DR Cosmic; 873701
DR Cosmic; 875296
DR Cosmic; 875425
DR Cosmic; 875847
DR Cosmic; 876644
DR Cosmic; 876706
DR Cosmic; 887223
DR Cosmic; 889535
DR Cosmic; 897457
DR Cosmic; 902790
DR Cosmic; 905936
DR Cosmic; 913887
DR Cosmic; 934564
DR Cosmic; 947355
DR Cosmic; 948126
DR Cosmic; 948861
DR Cosmic; 985996
DR Cosmic; 995410
DR Cosmic; 1043815
DR Cosmic; 1044257
DR Cosmic; 1045410
DR Cosmic; 1057752
DR Cosmic; 1066205
DR Cosmic; 1067220
DR Cosmic; 1092600
DR Cosmic; 1102383
DR Cosmic; 1122325
DR Cosmic; 1131683
DR Cosmic; 1132568
DR Cosmic; 1132689
DR Cosmic; 1154644
DR Cosmic; 1175840
DR Cosmic; 1176588
DR Cosmic; 1183769
DR Cosmic; 1184080
DR Cosmic; 1184333
DR Cosmic; 1187306
DR Cosmic; 1218874
DR Cosmic; 1223141
DR Cosmic; 1305353
DR Cosmic; 1310945
DR Cosmic; 1332008
DR Cosmic; 1436021
DR Cosmic; 1466804
DR Cosmic; 1466815
DR Cosmic; 1479594
DR Cosmic; 1486132
DR Cosmic; 1519359
DR Cosmic; 1524003
DR Cosmic; 1524333
DR Cosmic; 1552179
DR Cosmic; 1571772
DR Cosmic; 1609495
DR Cosmic; 1672408
DR Cosmic; 1676727
DR Cosmic; 1708402
DR Cosmic; 1805253
DR Cosmic; 1927246
DR Cosmic; 1945865
DR Cosmic; 1995437
DR Cosmic; 1998442
DR Cosmic; 2036656
DR Cosmic; 2046556
DR Cosmic; 2052593
DR Cosmic; 2145576
DR Cosmic; 2301978
DR Cosmic; 2433755
DR Cosmic; 2464667
DR Cosmic; 2550353
DR Cosmic-CLP; 905936
DR DSMZ; ACC-581
DR ECACC; 91091005
DR ENCODE; ENCBS004UZY
DR ENCODE; ENCBS009DQE
DR ENCODE; ENCBS257IHV
DR ENCODE; ENCBS378ENC
DR ENCODE; ENCBS389ENC
DR ENCODE; ENCBS409ENC
DR ENCODE; ENCBS409MTT
DR ENCODE; ENCBS431ENC
DR ENCODE; ENCBS471AAA
DR ENCODE; ENCBS472AAA
DR ENCODE; ENCBS475AAA
DR ENCODE; ENCBS476AAA
DR ENCODE; ENCBS494OPB
DR ENCODE; ENCBS650OZU
DR ENCODE; ENCBS847SOB
DR GDSC; 905936
DR GEO; GSM810
DR GEO; GSM50188
DR GEO; GSM50252
DR GEO; GSM115118
DR GEO; GSM206501
DR GEO; GSM481405
DR GEO; GSM513818
DR GEO; GSM514292
DR GEO; GSM580039
DR GEO; GSM580040
DR GEO; GSM741266
DR GEO; GSM750773
DR GEO; GSM750793
DR GEO; GSM784012
DR GEO; GSM799331
DR GEO; GSM799394
DR GEO; GSM827446
DR GEO; GSM846355
DR GEO; GSM887062
DR GEO; GSM888132
DR GEO; GSM945287
DR GEO; GSM945304
DR GEO; GSM1153399
DR GEO; GSM1181250
DR GEO; GSM1181367
DR GEO; GSM1346874
DR GEO; GSM1374516
DR GEO; GSM1374517
DR GEO; GSM1374518
DR GEO; GSM1404391
DR GEO; GSM1404392
DR GEO; GSM1448092
DR GEO; GSM1669868
DR ICLC; HTL95025
DR IZSLER; BS TCL 100
DR KCB; KCB 200706YJ
DR KCLB; 10247
DR Lonza; 691
DR MeSH; D045325
DR NCBI_Iran; C570
DR PRIDE; PXD000089
DR PRIDE; PXD000394
DR PRIDE; PXD001352
DR PRIDE; PXD001426
DR PRIDE; PXD002793
DR RCB; RCB2979
DR SKY/M-FISH/CGH; 1687
DR SKY/M-FISH/CGH; 2778
DR SKY/M-FISH/CGH; 2785
DR SKY/M-FISH/CGH; 3883
DR TOKU-E; 1422
DR Wikidata; Q28334584
RX PubMed=2041050;
RX PubMed=6437669;
RX PubMed=7214343;
RX PubMed=7761852;
RX PubMed=9000147;
RX PubMed=9000572;
RX PubMed=9515795;
RX PubMed=10612807;
RX PubMed=10674020;
RX PubMed=10737795;
RX PubMed=11226274;
RX PubMed=11314036;
RX PubMed=11414198;
RX PubMed=11526487;
RX PubMed=12584437;
RX PubMed=17088437;
RX PubMed=17363507;
RX PubMed=18340113;
RX PubMed=19372543;
RX PubMed=19927377;
RX PubMed=20606684;
RX PubMed=22336246;
RX PubMed=22460905;
RX PubMed=23671654;
RX PubMed=23856246;
RX PubMed=23933261;
RX PubMed=24042735;
RX PubMed=24755471;
RX PubMed=25485619;
RX PubMed=25576301;
RX PubMed=25926053;
RX PubMed=25984343;
RX PubMed=26537799;
RX PubMed=27397505;
RX PubMed=27807467;
RX PubMed=28196595;
WW https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=17
WW http://www.pawefish.path.cam.ac.uk/ColonCellLineDescriptions/HCT116.html
WW http://genome.ucsc.edu/ENCODE/protocols/cell/human/HCT-116_protocol.pdf
WW http://www.addexbio.com/productdetail?pid=41
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-88.html
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: ENCODE project common cell types; tier 3.
CC Part of: FGFR genetic alteration cell panel (ATCC TCP-1034).
CC Part of: JFCR39 cancer cell line panel.
CC Part of: KuDOS 95 cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: NCI60 cancer cell line panel.
CC Doubling time: 36 hours (PubMed=25984343); 17.4 hours (DTP); ~25-48 hours (DSMZ).
CC Microsatellite instability: Instable (MSI-high) (PubMed=9000147; PubMed=10674020; PubMed=23671654; PubMed=24042735; PubMed=25926053; Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep glycome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: H3K4me3 ChIP-seq epigenome analysis.
CC Omics: HLA class I peptidome analysis by proteomics.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'HCT-166' in BTO BTO:0004743.
CC Misspelling: Occasionally 'HTC116'.
ST Source(s): ATCC; Cosmic-CLP; DSMZ; ECACC; KCLB; PubMed=11416159; PubMed=19372543; PubMed=25877200
ST Amelogenin: X,Y (ATCC; Cosmic-CLP; ECACC; KCLB)
ST Amelogenin: X (DSMZ; PubMed=11416159; PubMed=19372543; PubMed=25877200)
ST CSF1PO: 7,10 (ATCC; DSMZ; ECACC; KCLB; PubMed=11416159; PubMed=19372543; PubMed=25877200)
ST CSF1PO: 7,9,10,11 (Cosmic-CLP)
ST D13S317: 10,12
ST D16S539: 11,12,13 (DSMZ)
ST D16S539: 11,13 (ATCC; Cosmic-CLP; ECACC; PubMed=19372543; PubMed=25877200)
ST D18S51: 16,17 (PubMed=19372543)
ST D18S51: 17 (PubMed=25877200)
ST D19S433: 12,13
ST D21S11: 29,30
ST D2S1338: 16
ST D3S1358: 12,19
ST D5S818: 10,11
ST D7S820: 11,12
ST D8S1179: 12,14
ST FGA: 18,23
ST Penta D: 9,13
ST Penta E: 13,14
ST TH01: 8,9 (ATCC; Cosmic-CLP; ECACC; KCLB; PubMed=11416159; PubMed=19372543; PubMed=25877200)
ST TH01: 8 (DSMZ)
ST TPOX: 8,9 (ATCC; Cosmic-CLP)
ST TPOX: 8 (DSMZ; ECACC; KCLB; PubMed=19372543; PubMed=25877200)
ST vWA: 17,22 (ATCC; Cosmic-CLP; ECACC; KCLB; PubMed=25877200)
ST vWA: 17,21 (DSMZ)
ST vWA: 17 (PubMed=11416159; PubMed=19372543)
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_R729 ! HCT 116a
OI CVCL_R730 ! HCT 116b
SX Male
CA Cancer cell line
//
ID HCT 116 ADAM17
AC CVCL_HG03
SY HCT116 ADAM17
DR Ximbio; 153209
RX PubMed=20570921;
CC Transfected with: MGI; MGI:1096335; Adam17.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT 116 AKT1(-/-)
AC CVCL_HD66
SY AKT1 (-/-) HCT116
RX PubMed=20133737;
WW https://www.horizondiscovery.com/human-akt1-hct116-cell-line-hd-r02-004
CC Knockout cell: Method=Homologous recombination; HGNC; 391; AKT1.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT 116 AKT2(-/-)
AC CVCL_HD67
SY AKT2 (-/-) HCT116
RX PubMed=20133737;
WW https://www.horizondiscovery.com/human-akt2-hct116-cell-line-hd-r02-005
CC Knockout cell: Method=Homologous recombination; HGNC; 392; AKT2.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT 116 APOC1(-/-)
AC CVCL_HD68
SY APOC1 (-/-) HCT116
WW https://www.horizondiscovery.com/human-apoc1-hct116-cell-line-hd-r02-007
CC Knockout cell: Method=Homologous recombination; HGNC; 607; APOC1.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT 116 AXL KO Tet-inducible
AC CVCL_HG04
DR Ximbio; 153206
RX PubMed=24170546;
CC Knockout cell: Method=shRNA knockdown; HGNC; 905; AXL.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT 116 BAX(-/-)
AC CVCL_HD69
SY BAX (-/-) HCT116
RX PubMed=11062132;
WW https://www.horizondiscovery.com/bax-hct116-cell-line-hd-r02-008
CC Knockout cell: Method=Homologous recombination; HGNC; 959; BAX.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT 116 BBC3(-/-)
AC CVCL_HD70
SY BBC3 (-/-) HCT116; HCT116 PUMA-/-
RX PubMed=12574499;
WW https://www.horizondiscovery.com/human-bbc3-hct116-cell-line-hd-r02-040
CC Knockout cell: Method=Homologous recombination; HGNC; 17868; BBC3.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT 116 BLM(-/-)
AC CVCL_HD71
SY BLM (-/-) HCT116; BLM-/- HCT116
RX PubMed=14695165;
WW https://www.horizondiscovery.com/human-blm-hct116-cell-line-hd-r02-011
CC Knockout cell: Method=Homologous recombination; HGNC; 1058; BLM.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT 116 BRCA2(-/-)
AC CVCL_AS10
SY HCT 116 BRCA2-/-
DR Ximbio; 152628
RX PubMed=25043256;
CC Knockout cell: Method=Homologous recombination; HGNC; 1101; BRCA2.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT 116 CDK2(-/-)
AC CVCL_HD72
SY CDK2 (-/-) HCT116; CDK2-/- HCT116
RX PubMed=20195506;
WW https://www.horizondiscovery.com/human-cdk2-hct116-cell-line-hd-r02-015
CC Knockout cell: Method=Homologous recombination; HGNC; 1771; CDK2.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT 116 CDKN1A(-/-)
AC CVCL_HD73
SY CDKN1A (-/-) HCT116; HCT116 p21-/-
RX PubMed=8756351;
WW https://www.horizondiscovery.com/human-cdkn1a-hct116-cell-line-hd-r02-035
CC Knockout cell: Method=Homologous recombination; HGNC; 1784; CDKN1A.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT 116 CTNNB1(+/-)
AC CVCL_HD74
SY CTNNB1 (+/-) HCT116; CTNNB1 WT/- HCT116
RX PubMed=12060769;
WW https://www.horizondiscovery.com/human-ctnnb1-hct116-cell-line-hd-104-009
CC Characteristics: In HCT 116 one of the two CTNNB1 alleles has a 3-bp deletion that eliminates S-45. This cell line is KO for the mutant allele.
CC Knockout cell: Method=Homologous recombination (1 of 2 alleles); HGNC; 2514; CTNNB1.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT 116 DIABLO(-/-)
AC CVCL_HD75
SY DIABLO (-/-) HCT116; SMAC-KO HCT116
RX PubMed=15557007;
WW https://www.horizondiscovery.com/human-diablo-hct116-cell-line-hd-r02-045
CC Knockout cell: Method=Homologous recombination; HGNC; 21528; DIABLO.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT 116 DICER1(-/-)
AC CVCL_HD76
SY DICER1 (-/-) HCT116
RX PubMed=16505370;
WW https://www.horizondiscovery.com/human-dicer1-hct116-cell-line-hd-r02-019
CC Knockout cell: Method=Homologous recombination; HGNC; 17098; DICER1.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT 116 DNMT3B(-/-)
AC CVCL_HD77
SY DNMT3B (-/-) HCT116; HCT116 DNMT3b-/-; 3bKO
WW https://www.horizondiscovery.com/human-dnmt3b-hct116-cell-line-hd-r02-023
CC Knockout cell: Method=Homologous recombination; HGNC; 2979; DNMT3B.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT 116 EP300 WT
AC CVCL_HG26
SY HCT 116 p300 WT
DR Ximbio; 153183
RX PubMed=15123817;
CC Characteristics: HCT 116 is hemizygous for EP300. This cell line is a normal derivative of HCT 116 from which a number of clones KO for the EP300 single allele were established.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT 116 EP300(-) clone D10
AC CVCL_HG27
SY HCT 116 p300 KO [D10]; p300 KO Clone D10
DR Ximbio; 151479
RX PubMed=15123817;
CC Characteristics: HCT 116 is hemizygous for EP300. This cell line is KO for the single allele.
CC Knockout cell: Method=Homologous recombination; HGNC; 3373; EP300.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_HG26 ! HCT 116 EP300 WT
SX Male
CA Cancer cell line
//
ID HCT 116 EP300(-) clone F2
AC CVCL_HG28
SY HCT 116 p300 KO [F2]; p300 KO Clone F2
DR Ximbio; 153185
RX PubMed=15123817;
CC Characteristics: HCT 116 is hemizygous for EP300. This cell line is KO for the single allele.
CC Knockout cell: Method=Homologous recombination; HGNC; 3373; EP300.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_HG26 ! HCT 116 EP300 WT
SX Male
CA Cancer cell line
//
ID HCT 116 EP300(-) clone F5
AC CVCL_HG29
SY HCT 116 p300 KO [F5]; p300 KO Clone F5
DR Ximbio; 153184
RX PubMed=15123817;
CC Characteristics: HCT 116 is hemizygous for EP300. This cell line is KO for the single allele.
CC Knockout cell: Method=Homologous recombination; HGNC; 3373; EP300.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_HG26 ! HCT 116 EP300 WT
SX Male
CA Cancer cell line
//
ID HCT 116 EP300(-) rescued
AC CVCL_HG30
SY HCT 116 p300 KO Rescue
DR Ximbio; 153186
RX PubMed=15123817;
CC Characteristics: HCT 116 is hemizygous for EP300. This cell line is KO for the single allele and is rescued by transfection of a wild-type copy of EP300.
CC Knockout cell: Method=Homologous recombination; HGNC; 3373; EP300.
CC Transfected with: HGNC; 3373; EP300.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_HG29 ! HCT 116 EP300(-) clone F5
SX Male
CA Cancer cell line
//
ID HCT 116 EphA2 KO Tet-inducible
AC CVCL_HG05
DR Ximbio; 153207
RX PubMed=26283684;
CC Knockout cell: Method=shRNA knockdown; HGNC; 3386; EPHA2.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT 116 FBXW7(-/-)
AC CVCL_HD78
SY FBXW7 (-/-) HCT116; HCT116 hCDC4 -/-
RX PubMed=14999283;
WW https://www.horizondiscovery.com/human-fbxw7-hct116-cell-line-hd-r02-013
CC Knockout cell: Method=Homologous recombination; HGNC; 16712; FBXW7.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT 116 KDM5A(+/-)
AC CVCL_HD79
SY KDM5A (+/-) HCT116
WW https://www.horizondiscovery.com/human-kdm5a-hct116-cell-line-hd-104-053
CC Knockout cell: Method=Homologous recombination (1 of 2 alleles); HGNC; 9886; KDM5A.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT 116 KDM5A(-/-)
AC CVCL_HD80
SY KDM5A (-/-) HCT116
WW https://www.horizondiscovery.com/human-kdm5a-hct116-cell-line-hd-104-105
CC Knockout cell: Method=Homologous recombination; HGNC; 9886; KDM5A.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT 116 KRAS(+/-)
AC CVCL_HD81
SY KRAS (+/-) HCT116
RX PubMed=19661383;
WW https://www.horizondiscovery.com/kras-hct116-cell-line-hd-104-008
CC Knockout cell: Method=Homologous recombination (1 of 2 alleles); HGNC; 6407; KRAS.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT 116 LIG4(+/-)
AC CVCL_HD82
SY LIG4 (+/-) HCT116; LIGIV+/- HCT116
RX PubMed=20195511;
WW https://www.horizondiscovery.com/human-lig4-hct116-cell-line-hd-r02-062
CC Knockout cell: Method=Homologous recombination (1 of 2 alleles); HGNC; 6601; LIG4.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT 116 LIG4(-/-)
AC CVCL_HD83
SY LIG4 (-/-) HCT116; LIGIV-/- HCT116
RX PubMed=20195511;
WW https://www.horizondiscovery.com/human-lig4-hct116-cell-line-hd-r02-063
CC Knockout cell: Method=Homologous recombination; HGNC; 6601; LIG4.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT 116 MLH1(+/-)
AC CVCL_HD84
SY MLH1 (+/-) HCT116; BVEC-E2; Bipartite Vector Exon 9 Corrected clone E2
RX PubMed=17082796;
WW https://www.horizondiscovery.com/human-mlh1-hct116-cell-line-hd-104-006
CC Characteristics: HCT 116 has a point mutation C755A in exon 9 of MLH1. This cell line is knockin by homologous recombination of the wild-type MLH1 in 1 of the 2 alleles .
CC Knockout cell: Method=Homologous recombination (1 of 2 alleles); HGNC; 7127; MLH1.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT 116 NHEJ1(+/-)
AC CVCL_HD85
SY NHEJ1 (+/-) HCT116; XLF+/- HCT116
RX PubMed=20195511;
WW https://www.horizondiscovery.com/human-nhej1-hct116-cell-line-hd-r02-067
CC Knockout cell: Method=Homologous recombination (1 of 2 alleles); HGNC; 25737; NHEJ1.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT 116 NHEJ1(-/-)
AC CVCL_HD86
SY NHEJ1 (-/-) HCT116; XLF-/- HCT116
RX PubMed=20195511;
WW https://www.horizondiscovery.com/human-nhej1-hct116-cell-line-hd-r02-068
CC Knockout cell: Method=Homologous recombination; HGNC; 25737; NHEJ1.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT 116 PDPK1(+/-)
AC CVCL_HD87
SY PDPK1 (+/-) HCT116
RX PubMed=20133737;
WW https://www.horizondiscovery.com/human-pdpk1-hct116-cell-line-hd-r02-080
CC Knockout cell: Method=Homologous recombination (1 of 2 alleles); HGNC; 8816; PDPK1.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT 116 PPARD(-/-)
AC CVCL_HD88
SY PPARD (-/-) HCT116; HCT116 PPARdelta -/-
RX PubMed=11226285;
WW https://www.horizondiscovery.com/human-ppard-hct116-cell-line-hd-r02-038
CC Knockout cell: Method=Homologous recombination; HGNC; 9235; PPARD.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT 116 PRKDC(+/-)
AC CVCL_HD89
SY PRKDC (+/-) HCT116
RX PubMed=18710952;
WW https://www.horizondiscovery.com/human-prkdc-hct116-cell-line-hd-r02-048
CC Knockout cell: Method=Homologous recombination (1 of 2 alleles); HGNC; 9413; PRKDC.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT 116 PRKDC(-/-)
AC CVCL_HD90
SY PRKDC (-/-) HCT116
RX PubMed=18710952;
WW https://www.horizondiscovery.com/human-prkdc-hct116-cell-line-hd-r02-049
CC Knockout cell: Method=Homologous recombination; HGNC; 9413; PRKDC.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT 116 PTEN(+/-)
AC CVCL_HD91
SY PTEN (+/-) HCT116
WW https://www.horizondiscovery.com/human-pten-hct116-cell-line-hd-104-057
CC Knockout cell: Method=Homologous recombination (1 of 2 alleles); HGNC; 9588; PTEN.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT 116 PTEN(-/-)
AC CVCL_HD92
SY PTEN (-/-) HCT116
RX PubMed=15466180;
WW https://www.horizondiscovery.com/human-pten-hct116-cell-line-hd-104-004
CC Knockout cell: Method=Homologous recombination; HGNC; 9588; PTEN.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT 116 PTTG1(-/-)
AC CVCL_HD93
SY PTTG1 (-/-) HCT116; hSecurin-/- HCT116
RX PubMed=11371342;
RX PubMed=16292982;
WW https://www.horizondiscovery.com/human-pttg1-hct116-cell-line-hd-r02-043
CC Knockout cell: Method=Homologous recombination; HGNC; 9690; PTTG1.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT 116 SFN(-/-)
AC CVCL_HD94
SY SFN (-/-) HCT116; 14-3-3s-/- HCT116; 14-3-3sigma-/- HCT116
RX PubMed=10524633;
WW https://www.horizondiscovery.com/human-sfn-hct116-cell-line-hd-r02-001
CC Knockout cell: Method=Homologous recombination; HGNC; 10773; SFN.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT 116 SMAD4(-/-)
AC CVCL_HD95
SY SMAD4 (-/-) HCT116; Smad-/- HCT116
RX PubMed=9482899;
WW https://www.horizondiscovery.com/human-smad4-hct116-cell-line-hd-104-005
CC Knockout cell: Method=Homologous recombination; HGNC; 6770; SMAD4.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT 116 TP53(+/-)
AC CVCL_HD96
SY TP53 (+/-) HCT116
RX PubMed=19225112;
WW https://www.horizondiscovery.com/human-tp53-hct116-cell-line-hd-r02-037
CC Knockout cell: Method=Homologous recombination (1 of 2 alleles); HGNC; 11998; TP53.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT 116 TP53(-/-)
AC CVCL_HD97
SY TP53 (-/-) HCT116; HCT116-p53-null
RX PubMed=19225112;
WW https://www.horizondiscovery.com/human-tp53-hct116-cell-line-hd-104-001
CC Knockout cell: Method=Homologous recombination; HGNC; 11998; TP53.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT 116 USP7(+/-)
AC CVCL_HD98
SY USP7 (+/-) HCT116; HAUSP+/- HCT116
RX PubMed=15118411;
WW https://www.horizondiscovery.com/human-usp7-hct116-cell-line-hd-r02-029
CC Knockout cell: Method=Homologous recombination (1 of 2 alleles); HGNC; 12630; USP7.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT 116 USP7(-/-)
AC CVCL_HD99
SY USP7 (-/-) HCT116; HAUSP-/- HCT116
RX PubMed=15118411;
WW https://www.horizondiscovery.com/human-usp7-hct116-cell-line-hd-r02-028
CC Knockout cell: Method=Homologous recombination; HGNC; 12630; USP7.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT 116 XRCC4(-/-)
AC CVCL_HE00
SY XRCC4 (-/-) HCT116
WW https://www.horizondiscovery.com/human-xrcc4-hct116-cell-line-hd-r02-076
CC Knockout cell: Method=Homologous recombination; HGNC; 12831: XRCC4.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT 116 XRCC6(+/-)
AC CVCL_HE01
SY XRCC6 (+/-) HCT116; Ku70+/- HCT116
RX PubMed=18387344;
RX PubMed=18562296;
RX PubMed=20195511;
WW https://www.horizondiscovery.com/human-xrcc6-hct116-cell-line-hd-r02-053
CC Knockout cell: Method=Homologous recombination (1 of 2 alleles); HGNC; 4055; XRCC6.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT 116-I6
AC CVCL_HG06
SY HCT116-I6
DR Ximbio; 153208
RX PubMed=24170546;
CC Characteristics: Demonstrates a 4x and 20x increase in migration and invasion rate respectively compared to HCT 116.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT 116-luc2
AC CVCL_5J19
CC Transfected with: UniProtKB; P08659; Firefly luciferase (with optimized codon usage for mammalian expression).
CC Discontinued: PerkinElmer; Catalog number 124318.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT 116-OX
AC CVCL_4V73
RX PubMed=24761924;
CC Selected for resistance to: ChEBI; CHEBI:31941; Oxaliplatin (Elotaxin; L-OHP).
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT 116-Red-FLuc
AC CVCL_5I94
SY HCT116-Red-FLuc; HCT116 Red-FLuc
WW http://www.perkinelmer.com/Catalog/Product/ID/BW124318
CC Transfected with: UniProtKB; Q1AG35; Italian firefly luciferase.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT 116a
AC CVCL_R729
SY HCT-116a
RX PubMed=3349466;
RX PubMed=6437669;
RX PubMed=7214343;
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0291 ! HCT 116
OI CVCL_R730 ! HCT 116b
SX Male
CA Cancer cell line
//
ID HCT 116b
AC CVCL_R730
RX PubMed=6437669;
RX PubMed=7214343;
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0291 ! HCT 116
OI CVCL_R729 ! HCT 116a
SX Male
CA Cancer cell line
//
ID HCT 116R11
AC CVCL_4V28
SY HCT116R11
RX PubMed=6437674;
CC Selected for resistance to: ChEBI; CHEBI:27504; Mitomycin C (MMC).
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT 116R26
AC CVCL_4V29
SY HCT116R26
RX PubMed=6437674;
CC Selected for resistance to: ChEBI; CHEBI:27504; Mitomycin C (MMC).
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT 15
AC CVCL_0292
SY HCT-15; HCT15
DR BTO; BTO:0002201
DR CLO; CLO_0003666
DR EFO; EFO_0002188
DR MCCL; MCC:0000182
DR CLDB; cl1576
DR CLDB; cl4985
DR ATCC; CCL-225
DR BCRC; 60539
DR BioSample; SAMN01821556
DR BioSample; SAMN01821630
DR BioSample; SAMN03471553
DR CCLE; HCT15_LARGE_INTESTINE
DR CCRID; 3111C0001CCC000247
DR CCRID; 3131C0001000700133
DR ChEMBL-Cells; CHEMBL3307945
DR ChEMBL-Targets; CHEMBL612263
DR Cosmic; 711261
DR Cosmic; 873700
DR Cosmic; 875902
DR Cosmic; 887222
DR Cosmic; 897458
DR Cosmic; 905007
DR Cosmic; 905937
DR Cosmic; 913889
DR Cosmic; 934567
DR Cosmic; 947354
DR Cosmic; 995403
DR Cosmic; 1044258
DR Cosmic; 1057756
DR Cosmic; 1066206
DR Cosmic; 1092601
DR Cosmic; 1122324
DR Cosmic; 1132569
DR Cosmic; 1175841
DR Cosmic; 1184092
DR Cosmic; 1187307
DR Cosmic; 1218878
DR Cosmic; 1305354
DR Cosmic; 1310950
DR Cosmic; 1312338
DR Cosmic; 1436020
DR Cosmic; 1466814
DR Cosmic; 1479592
DR Cosmic; 1526922
DR Cosmic; 1609492
DR Cosmic; 1676747
DR Cosmic; 1708403
DR Cosmic; 1995438
DR Cosmic; 1998443
DR Cosmic; 2036655
DR Cosmic; 2156942
DR Cosmic; 2301979
DR Cosmic-CLP; 905937
DR DSMZ; ACC-357
DR ECACC; 91030712
DR GDSC; 905937
DR GEO; GSM50189
DR GEO; GSM50253
DR GEO; GSM206502
DR GEO; GSM481406
DR GEO; GSM513816
DR GEO; GSM514293
DR GEO; GSM741257
DR GEO; GSM750792
DR GEO; GSM784011
DR GEO; GSM799332
DR GEO; GSM799395
DR GEO; GSM846356
DR GEO; GSM844554
DR GEO; GSM887063
DR GEO; GSM888133
DR GEO; GSM1153402
DR GEO; GSM1181251
DR GEO; GSM1181363
DR GEO; GSM1346875
DR GEO; GSM1374519
DR GEO; GSM1374520
DR GEO; GSM1374521
DR GEO; GSM1374522
DR GEO; GSM1448178
DR GEO; GSM1669869
DR ICLC; HTL00001
DR IGRhCellID; HCT15
DR KCB; KCB 201197YJ
DR KCLB; 10225
DR Lonza; 492
DR SKY/M-FISH/CGH; 2786
DR TKG; TKG 0504
DR TOKU-E; 1423
RX PubMed=2041050;
RX PubMed=9000147;
RX PubMed=9000572;
RX PubMed=9809040;
RX PubMed=10737795;
RX PubMed=11314036;
RX PubMed=11414198;
RX PubMed=11526487;
RX PubMed=12584437;
RX PubMed=17088437;
RX PubMed=19372543;
RX PubMed=20606684;
RX PubMed=22336246;
RX PubMed=22460905;
RX PubMed=23856246;
RX PubMed=23933261;
RX PubMed=24042735;
RX PubMed=24755471;
RX PubMed=25485619;
RX PubMed=25926053;
RX PubMed=26537799;
RX PubMed=27397505;
RX PubMed=27807467;
RX PubMed=28196595;
WW https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=20
WW http://www.pawefish.path.cam.ac.uk/ColonCellLineDescriptions/HCT15.html
WW http://www.addexbio.com/productdetail?pid=381
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: JFCR39 cancer cell line panel.
CC Part of: KuDOS 95 cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: NCI60 cancer cell line panel.
CC Part of: PI3K genetic alteration cell panel (ATCC TCP-1028).
CC Part of: RAS genetic alteration cell panel (ATCC TCP-1031).
CC Doubling time: 20.6 hours (DTP); ~20-25 hours (DSMZ).
CC Microsatellite instability: Instable (MSI-high) (PubMed=11526487; PubMed=24042735; PubMed=25926053; Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep glycome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; DSMZ; ECACC; KCLB; PubMed=11416159; PubMed=19372543; PubMed=25877200; TKG
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 8,11
ST D16S539: 12,13
ST D18S51: 11,17
ST D19S433: 14,16
ST D21S11: 29,32.2
ST D2S1338: 17,25
ST D3S1358: 17
ST D5S818: 13
ST D7S820: 10,12
ST D8S1179: 15
ST FGA: 22
ST Penta D: 9,14
ST Penta E: 7,14
ST TH01: 7,9.3
ST TPOX: 8,11
ST vWA: 18,19
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3449 ! __Parent_cell_line_of_DLD-1/HCT 8/HCT 15/HRT-18
SX Male
CA Cancer cell line
//
ID HCT 15-Luc#1
AC CVCL_4Y02
SY HCT-15-Luc#1
DR JCRB; JCRB1479
DR JCRB; NIHS0710
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 8,11
ST D16S539: 12,13
ST D5S818: 13
ST D7S820: 10,12
ST TH01: 7,9.3
ST TPOX: 8,11
ST vWA: 18,19
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0292 ! HCT 15
SX Male
CA Cancer cell line
//
ID HCT 8
AC CVCL_2478
SY HCT-8; HCT8
DR BTO; BTO:0002255
DR CLO; CLO_0003667
DR EFO; EFO_0002189
DR CLDB; cl1577
DR CLDB; cl1578
DR CLDB; cl4949
DR CLDB; cl5197
DR BioSample; SAMN03473138
DR CCLE; HCT8_LARGE_INTESTINE
DR CCRID; 3111C0001CCC000104
DR CCRID; 3131C0001000700018
DR ChEMBL-Cells; CHEMBL3308035
DR ChEMBL-Cells; CHEMBL3308660
DR ChEMBL-Targets; CHEMBL613510
DR ChEMBL-Targets; CHEMBL614815
DR Cosmic; 887226
DR Cosmic; 948853
DR Cosmic; 983738
DR Cosmic; 988873
DR Cosmic; 1043814
DR Cosmic; 1310946
DR Cosmic; 1479593
DR Cosmic; 1609484
DR Cosmic; 1676735
DR Cosmic; 2267316
DR Cosmic; 2301980
DR ECACC; 90032006
DR GEO; GSM206504
DR GEO; GSM513910
DR GEO; GSM514294
DR GEO; GSM827344
DR GEO; GSM1346876
DR GEO; GSM1374523
DR GEO; GSM1374524
DR GEO; GSM1448162
DR ICLC; HTL99005
DR IGRhCellID; HCT8
DR IZSLER; BS TCL 97
DR KCB; KCB 2011103YJ
DR KCLB; 10244
RX PubMed=8422623;
RX PubMed=9809040;
RX PubMed=10674020;
RX PubMed=24755471;
RX PubMed=25485619;
RX PubMed=25926053;
RX PubMed=26537799;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Instable (MSI) (PubMed=10674020; PubMed=25926053).
CC Omics: Deep glycome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'HCT 18' in ChEMBL CHEMBL614815 and CHEMBL3308660.
ST Source(s): KCLB; PubMed=25877200
ST Amelogenin: X,Y (KCLB)
ST Amelogenin: X (PubMed=25877200)
ST CSF1PO: 12
ST D13S317: 8,11
ST D16S539: 12,13
ST D18S51: 11,17
ST D21S11: 29,32.2
ST D3S1358: 17
ST D5S818: 13
ST D7S820: 10,12 (KCLB)
ST D7S820: 10,11.3 (PubMed=25877200)
ST D8S1179: 15
ST FGA: 22
ST Penta D: 9,14
ST Penta E: 7,14
ST TH01: 7,9.3
ST TPOX: 8,11
ST vWA: 18,19
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3449 ! __Parent_cell_line_of_DLD-1/HCT 8/HCT 15/HRT-18
SX Male
CA Cancer cell line
//
ID HCT C
AC CVCL_A607
RX PubMed=6437669;
RX PubMed=6830688;
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A608 ! HCT C Col
SX Male
CA Cancer cell line
//
ID HCT C Col
AC CVCL_A608
SY C Col
RX PubMed=6437669;
RX PubMed=6830688;
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A607 ! HCT C
SX Male
CA Cancer cell line
//
ID HCT-1
AC CVCL_M747
SY HCT 1; HCT1
RX PubMed=3009333;
CC Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
OX NCBI_TaxID=10036; ! Mesocricetus auratus
SX Male
CA Transformed cell line
//
ID HCT-116 clone#2-Luc
AC CVCL_J254
DR JCRB; JCRB1408
DR JCRB; NIHS0649
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Discontinued: JCRB; NIHS0649; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 7,10
ST D13S317: 10,12
ST D16S539: 11,13,14
ST D5S818: 10,11
ST D7S820: 11,12
ST TH01: 8,9
ST TPOX: 8
ST vWA: 17,18,22,23
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT-116-MEK-R
AC CVCL_V401
DR Cosmic; 1927247
RX PubMed=22402123;
CC Selected for resistance to: ChEBI; CHEBI:88249; 391210-10-9 (PD032591).
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT-116/VM34
AC CVCL_4V05
SY HCT116(VM)34; HCT-VM34
RX PubMed=1717144;
CC Selected for resistance to: ChEBI; CHEBI:75988; Teniposide (VM-26).
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT-116/VM46
AC CVCL_N508
SY HCT116/VM46; HCT116-VM46; HCT116(VM46); HCT-VM46; HCT/VM46; VM46
DR ChEMBL-Cells; CHEMBL3307407
DR ChEMBL-Targets; CHEMBL614575
CC Selected for resistance to: ChEBI; CHEBI:75988; Teniposide (VM-26).
CC Misspelling: Occasionally 'HCT166/VM46'.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT-116/VP35
AC CVCL_N509
SY HCT116/VP35; HCT116(VP35); HCT116(VP)35; HCT-VP35; HCT/VP35; VP35
RX PubMed=1717144;
CC Selected for resistance to: ChEBI; CHEBI:4911; Etoposide (VP-16).
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT-116RB
AC CVCL_IU66
RX PubMed=12507930;
CC Selected for resistance to: ChEBI; CHEBI:9177; Sodium deoxycholate (NaDOC).
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT-116RC
AC CVCL_IU67
RX PubMed=12507930;
CC Selected for resistance to: ChEBI; CHEBI:9177; Sodium deoxycholate (NaDOC).
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT-116RD,
AC CVCL_IU68
RX PubMed=12507930;
CC Selected for resistance to: ChEBI; CHEBI:9177; Sodium deoxycholate (NaDOC).
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT-2
AC CVCL_2920
SY HCT 2; HCT2
DR JCRB; JCRB1362
RX PubMed=3009333;
CC Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
OX NCBI_TaxID=10036; ! Mesocricetus auratus
SX Female
CA Transformed cell line
//
ID HCT-8/E11
AC CVCL_5679
SY E11
DR TOKU-E; 3539
RX PubMed=7553655;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2478 ! HCT 8
SX Male
CA Cancer cell line
//
ID HCT-8/R1
AC CVCL_5945
RX PubMed=7553655;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2478 ! HCT 8
SX Male
CA Cancer cell line
//
ID HCT-8/S10
AC CVCL_5947
RX PubMed=7553655;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2478 ! HCT 8
SX Male
CA Cancer cell line
//
ID HCT-8/S11
AC CVCL_5682
DR TOKU-E; 4073
RX PubMed=7553655;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2478 ! HCT 8
SX Male
CA Cancer cell line
//
ID HCT-8R
AC CVCL_S851
RX PubMed=908038;
RX PubMed=3349466;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2478 ! HCT 8
SX Male
CA Cancer cell line
//
ID HCT116-53BPI(+/-)
AC CVCL_1R00
DR RCB; RCB2996
CC Knockout cell: Method=Homologous recombination (1 of 2 alleles); HGNC; 11999; TP53BP1.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT116-Artemis(+/-)
AC CVCL_T770
SY HCT116-ARTEMIS(+/-); Artemis+/-
DR RCB; RCB2984
RX PubMed=21785230;
CC Knockout cell: Method=Homologous recombination (1 of 2 alleles); HGNC; 17642; DCLRE1C.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT116-Artemis(-/-)
AC CVCL_T771
SY HCT116-ARTEMIS(-/-); Artemis-/-
DR RCB; RCB2985
RX PubMed=21785230;
CC Knockout cell: Method=Homologous recombination; HGNC; 17642; DCLRE1C.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT116-DNAPKcs(+/-)
AC CVCL_1R01
DR RCB; RCB2992
CC Knockout cell: Method=Homologous recombination (1 of 2 alleles); HGNC; 9413; PRKDC.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT116-Dual
AC CVCL_5I74
WW http://www.invivogen.com/hct116-dual
CC Transfected with: HGNC; 439; ALPP.
CC Transfected with: Lucia luciferase; a synthetic gene designed on natural secreted luciferase genes from marine copepods.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT116-Ku70(+/-)
AC CVCL_1R02
DR RCB; RCB2991
CC Knockout cell: Method=Homologous recombination (1 of 2 alleles); HGNC; 4055; XRCC6.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT116-LIG3(+/-)
AC CVCL_1R03
DR RCB; RCB2994
CC Knockout cell: Method=Homologous recombination (1 of 2 alleles); HGNC; 6600; LIG3.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT116-LIG4(+/-)
AC CVCL_1R04
DR RCB; RCB2995
CC Knockout cell: Method=Homologous recombination (1 of 2 alleles); HGNC; 6601; LIG4.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT116-MDC1(+/-)
AC CVCL_1R05
DR RCB; RCB2986
CC Knockout cell: Method=Homologous recombination (1 of 2 alleles); HGNC; 21163; MDC1.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT116-MDC1(-/-)
AC CVCL_1R06
DR RCB; RCB2987
CC Knockout cell: Method=Homologous recombination; HGNC; 21163; MDC1.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT116-POLM(+/-)
AC CVCL_1R07
DR RCB; RCB2993
CC Knockout cell: Method=Homologous recombination (1 of 2 alleles); HGNC; 9185; POLM.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT116-RAD18(+/-)
AC CVCL_1R08
SY RAD18+/-
DR RCB; RCB2982
RX PubMed=17158148;
CC Knockout cell: Method=Homologous recombination (1 of 2 alleles); HGNC; 18278; RAD18.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT116-RAD18(-/-)
AC CVCL_1R09
SY RAD18-/-
DR RCB; RCB2983
RX PubMed=17158148;
CC Knockout cell: Method=Homologous recombination; HGNC; 18278; RAD18.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT116-REV1(+/-)
AC CVCL_1R10
DR RCB; RCB2988
CC Knockout cell: Method=Homologous recombination (1 of 2 alleles); HGNC; 14060; REV1.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT116-REV1(-/-)
AC CVCL_1R11
DR RCB; RCB2989
CC Knockout cell: Method=Homologous recombination; HGNC; 14060; REV1.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT116-REV3L(+/-)
AC CVCL_1R12
DR RCB; RCB2990
CC Knockout cell: Method=Homologous recombination (1 of 2 alleles); HGNC; 9968; REV3L.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT116-SN50
AC CVCL_Y553
RX PubMed=15027118;
RX PubMed=18340113;
CC Selected for resistance to: ChEBI; CHEBI:8988; SN-38 (7-ethyl-10-hydroxy-camptothecin).
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT116-SN6
AC CVCL_Y554
RX PubMed=15027118;
RX PubMed=18340113;
CC Selected for resistance to: ChEBI; CHEBI:8988; SN-38 (7-ethyl-10-hydroxy-camptothecin).
CC Omics: Transcriptome analysis.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT116-XRCC4(+/-)
AC CVCL_T772
SY XRCC4+/-
DR RCB; RCB2980
RX PubMed=21785230;
CC Knockout cell: Method=Homologous recombination (1 of 2 alleles); HGNC; 12831; XRCC4.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT116-XRCC4(-/-)
AC CVCL_T773
SY XRCC4-/-
DR RCB; RCB2981
RX PubMed=21785230;
CC Knockout cell: Method=Homologous recombination; HGNC; 12831; XRCC4.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT116/5FUR
AC CVCL_AU09
WW https://www.mdanderson.org/education-and-research/resources-for-professionals/scientific-resources/core-facilities-and-services/characterized-cell-line-core-facility/services/cclc-list-to-distribute-updated.xlsx
CC Selected for resistance to: ChEBI; CHEBI:46345; 5-fluorouracil (5-FU).
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT116/BEVA
AC CVCL_AU10
WW https://www.mdanderson.org/education-and-research/resources-for-professionals/scientific-resources/core-facilities-and-services/characterized-cell-line-core-facility/services/cclc-list-to-distribute-updated.xlsx
CC Selected for resistance to: Bevacizumab (Avastin).
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCT116/SN38R
AC CVCL_AU11
WW https://www.mdanderson.org/education-and-research/resources-for-professionals/scientific-resources/core-facilities-and-services/characterized-cell-line-core-facility/services/cclc-list-to-distribute-updated.xlsx
CC Selected for resistance to: ChEBI; CHEBI:8988; SN-38 (7-ethyl-10-hydroxy-camptothecin).
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID HCTK-1
AC CVCL_5763
SY HCTK1
DR BTO; BTO:0004018
RX PubMed=8561821;
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCu 10
AC CVCL_M850
SY Hcu 10; HCU 10; HCu-10
DR BioSample; SAMN03151647
RX PubMed=3167823;
RX PubMed=6571927;
RX PubMed=7408279;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Hcu 10, Hcu 18, Hcu 22, Hcu 27, Hcu 33, Hcu 37 and Hcu 39 have been shown to be identical (PubMed=3167823, PubMed=20143388).
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_M852 ! HCu 18
OI CVCL_M853 ! HCu 22
OI CVCL_M854 ! HCu 27
OI CVCL_M855 ! HCu 33
OI CVCL_M856 ! HCu 37
OI CVCL_M857 ! HCu 39
CA Cancer cell line
//
ID HCu 13
AC CVCL_M851
SY Hcu 13; HCU 13; HCu-13
RX PubMed=3167823;
RX PubMed=6571927;
RX PubMed=7408279;
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HCu 18
AC CVCL_M852
SY Hcu 18; HCU 18; HCu-18
DR BioSample; SAMN03151648
RX PubMed=3167823;
RX PubMed=6571927;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Hcu 10, Hcu 18, Hcu 22, Hcu 27, Hcu 33, Hcu 37 and Hcu 39 have been shown to be identical (PubMed=3167823, PubMed=20143388).
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_M850 ! HCu 10
OI CVCL_M853 ! HCu 22
OI CVCL_M854 ! HCu 27
OI CVCL_M855 ! HCu 33
OI CVCL_M856 ! HCu 37
OI CVCL_M857 ! HCu 39
CA Cancer cell line
//
ID HCu 22
AC CVCL_M853
SY HCu-22
DR BioSample; SAMN03151649
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Hcu 10, Hcu 18, Hcu 22, Hcu 27, Hcu 33, Hcu 37 and Hcu 39 have been shown to be identical (PubMed=20143388).
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_M850 ! HCu 10
OI CVCL_M852 ! HCu 18
OI CVCL_M854 ! HCu 27
OI CVCL_M855 ! HCu 33
OI CVCL_M856 ! HCu 37
OI CVCL_M857 ! HCu 39
CA Cancer cell line
//
ID HCu 27
AC CVCL_M854
SY HCu-27
DR BioSample; SAMN03151650
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Hcu 10, Hcu 18, Hcu 22, Hcu 27, Hcu 33, Hcu 37 and Hcu 39 have been shown to be identical (PubMed=20143388).
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_M850 ! HCu 10
OI CVCL_M852 ! HCu 18
OI CVCL_M853 ! HCu 22
OI CVCL_M855 ! HCu 33
OI CVCL_M856 ! HCu 37
OI CVCL_M857 ! HCu 39
CA Cancer cell line
//
ID HCu 33
AC CVCL_M855
SY Hcu 33; HCu-33
DR BioSample; SAMN03151651
RX PubMed=3167823;
RX PubMed=6571927;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Hcu 10, Hcu 18, Hcu 22, Hcu 27, Hcu 33, Hcu 37 and Hcu 39 have been shown to be identical (PubMed=3167823, PubMed=20143388).
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_M850 ! HCu 10
OI CVCL_M852 ! HCu 18
OI CVCL_M853 ! HCu 22
OI CVCL_M854 ! HCu 27
OI CVCL_M856 ! HCu 37
OI CVCL_M857 ! HCu 39
CA Cancer cell line
//
ID HCu 35
AC CVCL_M859
SY Hcu 35
RX PubMed=6571927;
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HCu 37
AC CVCL_M856
SY Hcu 37; HCu-37
DR BioSample; SAMN03151652
RX PubMed=3167823;
RX PubMed=6571927;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Hcu 10, Hcu 18, Hcu 22, Hcu 27, Hcu 33, Hcu 37 and Hcu 39 have been shown to be identical (PubMed=3167823, PubMed=20143388).
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_M850 ! HCu 10
OI CVCL_M852 ! HCu 18
OI CVCL_M853 ! HCu 22
OI CVCL_M854 ! HCu 27
OI CVCL_M855 ! HCu 33
OI CVCL_M857 ! HCu 39
CA Cancer cell line
//
ID HCu 39
AC CVCL_M857
SY Hcu 39; HCU 39; HCu-39
DR BioSample; SAMN03151653
RX PubMed=3167823;
RX PubMed=6571927;
RX PubMed=7408279;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Hcu 10, Hcu 18, Hcu 22, Hcu 27, Hcu 33, Hcu 37 and Hcu 39 have been shown to be identical (PubMed=3167823, PubMed=20143388).
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_M850 ! HCu 10
OI CVCL_M852 ! HCu 18
OI CVCL_M853 ! HCu 22
OI CVCL_M854 ! HCu 27
OI CVCL_M855 ! HCu 33
OI CVCL_M856 ! HCu 37
CA Cancer cell line
//
ID HCu 57
AC CVCL_M860
SY Hcu 57
RX PubMed=6571927;
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HCV-29
AC CVCL_8228
SY HCV 29; HCV29
DR Cosmic; 925834
DR Cosmic; 1286002
DR Cosmic; 1927313
DR Cosmic; 2212692
RX PubMed=3708594;
RX PubMed=3800330;
RX PubMed=6244232;
RX PubMed=7905254;
RX PubMed=23401075;
ST Source(s): PubMed=11416159
ST Amelogenin: X,Y
ST D18S51: 13,14
ST D21S11: 28,29
ST D8S1179: 13,16
ST FGA: 22
ST TH01: 6,8
ST vWA: 19,21
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HCV-29TMV
AC CVCL_8229
SY HCV-29Tmv
DR BioSample; SAMN03151942
RX PubMed=8105864;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a T24 derivative (PubMed=8105864, PubMed=20143388).
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0554 ! T24
SX Female
CA Cancer cell line
//
ID HD II
AC CVCL_6D71
RX PubMed=3597519;
RX PubMed=6190961;
CC Breed/subspecies: C3H.
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID HD-70
AC CVCL_2921
DR JCRB; JCRB1335
DR JCRB; NIHS0540
RX PubMed=1735070;
CC Doubling time: 28 hours (PubMed=1735070; JCRB).
CC Discontinued: JCRB; NIHS0540; true.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 13
ST D16S539: 12
ST D5S818: 8,12
ST D7S820: 10,12
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 18
DI NCIt; C9357; Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HD-iPS1
AC CVCL_D078
SY HD-IPS1; HD1-iPS1
DR ISCR; 26
RX PubMed=18691744;
CC From: Children's Hospital Boston; Boston; USA.
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8519 ! GM04281
SX Female
CA Induced pluripotent stem cell
//
ID HD-iPS11
AC CVCL_D079
SY HD-IPS11
DR ISCR; 28
RX Patent=US20110151447;
RX PubMed=18691744;
CC From: Children's Hospital Boston; Boston; USA.
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8519 ! GM04281
SX Female
CA Induced pluripotent stem cell
//
ID HD-iPS4
AC CVCL_D080
SY HD-IPS4; HD1-iPS4
DR ISCR; 27
RX Patent=US20110151447;
RX PubMed=18691744;
CC From: Children's Hospital Boston; Boston; USA.
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8519 ! GM04281
SX Female
CA Induced pluripotent stem cell
//
ID HD-iPShet 3F-1
AC CVCL_W315
RX PubMed=22405424;
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Induced pluripotent stem cell
//
ID HD-iPShom 3F-1
AC CVCL_W310
RX PubMed=22405424;
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W311 ! HD-iPShom 3F-2
OI CVCL_W312 ! HD-iPShom 4F-1
OI CVCL_W313 ! HD-iPShom 4F-2
SX Male
CA Induced pluripotent stem cell
//
ID HD-iPShom 3F-2
AC CVCL_W311
RX PubMed=22405424;
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W310 ! HD-iPShom 3F-1
OI CVCL_W312 ! HD-iPShom 4F-1
OI CVCL_W313 ! HD-iPShom 4F-2
SX Male
CA Induced pluripotent stem cell
//
ID HD-iPShom 4F-1
AC CVCL_W312
RX PubMed=22405424;
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W310 ! HD-iPShom 3F-1
OI CVCL_W311 ! HD-iPShom 3F-2
OI CVCL_W313 ! HD-iPShom 4F-2
SX Male
CA Induced pluripotent stem cell
//
ID HD-iPShom 4F-2
AC CVCL_W313
RX PubMed=22405424;
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W310 ! HD-iPShom 3F-1
OI CVCL_W311 ! HD-iPShom 3F-2
OI CVCL_W312 ! HD-iPShom 4F-1
SX Male
CA Induced pluripotent stem cell
//
ID HD-iPShom 4F-3
AC CVCL_W314
RX PubMed=22405424;
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID HD-Mar
AC CVCL_B367
SY HD-MAR
DR ATCC; CRL-2626
DR BioSample; SAMN03471754
RX PubMed=6154663;
CC Doubling time: 24-30 hours (PubMed=6154663).
CC Discontinued: ATCC; CRL-2626; true.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 6,10
ST D13S317: 8,13
ST D16S539: 13
ST D5S818: 11
ST D7S820: 10,12
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C9357; Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HD-Mar-2
AC CVCL_2247
SY HD-MAR-2; HD-MAR2; HD-Mar2
DR CLO; CLO_0050144
DR BioSample; SAMN03473438
DR Cosmic; 933541
DR DSMZ; ACC-685
DR RCB; RCB1981
DR TKG; TKG 0198
CC Doubling time: ~50 hours (DSMZ).
ST Source(s): DSMZ; RCB; TKG
ST Amelogenin: X,Y
ST CSF1PO: 6,10
ST D13S317: 8,13
ST D16S539: 13
ST D5S818: 11
ST D7S820: 10,12
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C9357; Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B367 ! HD-Mar
SX Male
CA Cancer cell line
//
ID HD-MB03
AC CVCL_S506
DR DSMZ; ACC-740
RX PubMed=23054560;
CC Doubling time: 23.32 hours (early passage), 23.98 hours (late passage) (PubMed=23054560); ~48 hours (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 11,12
ST D16S539: 9,11
ST D5S818: 11
ST D7S820: 9,10
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 18,19
DI NCIt; C3222; Medulloblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HD-MY-Z
AC CVCL_1273
SY HD-MyZ; HDMYZ
DR CLO; CLO_0003672
DR EFO; EFO_0002190
DR BioSample; SAMN03473357
DR CCLE; HDMYZ_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR ChEMBL-Cells; CHEMBL3308544
DR ChEMBL-Targets; CHEMBL2366322
DR Cosmic; 907050
DR Cosmic; 1086356
DR Cosmic; 1278833
DR Cosmic-CLP; 907050
DR DSMZ; ACC-346
DR GDSC; 907050
DR GEO; GSM887065
DR GEO; GSM888135
DR GEO; GSM1669871
DR IGRhCellID; HDMYZ
RX DOI=10.1159/000425254;
RX PubMed=8386741;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~35 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 8,11
ST D16S539: 11,14
ST D5S818: 11
ST D7S820: 9,11
ST TH01: 9
ST TPOX: 10,11
ST vWA: 17
DI NCIt; C9357; Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HD00n
AC CVCL_W578
RX PubMed=22748968;
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_7426 ! GM05400
SX Male
CA Induced pluripotent stem cell
//
ID HD109i.1
AC CVCL_W579
RX PubMed=22748968;
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID HD129
AC CVCL_Y595
SY HD129/FE08-005-L1; HD129/D28E13; D28
WW http://www.agence-biomedecine.fr/IMG/pdf/chu_montpellier_hd129.pdf
CC From: University Hospital of Montpellier; Montpellier; France.
CC Registration: French Agence de la Biomedecine; FE08-005-L1.
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID HD168
AC CVCL_9179
DR CLO; CLO_0003669
DR ATCC; HB-252
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID HD180i.5
AC CVCL_W580
DR SKIP; SKIP000317
RX PubMed=22748968;
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_W576 ! GM09197
SX Male
CA Induced pluripotent stem cell
//
ID HD180i.6
AC CVCL_W581
RX PubMed=22748968;
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_W576 ! GM09197
SX Male
CA Induced pluripotent stem cell
//
ID HD180i.7
AC CVCL_W582
RX PubMed=22748968;
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_W576 ! GM09197
SX Male
CA Induced pluripotent stem cell
//
ID HD180n
AC CVCL_W583
RX PubMed=22748968;
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_W576 ! GM09197
SX Male
CA Induced pluripotent stem cell
//
ID HD2-4
AC CVCL_J684
DR CLO; CLO_0003670
DR ATCC; HB-86
CC Monoclonal antibody target: UniProtKB; P02741; Human CRP.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID HD21i.5
AC CVCL_W584
RX PubMed=22748968;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID HD287
AC CVCL_Y596
SY HD287/D73E6; D73
WW http://www.agence-biomedecine.fr/IMG/pdf/chu_montpellier_hd287.pdf
CC From: University Hospital of Montpellier; Montpellier; France.
CC Registration: French Agence de la Biomedecine; FE10-0158-L1.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID HD28i.2
AC CVCL_W585
RX PubMed=22748968;
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_F173 ! GM03814
SX Female
CA Induced pluripotent stem cell
//
ID HD291
AC CVCL_Y597
SY HD291/D74E2; D74
RX PubMed=21714037;
WW http://www.agence-biomedecine.fr/IMG/pdf/chu_montpellier_hd291.pdf
CC From: University Hospital of Montpellier; Montpellier; France.
CC Registration: French Agence de la Biomedecine; FE10-0162-L1.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID HD3
AC CVCL_H252
RX PubMed=2288877;
DI NCIt; C43584; Rectosigmoid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0320 ! HT-29
SX Female
CA Cancer cell line
//
ID HD33i.2
AC CVCL_W586
RX PubMed=22748968;
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_W557 ! GM02183
SX Female
CA Induced pluripotent stem cell
//
ID HD33i.8
AC CVCL_W587
DR SKIP; SKIP000315
RX PubMed=22748968;
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_W557 ! GM02183
SX Female
CA Induced pluripotent stem cell
//
ID HD33n
AC CVCL_W588
RX PubMed=22748968;
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_W557 ! GM02183
SX Female
CA Induced pluripotent stem cell
//
ID HD4
AC CVCL_H253
RX PubMed=2288877;
DI NCIt; C43584; Rectosigmoid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0320 ! HT-29
SX Female
CA Cancer cell line
//
ID HD5
AC CVCL_GS37
RX PubMed=3143916;
OX NCBI_TaxID=10090; ! Mus musculus
CA Embryonic stem cell
//
ID HD6
AC CVCL_H254
RX PubMed=2288877;
CC Characteristics: Clone after treatment with hexamethylene bisacetamide (HMBA).
DI NCIt; C43584; Rectosigmoid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0320 ! HT-29
SX Female
CA Cancer cell line
//
ID HD60i.3
AC CVCL_W589
RX PubMed=22748968;
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_F063 ! GM03621
SX Female
CA Induced pluripotent stem cell
//
ID HD60i.4
AC CVCL_W590
DR SKIP; SKIP000316
RX PubMed=22748968;
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_F063 ! GM03621
SX Female
CA Induced pluripotent stem cell
//
ID HD60n
AC CVCL_W591
RX PubMed=22748968;
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_F063 ! GM03621
SX Female
CA Induced pluripotent stem cell
//
ID HD8
AC CVCL_H255
RX PubMed=2288877;
CC Characteristics: Clone after treatment with hexamethylene bisacetamide (HMBA).
DI NCIt; C43584; Rectosigmoid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0320 ! HT-29
SX Female
CA Cancer cell line
//
ID HD83
AC CVCL_Y598
SY HD83/FE07-135-L1; HD83/D17/FE07-135-L1; HD83/D17E12; D17
RX PubMed=19128516;
RX PubMed=21714037;
WW http://www.agence-biomedecine.fr/IMG/pdf/chu_montpellier_hd83.pdf
CC From: University Hospital of Montpellier; Montpellier; France.
CC Registration: French Agence de la Biomedecine; FE07-135-L1.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID HD90
AC CVCL_C391
SY HD90/FE07-142-L1; HD90/D18/FE07-142-L1; HD90/D18E7; D18; UHOMe001-A
DR hPSCreg; UHOMe001-A
RX DOI=10.1016/S1472-6483(10)62372-3;
RX PubMed=19128516;
WW http://www.agence-biomedecine.fr/IMG/pdf/chu_montpellier_hd90.pdf
CC From: University Hospital of Montpellier; Montpellier; France.
CC Registration: French Agence de la Biomedecine; FE07-142-L1.
DI NCIt; C3105; Von Hippel-Lindau syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID HDC
AC CVCL_K098
DR CLO; CLO_0050940
DR BioSample; SAMN03472211
DR RCB; RCB0679
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 9,12
ST D13S317: 9,12
ST D16S539: 9,11
ST D5S818: 11,13
ST D7S820: 12
ST TH01: 6,7
ST TPOX: 8
ST vWA: 14,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID HDC-101
AC CVCL_A372
SY HDC101
DR Cosmic; 715198
DR Cosmic; 2301981
DR GEO; GSM1346837
RX PubMed=1980607;
RX PubMed=7812507;
RX PubMed=8168998;
RX PubMed=24755471;
DI NCIt; C7421; Rectosigmoid carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HDC-102
AC CVCL_A373
SY HDC102
DR Cosmic; 715199
RX PubMed=1980607;
RX PubMed=7812507;
RX PubMed=8168998;
CC Derived from metastatic site: Lung.
DI NCIt; C7421; Rectosigmoid carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HDC-108
AC CVCL_A374
SY HDC108
DR Cosmic; 715201
RX PubMed=1980607;
DI NCIt; C9383; Rectal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HDC-111
AC CVCL_A375
SY HDC111
DR Cosmic; 715202
RX PubMed=1980607;
RX PubMed=20606684;
DI NCIt; C9383; Rectal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HDC-114
AC CVCL_A376
SY HDC114
DR Cosmic; 715203
DR Cosmic; 1803944
DR GEO; GSM1448184
RX PubMed=1980607;
RX PubMed=7812507;
RX PubMed=8168998;
RX PubMed=25926053;
CC Microsatellite instability: Stable (MSS) (PubMed=25926053).
CC Omics: Transcriptome analysis.
CC Misspelling: 'HDCC114' in Cosmic 1803944.
DI NCIt; C7421; Rectosigmoid carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HDC-117
AC CVCL_A377
SY HDC117
DR Cosmic; 715204
RX PubMed=1980607;
RX PubMed=7812507;
RX PubMed=8168998;
DI NCIt; C7421; Rectosigmoid carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HDC-119
AC CVCL_A378
SY HDC119
DR Cosmic; 715205
RX PubMed=1980607;
DI NCIt; C9383; Rectal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HDC-120
AC CVCL_A379
SY HDC120
DR Cosmic; 715206
RX PubMed=1980607;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HDC-127
AC CVCL_W278
SY HDC127
RX PubMed=1980607;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HDC-133
AC CVCL_A380
SY HDC133
DR Cosmic; 715207
RX PubMed=1980607;
CC Derived from metastatic site: Liver.
DI NCIt; C9383; Rectal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HDC-135
AC CVCL_A381
SY HDC135
DR Cosmic; 715208
DR Cosmic; 1803943
DR GEO; GSM1448069
RX PubMed=1980607;
RX PubMed=20606684;
RX PubMed=25926053;
CC Microsatellite instability: Instable (MSI) (PubMed=25926053).
CC Omics: Transcriptome analysis.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HDC-137
AC CVCL_A382
SY HDC137
DR Cosmic; 715209
RX PubMed=1980607;
DI NCIt; C7421; Rectosigmoid carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HDC-142
AC CVCL_A383
SY HDC142
DR GEO; GSM1448129
RX PubMed=1980607;
RX PubMed=20606684;
RX PubMed=25926053;
CC Microsatellite instability: Stable (MSS) (PubMed=25926053).
CC Omics: Transcriptome analysis.
DI NCIt; C9383; Rectal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HDC-143
AC CVCL_A384
SY HDC143
DR Cosmic; 715210
DR Cosmic; 1805254
DR GEO; GSM1448185
RX PubMed=1980607;
RX PubMed=25926053;
CC Microsatellite instability: Instable (MSI) (PubMed=25926053).
CC Omics: Transcriptome analysis.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HDC-15
AC CVCL_A361
SY HDC15
RX PubMed=1980607;
CC Derived from metastatic site: Liver.
DI NCIt; C9383; Rectal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HDC-150
AC CVCL_W279
SY HDC150
RX PubMed=1980607;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HDC-54
AC CVCL_A362
SY HDC54
DR Cosmic; 715190
DR Cosmic; 2301982
DR GEO; GSM1346838
DR GEO; GSM1448130
RX PubMed=1980607;
RX PubMed=20606684;
RX PubMed=24755471;
RX PubMed=25926053;
CC Microsatellite instability: Stable (MSS) (PubMed=25926053).
CC Omics: Transcriptome analysis.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HDC-57
AC CVCL_A363
SY HDC57
DR Cosmic; 715191
DR Cosmic; 1805255
RX PubMed=1980607;
RX PubMed=7812507;
RX PubMed=8168998;
RX PubMed=20606684;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HDC-63
AC CVCL_A364
SY HDC63
DR Cosmic; 715192
RX PubMed=1980607;
RX PubMed=7812507;
RX PubMed=8168998;
CC Derived from metastatic site: Liver.
DI NCIt; C5543; Cecum adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HDC-73
AC CVCL_A365
SY HDC73
RX PubMed=1980607;
RX PubMed=20606684;
CC Derived from metastatic site: Liver.
DI NCIt; C7421; Rectosigmoid carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HDC-75
AC CVCL_A366
SY HDC75
DR Cosmic; 715193
RX PubMed=1980607;
DI NCIt; C9383; Rectal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HDC-77
AC CVCL_A367
SY HDC77
DR Cosmic; 715194
RX PubMed=1980607;
DI NCIt; C9383; Rectal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HDC-8
AC CVCL_A359
SY HDC8
DR Cosmic; 715188
DR GEO; GSM1448104
RX PubMed=1980607;
RX PubMed=7812507;
RX PubMed=8168998;
RX PubMed=20606684;
RX PubMed=25926053;
CC Microsatellite instability: Stable (MSS) (PubMed=25926053).
CC Omics: Transcriptome analysis.
DI NCIt; C9383; Rectal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HDC-82
AC CVCL_A368
SY HDC82
DR Cosmic; 715195
DR Cosmic; 2301983
DR GEO; GSM1346839
DR GEO; GSM1448128
RX PubMed=1980607;
RX PubMed=20606684;
RX PubMed=24755471;
RX PubMed=25926053;
CC Microsatellite instability: Stable (MSS) (PubMed=25926053).
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Liver.
DI NCIt; C7421; Rectosigmoid carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HDC-87
AC CVCL_A369
SY HDC87
DR Cosmic; 2301984
DR GEO; GSM1346840
RX PubMed=1980607;
RX PubMed=24755471;
DI NCIt; C9383; Rectal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HDC-8NMIIK1
AC CVCL_EI73
SY HDC-8 NMII K1
RX PubMed=7812507;
RX PubMed=8168998;
DI NCIt; C9383; Rectal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_A359 ! HDC-8
SX Male
CA Cancer cell line
//
ID HDC-9
AC CVCL_A360
SY HDC9
DR Cosmic; 1849337
DR GEO; GSM1448070
RX PubMed=1980607;
RX PubMed=7812507;
RX PubMed=8168998;
RX PubMed=20606684;
RX PubMed=22808230;
RX PubMed=25926053;
CC Microsatellite instability: Instable (MSI) (PubMed=25926053).
CC Omics: Transcriptome analysis.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HDC-90
AC CVCL_A370
SY HDC90
DR Cosmic; 715196
DR Cosmic; 2301985
DR GEO; GSM1346841
RX PubMed=1980607;
RX PubMed=24755471;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HDC-97
AC CVCL_A371
SY HDC97
DR Cosmic; 715197
RX PubMed=1980607;
DI NCIt; C7421; Rectosigmoid carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HDC-9NMI
AC CVCL_EI74
SY HDC-9 NMI
RX PubMed=7812507;
RX PubMed=8168998;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_A360 ! HDC-9
SX Male
CA Cancer cell line
//
ID HDF1388
AC CVCL_DP59
SY HDF-1388; aHDF1388
DR GEO; GSM1040299
DR GEO; GSM1040369
DR GEO; GSM1493702
DR PRIDE; PXD000071
DR Wikidata; Q28245330
RX PubMed=21460823;
RX PubMed=23210603;
RX PubMed=24259714;
CC From: Cell Applications, Inc.
CC Omics: Deep proteome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=21460823
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 9,13
ST D16S539: 11,13
ST D18S51: 15
ST D21S11: 29
ST D3S1358: 16,18
ST D5S818: 12
ST D7S820: 9,10
ST D8S1179: 8,10
ST FGA: 20,22
ST Penta D: 9,11
ST Penta E: 7,19
ST TH01: 6
ST TPOX: 8,9
ST vWA: 15,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID HDF1419
AC CVCL_DP65
SY aHDF1419
DR PRIDE; PXD000071
RX PubMed=23210603;
RX PubMed=24259714;
CC From: Cell Applications, Inc.
CC Omics: Deep proteome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID HDF1437
AC CVCL_DP66
SY HDF-1437
DR GEO; GSM1493708
DR GEO; GSM1899756
RX PubMed=21460823;
CC From: Cell Applications, Inc.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID HDF1554
AC CVCL_DP67
RX PubMed=21460823;
CC From: Cell Applications, Inc.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID HDF/TERT1
AC CVCL_9Q55
WW http://www.evercyte.com/hdf-tert1-85.html
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Telomerase immortalized cell line
//
ID HDLM-1
AC CVCL_M693
SY HDLM1
RX PubMed=3713248;
DI NCIt; C9357; Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0009 ! HDLM-2
OI CVCL_M697 ! HDLM-3
SX Male
CA Cancer cell line
//
ID HDLM-1d
AC CVCL_M695
RX PubMed=3359046;
DI NCIt; C9357; Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_M693 ! HDLM-1
SX Male
CA Cancer cell line
//
ID HDLM-2
AC CVCL_0009
SY HD-LM-2; HDLM2
DR CLO; CLO_0003671
DR CLDB; cl1580
DR BioSample; SAMN03473364
DR CCLE; HDLM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR ChEMBL-Cells; CHEMBL3308234
DR ChEMBL-Targets; CHEMBL2366231
DR Cosmic; 924110
DR Cosmic; 988701
DR Cosmic; 1013909
DR Cosmic; 1086355
DR Cosmic; 1278832
DR Cosmic; 1289699
DR Cosmic; 1290220
DR Cosmic; 1432040
DR Cosmic; 2276322
DR Cosmic; 2464309
DR Cosmic-CLP; 924110
DR DSMZ; ACC-17
DR GDSC; 924110
DR GEO; GSM335390
DR GEO; GSM381298
DR GEO; GSM499724
DR GEO; GSM499732
DR GEO; GSM552430
DR GEO; GSM887064
DR GEO; GSM888134
DR GEO; GSM1669870
DR IGRhCellID; HDLM2
DR Lonza; 471
DR PRIDE; PXD000589
RX PubMed=2602652;
RX PubMed=2690233;
RX PubMed=3713248;
RX PubMed=9685479;
RX PubMed=12581897;
RX PubMed=22460905;
RX PubMed=25894527;
RX PubMed=27397505;
WW http://www.proteinatlas.org/learn/cellines
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~70-75 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Cell surface proteome.
CC Omics: Deep antibody staining analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11,12
ST D16S539: 12
ST D5S818: 11
ST D7S820: 8,10
ST TH01: 6,7
ST TPOX: 8
ST vWA: 19
DI NCIt; C9357; Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_M693 ! HDLM-1
OI CVCL_M697 ! HDLM-3
SX Male
CA Cancer cell line
//
ID HDLM-2d
AC CVCL_M696
RX PubMed=3359046;
DI NCIt; C9357; Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0009 ! HDLM-2
SX Male
CA Cancer cell line
//
ID HDLM-3
AC CVCL_M697
SY HDLM3
RX PubMed=3713248;
DI NCIt; C9357; Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_M693 ! HDLM-1
OI CVCL_0009 ! HDLM-2
SX Male
CA Cancer cell line
//
ID HDm-15
AC CVCL_1Q26
RX PubMed=8314568;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0601 ! 3T6-Swiss albino
CA Hybrid cell line
//
ID HDm-18
AC CVCL_1Q27
RX PubMed=8314568;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0601 ! 3T6-Swiss albino
CA Hybrid cell line
//
ID HDm-20
AC CVCL_1Q28
RX PubMed=8314568;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0601 ! 3T6-Swiss albino
CA Hybrid cell line
//
ID HDm-4
AC CVCL_1Q29
SY GM10478
DR CLO; CLO_0028484
DR Coriell; GM10478
RX PubMed=2823107;
RX PubMed=8314568;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0601 ! 3T6-Swiss albino
CA Hybrid cell line
//
ID HDm-5
AC CVCL_1Q30
SY GM10479
DR CLO; CLO_0028480
DR Coriell; GM10479
RX PubMed=2276735;
RX PubMed=2823107;
RX PubMed=8314568;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0601 ! 3T6-Swiss albino
CA Hybrid cell line
//
ID HDm-9
AC CVCL_1Q31
RX PubMed=8314568;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0601 ! 3T6-Swiss albino
CA Hybrid cell line
//
ID HDN-16
AC CVCL_D019
SY HD-N-16
DR Cosmic; 1167990
RX PubMed=2601700;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HDN-3
AC CVCL_D020
RX PubMed=2601700;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HDQ-P1
AC CVCL_2067
SY HDQP1
DR BioSample; SAMN03471695
DR CCLE; HDQP1_BREAST
DR Cosmic; 1995439
DR Cosmic; 2164995
DR Cosmic-CLP; 1290922
DR DSMZ; ACC-494
DR GDSC; 1290922
DR GEO; GSM827279
DR GEO; GSM887066
DR GEO; GSM888136
DR GEO; GSM1669872
DR Lonza; 1216
RX PubMed=10913678;
RX PubMed=22460905;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~72 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 12
ST D16S539: 11
ST D18S51: 13
ST D21S11: 29
ST D3S1358: 15
ST D5S818: 11
ST D7S820: 11,12
ST D8S1179: 15
ST FGA: 22
ST Penta D: 11
ST Penta E: 11,13
ST TH01: 9.3
ST TPOX: 8
ST vWA: 16,18
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HDS
AC CVCL_W592
RX PubMed=27463353;
WW https://www.sbir.gov/sbirsearch/detail/88095
CC Doubling time: ~24 hours (PubMed=27463353).
DI NCIt; C7402; Hairy cell leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID He Geg
AC CVCL_U777
SY Culture 346
DR ATCC; CRL-1174
RX PubMed=4582519;
CC Discontinued: ATCC; CRL-1174; true.
DI NCIt; C34807; Marfan syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
您正在向 biovector.net 发送关于产品 细胞株Cell Lines 27-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心 的询问
- 公告/新闻
免费订购电话: 400-800-2947